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InTroducTIon
Stroke unit care 
Acute stroke ranks second after ischemic heart disease as a cause of lost disability-adjusted 
life-years in high-income countries and as a cause of death worldwide. In Western societies, 
about 80% of strokes are caused by focal cerebral ischemia due to sudden arterial occlusion.1 
Intravenous administration of recombinant tissue plasminogen activator within 4.5 hrs 
after the onset of stroke increases the probability of a favorable outcome.2 After this initial 
recanalization therapy, patients are frequently admitted to a ward during their initial illness 
where they can receive care (called post-acute care) in a variety of ways and in a range of 
settings. 
Traditionally, the care of stroke patients was provided within departments of general 
(internal) medicine, neurology or geriatrics where they would be managed alongside a range 
of other patient groups. Organised inpatient care is a term used to describe the focusing of 
care for stroke patients in hospital under a multidisciplinary team who specialise in stroke 
management.3 An updated Cochrane systematic review in 2007 concluded that acute stroke 
patients are more likely to survive, return home and regain independence if they receive 
organised stroke unit care. This is typically provided by a coordinated multidisciplinary team 
operating within a ‘discrete stroke unit’, which can offer close physiological monitoring and 
a substantial period of rehabilitation if required.4 
A major focus for stroke unit care is to prevent and limit ongoing brain damage and 
to provide the best conditions for natural brain recovery. Optimal oxygenation, perfusion, 
nutrition, glycemic control, and temperature homeostasis are indicated, as in generally ill 
patients. In addition, specific protocols (mostly based on observational studies) exist for the 
acute stroke period.5 For acute ischemic stroke, treatment is focused on ‘penumbral salvage’. 
Initially after arterial occlusion, a central core of very low perfusion is surrounded by an area 
of dysfunction caused by metabolic and ionic disturbances but in which structural integrity 
is preserved (called the ischemic penumbra). In the first minutes to hours, therefore, clinical 
deficits do not necessarily reflect irreversible damage. Depending on the rate of residual 
cerebral blood flow (CBF) and the duration of ischemia, the penumbra will eventually be 
incorporated into the infarcted region if reperfusion is not achieved.6 The cerebral circulation 
has developed several specialised features to cope with the high metabolic demands of 
the (recovering) brain and the devastating consequences of cerebral ischemia (cerebral 
autoregulation). It is suggested that specialized stroke unit care with close monitoring of 
hemodynamic parameters (ideally including CBF) may be important in penumbral salvage.7-9
Which determinants of stroke unit care are important, is largely unknown but close 
observation for a critical period is suggested as one of the determinants. Failure of 
homeostatic mechanisms and susceptibility to complications (e.g., venous thrombosis and 
infections) during the acute phase of stroke are common. Supportive care on the stroke unit 
is therefore crucial. However, evidence supporting interventions at the stroke unit aiming 
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1to “correct” deranged physiology is lacking; even simple measures such as supplementary 
hydration and oxygen therapy are of unproven benefit. The role of blood pressure (BP) 
control in the immediate phase after stroke is unclear.5, 10
Traumatic brain injury care 
Traumatic brain injury (TBI) constitutes a major health and socio-economic problem 
throughout the world. It is the leading cause of mortality and disability among young 
individuals in high-income countries.11 Approximately, 10 to 15% of patients with TBI have 
serious injuries and are unconscious, requiring specialist care with mechanical ventilation 
and intensive monitoring. Severe TBI is a heterogeneous disorder with different forms of 
presentation. The nature, intensity, direction and duration of the external forces determine 
the pattern and extent of damage (primary damage). Ischemic damage is often superimposed 
on the primary damage and can be widespread or more perilesional (secondary damage). 
Over the past 10 years, much of the treatment of TBI has evolved towards standardized 
approaches, mostly focused on severe head injury.11 Approaches to TBI management focus 
mainly on prehospital emergency care, admission care and intensive care management. It 
is recognized that no single treatment can be uniformly appropriate across the wide range 
of conditions within TBI, and this vision would support the search for more individualized 
treatment options. 
Severe TBI patients with depressed level of consciousness and structural damage 
on brain CT are treated with sedation and mechanical ventilation. Clinical monitoring is 
therefore difficult. Special monitoring and treatment (non-surgical, surgical or combination) 
protocols for these patients have been developed over time. Treatment is focused on 
avoiding hypotension, decreasing cerebral metabolism and reducing brain swelling and 
raised intracranial pressure (ICP). Different concepts (like ‘Lund’ or ‘optimal perfusion’) have 
been launched over the years and all claim improved outcomes. Despite their differences, 
all these concepts have some important fundamental similarities.12 They all emphasize to 
improve and optimize the CBF and microcirculation and aim especially at the conditions for 
a tissue enclosed within rigid walls. Cerebral autoregulation plays an important protective 
role against the danger of hypoxia at low perfusion pressure, and the risk of brain edema at 
higher arterial pressure. 11, 13
Cerebral vasoregulation 
The brain is capable of adapting cerebral vascular resistance in order to compensate or reduce 
the effects of BP on CBF. This effect is known as cerebral vasoregulation or autoregulation.14 
Consequently, it’s incorrect to assume that changes in CBF always parallel changes in BP. In 
the past, easily performed measurements of BP were used as surrogate markers of changes 
in CBF, because the (mostly radio-active isotope based) techniques to evaluate cerebral 
vasoregulation available at that time were not easily applicable clinically.8 This has changed 
with the development of techniques like non-invasive bedside transcranial Doppler (TCD) and 
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near-infrared spectroscopy (NIRS) in the eighties and the evolution of complex intracranial 
signal analysis, like ICP and brain tissue oxygen tension (PbtO2).15 There is growing evidence 
that information from cerebral vasoregulation is crucial for correct interpretation of the 
impact of several interventions or events on the stroke or intensive care unit. Some simple 
or unnoticed events might be potentially dangerous for vulnerable brain tissue. Examples 
are early patient upright positioning and early mobilization on the stroke unit, nocturnal 
peripheral cerebral desaturations in stroke patients with obstructive sleep apnea (OSA) and 
estimating individual and flexible (optimal) BP targets during critical periods on the stroke 
or intensive care unit. 
Early upright positioning and mobilization 
Different guidelines recommend by consensus that patients should sit in and out of their bed 
and become mobile as soon as their clinical condition permits. Intuitively, early mobilisation 
may reduce immobility associated complications of stroke (muscle wasting, thrombosis, 
pressure sores, pneumonia) but there is limited evidence to support the practice.5, 10 The Very 
Early Rehabilitation Trials (AVERT) are currently assessing the value of early mobilisation in a 
multicentre randomised controlled trial but funding problems oppose short term answers.16 
A recent study showed that 60% of surveyed stroke specialists had concerns about early 
stroke mobilisation.17 These concerns regard cerebral hypoperfusion in the context of 
orthostatic hypotension and/or impaired cerebral vasoregulation/ autoregulation. 
In this thesis we aimed to study aspects of the complex interplay between BP, cerebral 
perfusion, body position and cerebral vasoregulatory/autoregulatory status in the (sub) 
acute phase of stroke and TBI. Our aims originated from practical (clinical) questions with 
the objective to improve study methods, therapies and patient outcome. 
aIms
This thesis addresses three primary questions:
1.  How does arterial BP react to postural changes (decubitus, supine, sitting and standing 
position) in acute stroke and critically ill patients. Is there a correlation between postural 
BP responses and outcome after stroke.
2.  What are the effects of in-bed-mobilization on estimates of cerebral perfusion and 
neurological status in the acute phase after stroke. 
3. How can the bedside monitoring of estimates of cerebral autoregulation or vasoregulation 
be improved in stroke and traumatic brain injury patients.
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ouTlIne of The ThesIs
These general aims have been translated in a series of experiments, retrospective analyses 
and background studies which are presented in the subsequent chapters of this thesis. 
Chapter 2 provides a further clinical background for the evaluation of cerebral hemodynamics 
in patients with stroke, subarachnoid hemorrhage (SAH) and TBI. We describe the application 
of different techniques and methods to measure CBF, cerebral blood flow velocity (CBFV), 
ICP and NIRS. The (historical) concept of cerebral vasoregulation/autoregulation is explained 
and the currently available methods to test and quantify cerebral vasoregulation or 
autoregulation in clinical practice are described.
Chapter 3 provides background information about clinical studies using the application 
of TCD to measure CBFV in ischemic stroke patients in the (sub) acute phase. This review 
addresses the question whether vasoregulation or autoregulation is impaired and to identify 
the effects of the disease on cerebral perfusion. 
Chapter 4 introduces the passive cyclic leg raising as a new maneuver to induce large 
flctuations in BP and CBFV, aimed at improving variability and reproducibility of dynamic 
cerebral autoregulation estimates. Specifically, we tested a bedside method that doesn’t 
require patient cooperation. This study was done in healthy volunteers. 
Chapter 5 introduces BP as one of the major vital parameters monitored in the stroke unit. 
The accuracy of indirect BP measurement is strongly influenced by the position of both the 
patient and the BP cuff during the measurement. Acute stroke patients are often nursed 
in lateral decubitus positions. The effect of these alternating body positions in relation to 
affected body side on the outcome and reliability of indirect (oscillometric) BP readings in 
acute stroke patients is studied.
Chapter 6 describes whether the results, presented in chapter 5, could be replicated in 
critically ill patients on the intensive care with continuous invasive BP monitoring. 
Chapter 7 continues research into postural BP measurements in acute stroke patients. In this 
chapter the effects of early upright positioning and mobilisation (supine, sitting and active 
standing) in the (sub) acute phase of ischemic stroke on both BP and functional outcome 
were examined.
Chapter 8 describes the application of continuous non-invasive BP, TCD and NIRS recordings 
during in-bed-mobilisation of acute stroke patients. These hemodynamic changes are related 
to neurological status, functional outcome and autoregulatory capacity to investigate the 
safety of early mobilisation. 
Chapter 9 describes whether bilateral frontal NIRS can be used for nocturnal monitoring 
of cerebral oxygenation in acute stroke patients. Changes are related to co-registered non-
invasive continuous BP and peripheral oxygen saturation measurements.   
Chapter 10 introduces the development of accurate methods for assessment of the 
relationship between cerebral perfusion pressure (CPP) and cerebral vasoregulation/ 
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autoregulation in severe TBI patients. In this chapter we investigated the relationship 
between slow fluctuations of BP and ICP pulse amplitude (a new index called PAx) using 
a moving correlation technique to reflect the global state of cerebral vasoreactivity and 
compared it to the well known index of pressure reactivity (PRx) as a moving correlation 
coefficient between averaged values of BP and ICP. Global cerebral vasoreactivity status was 
related to patient outcome. 
Chapter 11 describes the development of an automated methodology for the continuous 
updating of ‘optimal CPP’ for patients after severe TBI injury, using continuous monitoring 
of cerebrovascular pressure reactivity (methods described in chapter 10). We validate the 
‘optimal CPP’ algorithm by determining the association between outcome and the deviation 
of actual CPP from calculated ‘optimal CPP’.
Chapter 12 provides a summary and discussion of the findings in this thesis. 
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chapTer 2
cerebral vasoregulaTIon: clInIcal perspecTIves?
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absTracT
• Cerebral perfusion deficits after brain damage, caused by a cerebrovascular accident 
(CVA), subarachnoid hemorrhage (SAH) or severe traumatic brain injury (TBI), may be 
detected earlier and may be better understood with neuromonitoring techniques.
• Due to their unique properties, cerebral arterioles keep cerebral perfusion more or less 
constant. This process is called cerebral vasoregulation or autoregulation and can be 
measured with different techniques, which will be discussed in this article.
• In current clinical guidelines on treatment of stroke, SAH and TBI, impaired cerebral 
vasoregulation is often assumed. However, there is a need to measure cerebral 
vasoregulation status at the individual level, with follow-up over time.
• Some neuromonitoring techniques inform the clinician about subtle local regulation 
disorders (‘snapshot’ assessment). Other techniques are suitable for the global long-
term monitoring of vasoregulation (continuous ‘monitoring’ measurement) with results 
serving as feedback for treatment interventions and prognostification.
• Appropriate use in clinical practice requires standardization of the methods available for 
monitoring of cerebral vasoregulation.
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InTroducTIon
 
Advanced neuromonitoring techniques enable us to detect, study and understand altered 
cerebral blood flow (CBF) after initial damage after a stroke, subarachnoid hemorrhage (SAH) 
or severe traumatic brain injury (TBI).1,2 Perfusion disorders directly disrupt the supply of 
oxygen and glucose to the highly demanding brain. In addition, impaired washout of emboli, 
break through edema and hemorrhage are associated.3 The cerebral arterioles possess 
unique properties to optimally regulate cerebral perfusion, a process referred to as cerebral 
vasoregulation. Several local and systemic factors are involved in cerebral vasoregulation 
such as arterial CO2 tension, sympathetic nervous system activity, metabolic demand, 
respiration, and cerebral venous drainage. However the adaption of the arterioles to blood 
pressure (BP) changes has been studied most frequently (cerebral autoregulation).1,4 Under 
the influence of, for example, (chronic) hypertension, sudden vessel occlusion, vasospasms 
or cerebral swelling, the failure of cerebral vasoregulation causes perfusion deficits with 
significant neuronal dysfunction and ultimately cell death. With early recognition and 
treatment of these perfusion disorders, the neurological outcome of patients may improve.
Cerebral vasoregulation can be studied in many different ways. Often the response of 
the cerebral perfusion on slow BP changes is studied (cerebral autoregulation). Another 
technique is to (artificially) increase the arterial CO2 tension to assess what is called cerebral 
vasoreactivity.
In healthy individuals, spontaneous, slow changes in BP are present. With functional 
cerebral vasoregulation, cerebral perfusion remains constant despite these slow systemic 
BP fluctuations. Also sudden BP changes or volume shifts (within certain limits), for example 
after orthostatic challenges, do not affect cerebral perfusion significantly in healthy 
individuals. It is suggested that cerebral arterioles compensate for these BP reductions by 
active vasodilatation. BP increase is anticipated by vasoconstriction.4 It is generally accepted 
that cerebral vasoregulation works well in the wide range of mean BP values between 40 
and 150 mmHg. In patients with chronic hypertension these limits are likely shifted to higher 
values.5 With impaired vasoregulation due to a cerebrovascular event or brain swelling, 
cerebral perfusion is directly dependent on systemic BP values.6,7 In this situation even small 
BP changes may have serious consequences (neuronal dysfunction and cell death) caused 
by (prolonged and unnoticed) periods of hypoperfusion or hyperperfusion.1 Local factors, 
such as increased intracranial pressure (ICP), vasospasm or ischemia, may directly affect 
the perfusion in areas at risk. The (global) pressure within the skull can be measured by 
inserting an ICP probe or (external) ventricular drain. The cerebral perfusion pressure (CPP) is 
calculated as the BP minus the ICP. With ICP monitoring, intracranial space occupying lesions 
are more easily detected in sedated patients, but also effects of (aggressive) therapy can be 
examined.8
In current clinical guidelines, impaired cerebral vasoregulation is often assumed to be 
present in stroke, SAH and TBI patients. Consistent with this assumption, protocols advocate 
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strict limits for BP, ICP and ventilation (CO2) to optimize cerebral perfusion and oxygenation. 
For example, based on retrospective studies, protocols advice to keep CPP between 50-70 
mmHg for TBI patients during their intensive care unit (ICU) stay.9 Targeted adjustment 
of BP, ICP or intracranial volume (through evacuation of hematoma, cerebral spinal fluid 
(CSF) drainage or decompressive craniectomy) may improve cerebral perfusion. Research 
in this area is ongoing. Recent examples are the discontinuation of antihypertensive drugs 
in the acute phase after stroke, review of triple-H therapy with SAH, and the effects of 
decompressive craniectomy on TBI outcome.10-12 Measuring and taking into account the 
individual cerebral vasoregulation may form the missing link between the limited impact of 
these interventions on neurological outcome at the group level.13,14 In this paper, we discuss 
current ways to measure cerebral vasoregulation and its clinical applicability.
Cerebral vasoregulation and cerebral perfusion: static research 
Before the introduction of the transcranial Doppler (TCD) ultrasound technique, the cerebral 
perfusion was measured by calculating the washout of nitrous oxide (N2O) or the decay 
of radioactive isotopes.1,2,15 With these invasive methods absolute values  for the regional 
cerebral perfusion are obtained, related to the actual BP level (with a reasonable spatial 
resolution). By repeating the measurement (which takes a few minutes) on another BP 
level, information is obtained about the adaptation of arterioles to large BP increase or 
decrease. This steady state adjustment mechanism is called ‘static vasoregulation or 
autoregulation’ and classically displayed as the cerebral perfusion at different BP levels 
(‘Lassen autoregulation curve’). Such relative perfusion changes can often be interpreted 
more reliably inter-individually than the absolute perfusion values.16
The Lassen autoregulation curve has a plateau with an upper and a lower limit where 
the cerebral perfusion follows the BP passively (Figure 1a).15,17,18 The discussion about its 
exact shape and which factors (except BP)  influence the configuration of the curve, is still 
ongoing.19 Complete curves are only obtained in groups of individuals, offer limited follow-up 
over time (temporal resolution of minutes), require potentially dangerous BP interventions 
(with adrenaline, nitroprusside infusions) and generate information mainly about the 
extremes (the limits) of the vasoregulation. Nowadays, the static vasoregulation curve is 
often only  reproduced on two BP levels (Figure 1b).14,20
Using the positron emission tomography (PET) technique with radio-active oxygen 
before and after strong arteriolar vasodilatation (with the drug acetozolamide) is an 
attractive alternative method to perform static measurements. An important advantage of 
this technique is that not only is the cerebral blood volume (C15O gas) and perfusion (H2
15O) 
measured, but also is information on the local oxygen consumption (15O2 gas) obtained. 
Therefore, a statement about impaired vasoregulation in brain regions, which shows 
increased oxygen consumption besides reduced perfusion and volume after vasodilatation, 
is more convincing.16
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Within the limits of an intact ‘static’ vasoregulation/autoregulation (50-150 mmHg) changes 
in the average blood pressure (BP), have no or only minor influence on the cerebral perfusion. 
This curve - with a plateau between 50-150 mmHg - is cited in the literature as the ‘Lassen 
autoregulation curve’.15 Within this plateau the cerebral arterioles guarantee constant cerebral 
perfusion by vasoconstriction and vasodilatation. Outside the limits of vasoregulation, perfusion 
is unpredictable and follows BP changes passively (Figure 1a). With impaired vasoregulation, 
the cerebral perfusion (or surrogates like cerebral blood flow velocity) increases bilaterally 
with induced hypertension after infusion of adrenaline (Figure 1b, lower image).20 ACM PS L + R 
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Cerebral vasoregulation and cerebral perfusion: dynamic research 
TCD measurements (in which the flow velocity in the large intracranial arteries is measured) 
in combination with continuous BP measurements allow analysis of both the effectiveness 
and the speed of the cerebral vasoregulation bedside and over a prolonged period. This is 
called the ‘dynamic cerebral vasoregulation or autoregulation’. In one of the first studies 
decreases in BP were induced by sudden deflation of bilateral tight cuffs. The BP drop of 
a few seconds made  it possible to quantify the cerebral flow rate recovery in the middle 
cerebral artery (as a surrogate for global hemispheric perfusion) and compare it to a static 
vasoregulation method.20,21 The dynamic vascular response is probably complete after 10-
15 seconds, indicating that arterioles are able to counter slower BP fluctuations.22 Faster 
BP fluctuations - as with every heart beat - are not compensated (also known as the high 
pass filter principle of cerebral vasoregulation).18 The discussion whether dynamic and static 
vasoregulation are established by different mechanisms, or that they are both manifestations 
of the same physiological control system, is ongoing.17,18,20
In the literature, in addition to the cerebral perfusion also other intracranial signals 
are used for studying the dynamic vasoregulatory status. Examples are the near-infrared 
spectroscopy (NIRS) signal, which represents (mostly) the superficial intracranial venous 
system, local brain tissue oxygenation (PbtO2) and the ICP signal derived from a monitoring 
or CSF draining system.23-25 The latter is often available in severe SAH and TBI patients.17 
The basic principle of these dynamic measurements remains the same: a sudden (large) 
transient BP or volume change as the input signal and the resulting change in the intracranial 
compartment as output signal.17
Techniques for measuring and analyzing static and dynamic vasoregulation 
Table 1 shows the different techniques that are currently available or in development for 
displaying the cerebral vasoregulation. Clear differences are present regarding the spatial 
and temporal resolution, radiation exposure, usability in different patient categories, overall 
availability, cost and robustness, as well as interpretation of the obtained signals.2,7 Overall 
it seems possible to classify the techniques into ones that are useful for intensive long-term 
monitoring (‘monitoring assessment’) and others that allow a single, short but thorough 
evaluation (‘snapshot assessment’). For the nuclear (PET) and radiological (CT and MRI) 
techniques, the temporal resolution is still too low for dynamic measurements. Developments 
in this area are in progress. Simultaneous recording of continuous (noninvasive) BP are still 
missing.26
In the past, several models have been developed to quantify vasoregulation. For 
detailed information we refer to recent review articles.17,18,22,27 For both static and dynamic 
vasoregulation, these models are mainly linear with BP as ‘input’ and cerebral perfusion (or 
other intracranial signals) as ‘output’. The input signal is often a well-controlled hemodynamic 
stimulus (for ‘snapshot assessment’) or spontaneous slow BP fluctuations (for long-term 
‘monitoring assessment’). In Figure 2, some examples of the different analysis techniques 
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are displayed. Studies comparing different vasoregulation methods show moderate to 
good agreement.28,29 Reproducibility of most dynamic methods, quantified by intraclass 
correlation coefficients (ICCs), is disappointing and more work is needed to understand the 
determinants of variability and reproducibility in vasoregulatory parameters.30,31
This figure illustrates some common ‘dynamic’ autoregulation models currently available in stroke, 
subarachnoidal hemorrhage (SAH) and traumatic brain injury (TBI). The autoregulation index (ARI) 
is calculated by measuring the perfusion change induced after a sudden BP or volume change or (as in 
this example) with spontaneous BP fluctuations (Figure 2Aa). The response curve is compared with ten 
hypothetical curves, constructed from a mathematical model where different elements involved in the 
cerebral vasoregulatie are simulated (Figure 2Ab).18, 20 A value of 0 represents absence of autoregulation 
and 9 the fastest and most effective autoregulation response. In this example, the patient has an ARI of 
3 (suggesting impaired vasoregulation). CBFV indicates cerebral blood flow velocity; ABP, arterial blood 
pressure; ICP, intracranial pressure.
With the PRx method the correlation coefficient between spontaneous slow mean BP fluctuations and 
the mean ICP is calculated and averaged over a longer period. A positive correlation indicates that slow BP 
fluctuations are followed by cerebral blood volume and subsequent ICP changes in the same direction. This 
is suggestive of a ‘passive’ vascular bed and impaired cerebral vasoregulation (scatterplots, figure 2b).17 
With transfer function analysis different frequencies in the BP (continuous waveform with amplitude 
‘A’) and perfusion (interrupted waveform with amplitude ‘B’) signals are decomposed with mathematical 
functions. Provided there is sufficient coherence between the input (BP) and output (cerebral perfusion) 
signals, the ability of arterioles to filter (spontaneous or induced) slow BP frequencies (< 0.25 Hz) can be 
measured. With this method, the vasoregulation can be expressed in terms of ‘gain’ (damping effect ‘W1-
W2’), and ‘phase’ (speed of vasoregulation ‘W1-W2’) (Figure 2c).18,22,27
Figure 2
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Cerebral (CO2) vasoreactiviteit versus cerebral autoregulation 
Besides BP, arterial CO2 tension has a major impact on the cerebral arterioles and therefore 
perfusion. Hypercapnia causes vasodilatation with increased perfusion, hypocapnia causes 
vasoconstriction with decreased perfusion.4 This (slow) metabolic vasoregulation - also called 
the cerebral vasoreactivity – can be simply tested by breathing instructions or inhalation of a 
5-8% CO2 gas mixture. However there is no consensus how the exact protocol should be and 
how to improve the (especially long term) reproducibility.32 CO2 changes are also accompanied 
by systemic BP changes of approximately 10%.33 Instead of CO2, the drug acetozolamide can 
also be used as a potent vasodilator. The degree of vasodilatation after inhalation of the CO2 
mixture or acetozolamide infusion has a clear clinical prognostic value, possibly apart from 
an impairment in the cerebral autoregulation. A diminished CO2 vasoreactivity is associated 
with an increased risk of (delayed) ischemia in patients with severe carotid stenosis or SAH 
with vasospasm.34,35 Several studies show an impaired autoregulation with hypercapnia and 
conversely, an improvement with hypocapnie.36 Therefore, concomitant CO2 registration 
should not be omitted in vasoregulation studies.
Cerebral vasoregulation in routine clinical practice 
Intact cerebral vasoregulation protects the brain against acute or chronic perfusion disorders. 
Some of the above mentioned techniques are suitable for the clinician to detect subtle 
(asymptomatic) local regulatory disorders (‘snapshot assessment’) (Table 1). Abnormalities 
are possible additional (early) risk factors for endothelial or arteriolar dysfunction and 
cardiovascular disease, in accordance with impaired CO2 vasoreactivity in patients with 
significant carotid stenosis.35 Other techniques are more suitable to follow-up vasoregulation 
over time, e.g. to perform continuous monitoring in patients admitted to the ICU or stroke 
unit where information besides having prognostic value also can serve as feedback for 
treatment interventions (improving arteriolar function or not).37 Figure 3 shows that it is 
possible to retrieve an ‘optimal CPP’ level at population level (severe TBI patients) using a 
long-term monitoring method (PRx) using the signals BP and ICP. It is suggested that around 
this ‘optimal’ CPP value the cerebral arterioles are capable of keeping CBF constant with the 
largest reserve (Figure 3a). Also in the individual TBI patient, this value can be calculated 
continuously and might thus be of great support for ICU management decisions (figure 3b). 
A retrospective TBI study showed that on average deviation from this calculated ‘optimal 
CPP’ target value was associated with poor outcome.37
For both the ‘snapshot’ and ‘monitoring’ vasoregulation methods clear protocols and 
normal values are lacking at the moment. Promising retrospective studies have already 
demonstrated a clear independent relationship between impaired vasoregulation and poor 
outcome or complications after TBI and SAH.38,39,40
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Requirements for use of cerebral vasoregulation in clinical practice 
To implement vasoregulation measurements in neurological practice within a reasonable 
time period, a number of requirements have to be fulfilled. Firstly, in a research context 
the most practical techniques and methods have to be selected with easy to interpret 
intracranial signals, focused per clinical question (roughly ‘snapshot’ or ‘monitoring’). 
Secondly, normal values for vasoregulation in various disease states have to determined, 
In this figure the cerebrovascular pressure index PRx – representing the correlation coefficient 
between mean BP and mean ICP - is plotted against the CPP for a large cohort of severe traumatic 
brain injury (TBI) patients with continuous long term ICP monitoring (n = 327). From this graph 
an optimal target CPP value for  the whole TBI group can be estimated (retrospectively), e.g. the 
CPP value where vasoregulation is thought to work ‘optimal’ (represented by the lowest PRx value) 
(Figure 3a). Also for the individual patient (at present from retrospective data) such a vasoregulation 
curve can be generated (and updated) from a sequential monitoring session of 4 hours (Figure 3b). 
This information can assist the clinician in determining individual treatment goals, suited to 
the disease condition at that time.37, 43 ICP indicates intracranial pressure; CPP, cerebral perfusion 
pressure; PRx, pressure reactivity index; BP, blood pressure. 
Figure 3a
Figure 3b
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taking into account patient factors (such as age, sex and vascular risk factors) and 
acceptable reproducibility. Thirdly, combinations of intracranial signals (e.g. TCD and NIRS or 
ICP and PbtO2) have to be tested taking into account changes in cerebral metabolism, brain 
function (electroencephalography) or (vascular) anatomy.41 Fourthly, repeated, potentially 
dangerous (input) challenges such as hypotension or hypercapnia risking ischemia and 
increased ICP should be avoided. This implies the development of dynamic vasoregulation 
methods, preferably with simple interventions (breathing instructions, or repetitive postural 
changes) or use of spontaneous slow BP fluctuations.27 However, breathing instructions are 
not possible in aphasic or comatose patients, there are concerns regarding high ‘between-
subject’ variability and spontaneous BP fluctuations >10 mmHg are not always present.42 
Finally, the exact influences of various physiological parameters and (surgical and non-
surgical interventions) on the cerebral vasoregulation have to be investigated (for example, 
influence of CO2 tension or barbiturate coma).
conclusIon 
Early recognition and treatment of vasoregulation disorders seems crucial in efforts to 
improve the neurological outcome of patients with acute or chronic vessel occlusions, 
sudden hemorrhages, contusions, brain swelling or increased ICP. In this overview we 
describe the different vasoregulation evaluation options presently available. Standardization 
and selection of methods will facilitate the implementation of vasoregulation methods in 
clinical practice. In the near future, patient at risk for (subtle) perfusion disorders can be 
identified, who would benefit directly from application of vasoregulation-oriented therapies.
2
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absTracT
Background and Purpose 
Cerebral autoregulation may become impaired after stroke. To provide a review of the 
nature and extent of any autoregulation impairment after stroke and its course over time, 
a technique allowing repeated bedside measurements with good temporal resolution 
is required. Transcranial Doppler (TCD) in combination with continuous blood pressure 
measurements allows noninvasive continuous bedside investigation with high temporal 
resolution of both the dynamic and the steady-state components of cerebral autoregulation. 
Therefore, this review focuses on all TCD studies on cerebral autoregulation in the setting of 
documented ischemic stroke.
Methods 
PubMed and EMBASE were searched for studies of stroke, autoregulation and TCD. Studies 
were either acute phase (<96 hours after index stroke) or chronic phase (>96 hrs after index 
stroke) autoregulation studies. Quality of studies was studied in a standardised fashion.
Results 
Twenty-three studies met the inclusion criteria. General agreement existed on cerebral auto-
regulation being impaired, even after minor stroke. Bilateral impairment of autoregulation 
was documented, particularly after lacunar stroke. Studies showed progressive deterioration 
of cerebral autoregulation in the first five days after stroke and recovery over the next three 
months. Impaired cerebral autoregulation as assessed by TCD was related to neurological 
deterioration, the necessity for decompressive surgery and poor outcome. Synthesis of the 
data of various studies was, however, limited by studies not meeting key methodological 
criteria for observational studies.  
Conclusions 
TCD in combination with continuous blood pressure measurement offers a method with 
a high temporal resolution feasible for bedside evaluation of cerebral autoregulation in 
the stroke unit. TCD studies have shown impairment of cerebral autoregulation in various 
subtypes of ischemic stroke. To improve the synthesis of data from various research 
groups there is urgent need for standardization of methodology of TCD studies in cerebral 
autoregulation. 
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InTroducTIon 
It is generally accepted that cerebral autoregulation may become impaired after stroke.1 
Autoregulation impairment in the presence of moderate to severe ischemia may render 
penumbral tissue particularly vulnerable to alterations in cerebral perfusion. It may be 
crucial in the survival of ischemic penumbra, especially during interventions in the stroke 
unit such as blood pressure (BP) manipulation or mobilisation, and, as such, may confound 
trials of interventions in the stroke unit. Important research questions concern the reasons 
for cerebral autoregulation impairment, the nature of and extent to which autoregulation 
becomes impaired, and how impairment progresses over time. Autoregulation is hypothesized 
to become impaired by damage to cerebral arterioles and capillaries during ischemia or other 
chronic insults (like hypertension).2 Cessation of blood flow then rapidly initiates a related 
series of processes that effects endothelial cell and receptor dysfunction and smooth muscle 
activation, all leading to impaired vasoregulator function.3 The primary focus of this review is 
on the nature and extent of cerebral autoregulation impairment and its course over time. For 
this, a definition of autoregulation and a description of various evaluation methods is required. 
Cerebral autoregulation is the inherent ability of blood vessels to keep cerebral blood flow 
(CBF) relatively constant over a wide range of systemic BP levels by means of complex myogenic, 
neurogenic, and metabolic mechanisms. The CBF depends on vascular conductance and arterial 
BP. Cerebral vascular tone is sensitive to arterial CO2.
4 In response to a variation in perfusion 
pressure, an adaptation in cerebrovascular resistance will cause CBF to return to its baseline.5-8
Evaluations of cerebral autoregulation have traditionally been performed under steady-
state conditions: a measurement of CBF was obtained at a constant baseline BP and constant 
CBF, followed by another steady-state measurement after manipulation of BP. This ‘static’ 
autoregulation was supposed to be intact if CBF was maintained at or near the baseline 
level despite BP changes.9,10 The group of Stirling used such ‘classic’ steady-state methods to 
demonstrate different dysautoregulation responses to various anatomical ischemic locations, 
various risk factors and duration after stroke.11 Drawbacks of single steady-state evaluations 
are the vulnerability to confounding by spontaneous non-BP-related variability, such as CO2 
changes,12 the time-consuming nature of procedures, the need for invasive pharmacological 
interventions, and the lack of information on any period of hypoperfusion possibly preceding 
the eventual return to stable perfusion.6, 7 
More recent developments, such as transcranial Doppler ultrasonography (TCD) and 
servo-controlled finger photoplethysmography have offered the advantage of investigating 
beat-to-beat dynamics of the pressure-flow relationship of the cerebral circulation and of 
differentiating between fast and slow response mechanisms.6,7 This ‘dynamic’ approach 
uses the induced or spontaneous rapid changes in BP as an autoregulatory stimulus and 
compares BP and CBF velocity (CBFV) during the whole autoregulatory process (dynamic 
pressure autoregulation).5, 6, 13 Obviously, TCD can be used to study both CBFV responses 
to steady- state changes in BP (static pressure autoregulation),14, 15  and the autoregulatory 
3
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reserve and adaptability after, for example CO2 inhalation or breathing maneuvers (chemical 
vasomotor autoregulation or cerebrovascular reactivity).12 Although, Stirling Meyer found 
no correlation between the degree of static pressure dysautoregulation and impairment of 
chemical vasomotor autoregulation in stroke patients,16 many authors today interpret the 
isolated assessment of chemical vasomotor autoregulation as a steady-state method (i.e., 
measurement at 2 static levels of CO2).
17 
 Contrasting with the classical static autoregulation, no uniform method exists to provoke, 
measure, analyze and report dynamic or chemical vasomotor autoregulation. Recently, 
some excellent articles provided an overview of the different methods to provoke 
hemodynamics and quantify pressure autoregulation using TCD.6-8,18,19 TCD studies are 
highlighted in this review because TCD studies allow evaluation of both the steady-state 
and dynamic components of cerebral autoregulation, and because TCD together with finger 
photoplethysmography stands out as a technique with excellent temporal resolution allowing 
non-invasive continuous bedside monitoring of CBFV and BP, and thus autoregulation. 
The central question of this review is what the nature and extent of autoregulation 
impairment after stroke is as measured by TCD is. All 3 study approaches to cerebral 
autoregulation are considered: static pressure, dynamic pressure, and chemical vasomotor 
or combination autoregulation studies. 
maTerIals and meThods
Study identification 
Cochrane Collaboration methodology for meta-analysis reviews modified for observational 
studies (www.equator-network.org) was used.20 
Search strategy 
Studies were identified with a search strategy across 2 English language databases (Medline 
and Embase) between 1966 and October 2009 accommodating different MeSH terms or 
subcategories available on each database (Table S1, supplemental material). Bibliographies 
of selected articles were screened for additional relevant articles.
Inclusion and Exclusion criteria
Included were published TCD studies of human cerebral autoregulation after ischemic stroke. 
Eligibility was assessed by reading abstracts and, if necessary, whole articles. The effects of 
impaired cerebral autoregulation on neurological outcome were assessed.  Excluded were 
case reports, non-English language articles, posterior territory stroke studies and studies 
with ultrasound contrast agent injection. Carotid stenosis or known intracranial artery 
stenosis confounds the effect of stroke on cerebral autoregulation and were an additional 
reason for exclusion of studies.
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Data extraction 
The following data were extracted: (1) stroke population; (2) stroke severity; (3) number of 
patients and controls; (4) acute (<96 hours after index stroke) vs chronic phase assessment 
(>96 hours after index stroke); (5) cerebral autoregulation challenges (input); (6) method of 
data analysis; (7) autoregulation evaluation method (steady-state versus dynamic autoregu-
lation); (8) neurological outcome (Barthel score, NIHSS change or necessity of craniectomy); 
(9) main conclusions of the authors; (10) presence, timing and conclusion of follow-up stud-
ies; and (11) status of cerebral autoregulation in both hemispheres. Furthermore, important 
technical aspects of TCD observational studies such as bilateral probe recordings, reporting 
of CO2 values, and use of continuous BP recording during the measurements were extracted. 
Study quality was assessed using a checklist proposed previously for authors, editors and 
reviewers of meta-analyses of observational studies.20 This checklist was adapted to include 




Two-hundred thirty-eight publications met the search criteria and were evaluated. Inclusion 
criteria were met by 14 controlled studies and 13 observational studies. Three studies were ex-
cluded because of unclear timing of measurements after stroke onset,21-23 and 1 was excluded 
because TIA and minor stroke patients were grouped together.24 Hence, 23 publications were 
eligible for review. Study details are summarized in Tables 1 and 2. Patient number ranged from 
6 to 100. Sixteen studies included patients in the acute (range 20-96 hours) and 7 in the chronic 
(range 7-458 days) phase of stroke. Six studies had follow-up measurements between 3 days 
and 3 months after stroke. In 9 studies, the initial stroke severity was not reported,25-33 and eight 
studies failed to provide information about other clinical conditions (such as arrhythmias, dia-
betes mellitus and carotid pathology) associated with impaired cerebral autoregulation.25,30,32-37 
All studies allowed hypertensive patients to be included. In 2 studies, only information about 
the nonaffected hemisphere was presented because of permanent occlusion of contralateral 
middle cerebral artery.32,38 One study only provided information about the residual CBFV in 
the affected hemisphere.34 Eleven studies reported the end-tidal CO2 levels during the meas-
urements.25, 31,36,38-45 Six studies did not use continuous BP monitoring.25,27,29,34,37,45 One study 
included patients who received tissue plasminogen activator treatment.41 Information about 
clinical course and outcome after acute stroke in relation to autoregulation was provided in 
5 studies.32,35,41,45,46 One study reported about the correlation between cerebral autoregula-
tion and outcome after stroke.37 The Figure summarizes the different methods used to provoke 
cerebral hemodynamics and assess autoregulation in the selected stroke studies. The median 
score on the proposed quality checklist for observational TCD autoregulation studies was 7 of 13 
(range 11), reflecting incomplete reporting of key methodological criteria in most studies.  
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Acute stroke and steady-state autoregulation 
Three studies used different tests to calculate cerebrovascular reactivity in the acute 
phase of stroke. Cupini et al used the breath holding index in different infarct types, to 
show, particularly in 14 patients who already had multiple subcortical infarcts, impaired 
cerebrovascular reactivity in both hemispheres during the acute phase of a new stroke.31 Gur 
et al, using slow infusion of acetazolamide in patients with moderate stroke, found impaired 
autoregulation in cortical strokes only. Bilateral nonsignificant impairment was detected in 
the subgroup of 24 patients with subcortical stroke, although no corrections were made 
for asymptomatic lacunar infarct status. Additionally, they failed to find a correlation 
between baseline severity, disability scores and cerebrovascular reactivity.37  Cerebrovascular 
reactivity measurement using 5% CO2 inhalation in 100 minor stroke patients showed that 
impaired reserve capacity in the affected hemisphere was independently associated with 
early neurological deterioration within 72 hours.45 
Acute stroke and dynamic autoregulation 
All studies are unanimous in their conclusion that dynamic pressure cerebral autoregulation 
is impaired in acute stroke,30,41-44,47, 48 particularly when stroke is moderate to severe,41-44 or 
after follow-up.36,41 In 5 studies impaired autoregulation could also be demonstrated in the 
nonaffected hemisphere,41-44 which was particularly the case for first ever lacunar stroke.47 
Eames et al showed that these bilateral changes are unrelated to previous antihypertensive 
treatment, baseline BP levels or BP changes after stroke, age, and stroke subtype or stroke 
severity.42 In 3 studies dynamic cerebral autoregulation was recorded from spontaneous 
fluctuations of BP using the approaches of frequency domain (transfer function analysis 
(TFA)) and time domain analysis.36, 41, 47 In sum, TFA is a complex linear analysis to estimate 
the magnitude and the phase relationship between spontaneous or induced changes in 
BP and CBFV.5, 49 In the time domain analysis, either the delay of CBFV counter-regulation 
during changes in BP or the degree of correlation between averaged CBFV and BP over time 
is used.18, 47 Five studies calculated the autoregulatory index (ARI).30, 42-44,48 In sum, this is 
a linear curve-fitting procedure, which compares the CBFV response (measured directly or 
predicted) after a rapid step-like decrease in BP with a family of 10 theoretical flow-velocity 
curves to calculate dynamic cerebral autoregulation.6, 10, 13 Two studies used rapid thigh-cuff 
method deflation as input challenges.43,44 Three studies used spontaneous BP changes to 
reconstruct (by inverse fast-Fourier transform using TFA functions)5,49 the (predicted) CBFV 
step response.30,42,48  Comparable low-frequency ranges (0.06-0.12 Hz) were used for TFA 
analyses. 
Autoregulation seemed increasingly impaired in the first few days after a large stroke 
(mainly affected side) with unsuccessful thrombolysis,41 and did not improve in moderate 
stroke over two weeks time.43 In minor stroke patients, (after adjustment for covariates) 
cerebral autoregulation was similar to healthy controls after 2 weeks.30, 48
3
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































38  c e r e b r a l  h e m o d y n a m i c s  i n  s t r o k e  a n d  t r a u m a t i c  b r a i n  i n j u r y 
Chronic phase of stroke and steady-state and dynamic autoregulation 
Five of 7 studies found bilaterally impaired autoregulation between week 1 and 18 months 
after minor and moderate stroke.25, 27-29, 40  Novak et al only detected changes in the affected 
hemisphere of minor stroke patients,39 although the same group detected impaired dynamic 
autoregulation in both hemispheres during the Valsalva maneuver in 15 minor stroke 
patients using a nonlinear frequency shift method.40 Gommer et al, studying first ever 
lacunar infarct, found TFA values and cerebrovascular reserve capacities in the normal range 
when examining their patients after 3 months or longer.26 Information about stroke severity 
was not documented in this study. One research group repeated their initial measurements 
in the chronic phase and found some improvement after 3 months.28 Three studies included 
both steady-state  and dynamic cerebral autoregulation measurements in the same patients 
and found disturbed dynamic autoregulation only.26,43,44 
dIscussIon
There seems to be general agreement that stroke is associated with impaired cerebral 
autoregulation, even in minor stroke. Cerebral autoregulation may become impaired in both 
hemispheres, although in some large stroke studies only measurements in the nonoccluded 
middle cerebral artery vessel (nonaffected hemisphere) were possible. Interestingly, this 
bilateral effect seems to be more pronounced in lacunar stroke. Two studies showed (some 
degree of) progressive impairment of cerebral autoregulation in the first days after stroke, 
which may affect the penumbral salvage.36,41 Cerebral autoregulation has been shown to 
recover over the next 3 months. Impaired cerebral autoregulation in stroke is related to 
acute neurological deterioration, necessity of decompressive surgery, and poor outcome. 
How the process of cerebral autoregulation progresses from impairment to improvement 
and which factors determine this process, is  unclear. Three studies investigated both 
dynamic and steady state  autoregulation and found dynamic impairment only.26, 43, 44 This 
may be explained by differences in underlying mechanisms studied by dynamic vs steady-
state investigation techniques or simply a greater sensitivity of dynamic investigation 
techniques for detection of stroke related autoregulation changes. The clinical relevance 
of such changes is unclear. In only 1 study with healthy subjects, dynamic measurement of 
cerebral autoregulation (with rapid cuff deflation) yielded results similar to classical static 
testing (phenylephrine infusion) under conditions of intact autoregulation and following 
pharmacologically induced impairment.10 However, these evaluation of the ‘classical’ lower 
limits of the cerebral pressure autoregulatory plateau requires considerable manipulations 
of BP, making the method invasive and potentially harmful for stroke patients.12 Therefore, 
attention has been increasingly directed toward dynamic autoregulation.6-8,13 However, 
Zhang et al found that dynamic autoregulation may interact with changes in steady-state 
cerebrovascular resistance or vascular compliance or both leading to changes in dynamic 
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autoregulation by TFA function. In this regard, a more comprehensive model to include both 
the autoregulatory mechanisms and steady-state vascular parameters should be explored to 
improve the precision of the model prediction.15, 50 
The interpretation of the TCD autoregulation studies is hampered by several 
methodological issues. First, studies using TCD rely on the assumption that changes in CBFV 
are directly proportional to changes in CBF. For that to be true, the cross-sectional area of 
the insonated artery needs to remain constant.51,52 For this reason, the results of any TCD 
study of cerebral autoregulation should always be interpreted with caution, keeping in mind 
the possibility that a change in MCA diameter might have occurred.7 Disadvantages of TCD 
compared to other techniques are the limited spatial resolution of the ultrasound images (not 
allowing a spatial allocation of impaired autoregulation to specific cortical areas). Although 
cerebral autoregulation initially has been studied and defined at the small vessel level in 
experimental animal models, it can only be defined in living humans in terms of measuring 
regional large vessel or whole brain blood flow.53, 54 More specifically, the characterization of 
blood flow or velocity in a single vessel provides an approximation of the regional cerebral 
autoregulatory capacity.14,51,55 It is also conceivable that the perfused territory of the insonated 
vessel might change under pathologic conditions, such as focal ischemia or nonpathological 
conditions such as hypercapnia or hypocapnia and extreme hypoxia.7 Furthermore, in 
approximately 5% to 15% of the (stroke) patients an insufficient acoustic bone window is 
present. Second, in general there is a lack of a clear definition of cerebral autoregulation, a 
gold standard technique for steady-state and dynamic cerebral autoregulation assessment, 
and a reference value for clinically relevant ‘impaired’ cerebral autoregulation.18 Together 
with great heterogeneity in study methods, (Figure) analytical methods and patient 
categories selected this complicates comparing studies to a quality standard. Third, direct 
comparisons with other diagnostic techniques such as positron emission tomography and 
MRI are lacking because of major differences in temporal resolution. Also, there are several 
well-known confounders of TCD assessment of cerebral autoregulation regulation,13,18,56 
some of which are difficult to control outside the intensive care unit setting. For example, 
with protocols involving changes in posture and observations set to as much as minutes 
apart, there is always the possibility of the pressure-velocity relationship being strongly 
affected by changes in physiological parameters like sympathetic activation, cerebral venous 
pressure, breathing frequency and CO2 levels.
13 Only 11 studies reported CO2 levels during 
their measurements. Since CO2 has a marked influence on CBFV and also on autoregulation 
itself, the interpretation of measurements can be severely confounded in situations where 
significant changes in CO2 go undetected. As already mentioned, changes in steady-state 
cerebrovascular resistance or vascular compliance or both, for example, during steady-state 
cerebral autoregulation may influence beat-to-beat changes in CBF independent of dynamic 
autoregulation.15, 50  In addition, 6  studies (all steady-state) did not measure BP continuously. 
To determine autoregulation BP should ideally be measured continuously.6 Also, relatively 
small numbers of patients were studied, with even smaller numbers of control subjects 
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recruited.57 All this emphasizes the importance of more complex models with a multivariate 
approach to take into account the contribution of other variables that can influence CBF 
regulation.7, 8, 13  Finally, severe extra cranial or intracranial artery stenosis and clinical 
conditions (e.g. chronic hypertension, diabetes mellitus  and silent infarcts) may confound 
the assessment of cerebral autoregulation. 2, 17, 21, 58, 17, 23 The effects of presence of collateral 
or cross-flow needs to established in future studies. As an illustration, the finding of generally 
impaired autoregulation in lacunar stroke may be related to generalized small vessel disease 
attributable to chronic hypertension or diabetes. Longitudinal studies are required for 
lacunar stroke to show whether impaired cerebral autoregulation is a consequence of acute 
lacunar stroke or a correlate of widespread small vessel disease. 
Additional knowledge is needed about the physiological and pathological determinants 
of cerebral autoregulation in stroke, so that determinants of autoregulation can be better 
controlled for in future studies, or taken into account with the help of multivariate (time 
and frequency domain) models. Until proven otherwise, it is possible that some clinical 
conditions disrupt myogenic mechanisms while others impair autoregulation by blocking 
Overview of linear models and analytical methods used in autoregulation studies in ischemic stroke. 
More in-depth information is available in the reviews of Panerai et al 2008 and Beek van et al 2008.6,8 
CA indicates Cerebral autoregulation; ACZ, Acetozolamide; TTT, Tilt Table Testing; BP, Blood Pressure; 
CBFV, Cerebral blood flow velocity; MMPF, Multi Model Pressure Flow; TFA, Transfer function analysis.
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metabolic or neurogenic pathways.7 Dohmen et al demonstrated impaired autoregulation 
in the peri-infarct tissue of large middle cerebral artery infarct patients who had malignant 
brain edema by studying the relation between perfusion pressure and local oxygen pressure 
(invasive monitoring), together with metabolic makers of brain damage (microdialysis). 
They stress the important issue of combining continuous monitoring of surrogate markers 
of CBF (like CBFV) with local brain information.59 In that view, the use of (multichannel) 
near-infrared spectroscopy in stroke seems promising.18,60 Near-infrared spectroscopy is a 
noninvasive technique that allows continuous monitoring of cerebral hemoglobin oxygen 
desaturation, with significant positive relationship between CBFV en NIRS changes during 
clamping with carotid artery surgery.61 Also, MRI with blood oxygen level dependent signal is 
used to monitor dynamic autoregulation changes, with the benefit of allowing good spatial 
resolution.62
conclusIon
In summary, TCD appears to offer a practical bedside method with a high temporal resolution 
for cerebral autoregulation evaluation in stroke patients. TCD studies have shown impairment 
of cerebral autoregulation in various subtypes of ischemic stroke. In some patients, this 
impaired autoregulation is probably temporary and caused by the stroke, in others it is pre-
existent and might have contributed to the stroke (e.g., in chronic hypertension). In view of 
intervention studies in the stroke unit such as the ongoing BP-lowering trials in acute stroke, 
correct identification of patients with impaired or adapted autoregulation may lead to the 
establishment of important subgroups in such trials.63 Although some general conclusions 
can be drawn on the course of autoregulation over time, this topic requires further study. 
Variances in TCD study techniques, parameters and interpretations limits further conclusions 
(Figure). To improve the synthesis of data from various research groups (including stroke), 
there is great need for a uniform assessment of cerebral autoregulation in the whole field of 
autoregulation studies.
Future study goals are: (1) the determinants of cerebral autoregulation after stroke; (2) 
the development of multivariate models; (3) the status of both steady-state and dynamic 
autoregulation; (4) the course of cerebral autoregulation over time, and (5) the impact of 
cerebral autoregulation impairment on outcome with clinically relevant cut-off points. 
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supplemenTal maTerIal
 
  Table s1 Search Strategy used in Medline
A similar strategy using the closest available terms was used in Embase. 
The following key terms were used: (stroke (MESH) OR stroke (all fields)) AND (dynamic 
cerebral autoregulation (all fields) OR cerebrovascular autoregulation (all fields) OR 
cerebral autoregulation (all fields) OR cerebral vasomotor reactivity (all fields) OR 
cerebral perfusion (all fields) OR cerebral vasoregulation (all fields) OR cerebrovascular 
reactivity (all fields) OR chemical vasomotor autoregulation (all fields)) AND ((Doppler 
ultrasonography, transcranial (MESH) OR Doppler ultrasonography, transcranial (all fields) 
OR Doppler ultrasonography (all fields)).
     Table s2 A proposed checklist of observational TCD autoregulation studies20
Hypothesis statement in introduction or method section                              1
Threshold values of study outcome parameters described in 
introduction and/or methods 1
Sample size calculation before start of experiment 1
Publication in peer reviewed journal 1
Medical ethics review with informed consent   1
Conflict of interest authors described 1
Patient spectrum/population described sufficiently 1
Confounding factors sufficiently mentioned in introduction, 
methods or limitations 1
Analysis described sufficiently (mathematical and statistics)            1
Proven reproducibility of data 1
Consecutive patient recruitment  1
Type of  intervention/exposure  described sufficiently (or with 
literature reference) 1
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Introduction
Dynamic cerebral autoregulation (dCA) estimates require blood pressure (BP) fluctuations 
of sufficient amplitude. Current methods to induce fluctuations are not easily implemented 
or require patient cooperation. In search of an alternative method, we evaluated if BP 
fluctuations could be increased by cyclic passive leg raising (PCLR). We tested if reproducibility 
and variability of dCA parameters could be improved with this maneuver in 16 healthy 
subjects. 
Methods
Middle cerebral artery cerebral blood flow velocity (MCA CBFV), BP and end tidal CO2 (etCO2) 
were obtained at rest and during PCLR at 0.1 Hz. The BP-CBFV phase difference and gain were 
determined at 0.1 Hz and in the low frequency (LF) range (0.06 – 0.14 Hz). In addition the 
autoregulation index (ARI) was calculated. 
Results
The PCLR maneuver increased the power of BP fluctuations at 0.1 Hz and across the LF range. 
Only the reproducibility of gain increased significantly with the maneuver. Variability was 
not reduced by PCLR for any of the dCA parameters. During the maneuver patients were 
breathing faster and more irregularly, accompanied by increased etCO2 fluctuations and 
increased coherence between etCO2 and MCA CBFV. Multiple regression analysis showed 
that these concomitant changes were negatively correlated with the BP-MCA CBFV phase 
difference at 0.1 Hz. 
Conclusions
The clinical utility of the PCLR  maneuver is limited because of the concomitant changes in 
etCO2. This limits reproducibility of the most important dCA parameters. Future research on 
reproducibility and variability of dCA parameters should incorporate etCO2 variability or find 
methods to keep etCO2 levels constant.
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InTroducTIon
Dynamic cerebral autoregulation (dCA) describes the process of how cerebral blood flow 
(CBF) is regulated after blood pressure (BP) alterations of relatively short duration.1 This is 
different from the concept of static autoregulation, where the steady-state response of CBF 
is assessed after a prolonged large alteration in BP, classically induced by vasoactive drugs.2 
Several methods exist to estimate the dynamic response directly from the time domain, like 
with inflation and deflation of thigh cuffs.3 However, these methods are used infrequently 
due to fact that sudden decreases in BP poses a risk of brain ischemia and  sympathetic nerve 
system activation due to painful inflation of cuffs.4,5
In search for alternative methods, research has focused on using spontaneous BP 
fluctuations to challenge dCA.6 The dCA is often quantified by transfer function analysis 
(TFA), which results in a phase and gain spectrum.7 Another parameter is the autoregulation 
index (ARI) which describes the system response to a step-like disturbance.6,8 An inherent 
problem with these strategies is that spontaneous BP fluctuations have to be of sufficient 
amplitude to obtain reliable estimates of the dCA parameters. Although healthy subjects 
usually demonstrate sufficient spontaneous BP fluctuations, in 15% to 30% of patients 
this requirement is not fulfilled.9,10 Several maneuvers have been developed to increase BP 
fluctuations. These include deep breathing,11-13 oscillatory lower body negative pressure,14 
repeated squat-stand maneuvers,15,16 the hand grip test,17 repeated head-up tilt,18,19 the 
cold stress test and the Valsalva maneuver.20 Some authors have shown improvement 
of reproducibility and/or variability of dCA parameters with these methods,13,16,21 others 
reported no difference in reproducibility.22,23 
If methods to increase BP fluctuations are to be used in the clinical setting, they have 
to be practical, applicable at the bedside and require minimal patient cooperation. The 
latter requirement applies especially to certain neurological disorders, like in patients 
with decreased consciousness or aphasia. In search for alternative methods to induce BP 
fluctuations in the clinical setting, we tested the effect of passive cyclic leg raising (PCLR) 
on dCA calculation. During this maneuver venous blood shifts from the legs into the intra-
thoracic compartment, increasing both ventricular preloads, and subsequently cardiac output 
and BP. In its static form, leg raising is used to predict fluid responsiveness in patients with 
circulatory failure.24 By alternating raising and returning the legs to the horizontal plane, BP 
fluctuations are likely to occur. The objective of this study was to evaluate whether PCLR is 
able  to increase the low frequency (LF) BP power with improvement of reproducibility and 
variability of dCA parameters. 
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maTerIal and meThods
Subjects 
We tested 16 healthy subjects (8 males, mean age 32.5  ±9.5 years). Approval for this study was 
obtained from the local ethics committee. Informed consent was obtained from all subjects. 
None had a history of cardiovascular or neurological illness, hypertension or smoking.    
Measurement protocol 
Subjects were positioned in an adjustable medical chair, which was brought in a supine 
position for the measurement. If necessary, the chair was adjusted slightly to increase 
comfort. To prevent movement artifact, a semicircular inflatable pillow was positioned 
around the neck to overcome contact of the Transcranial Doppler (TCD) fixation system 
with the surface of the chair during PCLR. Non invasive BP estimates were obtained from 
a plethysmography system (Finometer-Pro, Finapress Medical Systems, Amsterdam, 
Netherlands), with a cuff placed around the index finger. Bilateral middle cerebral artery 
cerebral blood flow velocity (MCA CBFV) was measured with TCD (Nicolet Pioneer TC8080, 
Carefusion Corporation, San Diego, USA) using 2 MHz probes that were fixated using an 
adjustable headframe. End tidal CO2 (etCO2) was measured with a capnograph (Capnomac 
Ultima, GE Healthcare, Chalfont St Giles UK). All data were measured continuously at a 
sample frequency of 250 Hz. An analogue-digital converter in combination with Labview 
9.0 software (National Instruments, Austin, USA) was used to capture the data for storage. 
All participants had four measurement periods of 5 minutes each: two periods at rest, 
and two periods of leg raising. To minimize any time effects, an alternating measurement 
protocol was used, i.e. period 1: rest (R1), period 2: PCLR (PCLR1), period 3: rest (R2), period 4: 
PCLR (PCLR2). After each period of leg raising a short pause (between 2-3 minutes) during 
which no measurements were taken was inserted, to allow hemodynamic stabilization. 
Subjects were instructed to lie completely still,  not to oppose the leg raising. No breathing 
instructions were given. The PCLR maneuver was executed as follows: both legs were lifted 
at the ankles and brought to about a 60° angle from the horizontal plane in about 1 second. 
After holding this position for 4 seconds, the legs were brought back to the horizontal plane 
in about 1 second, after which this position was kept for 4 seconds. This maneuver was then 
repeated which resulted in a period of 10 seconds (0.1 Hz). First, a few cycles were executed 
to verify that no movement artifact occurred. If necessary the neck pillow or head frame 
were adjusted. PCLR at 0.1 Hz was maintained throughout the 5 minute leg raising period. 
Data analysis 
The recorded signals were visually inspected for artifacts. Occasional artifacts of short 
duration which were visible as narrow spikes in the TCD or BP signal were removed by linear 
interpolation. Beat to beat data were obtained from the BP signal by triggering on the 
ascending slope during systole. The data were resampled at 10 Hz by spline interpolation 
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to create a uniform time base. EtCO2 was determined from the capnography trace as the 
maximum over each cycle, and was subjected to separate interpolation at 10 Hz. Respiratory 
frequency was calculated from the etCO2 cycle length. Detrending was performed using a 
high pass 8th order zero phase Butterworth filter, with a cut-off frequency set at 0.04 Hz. 
This was followed by mean normalization and subtraction of 1 to create zero mean signals. 
A Hanning window was applied to the data, and the Welch method of spectral estimation 
based on Fast Fourier Transformation (FFT) was used with 50% overlap on data segments 
of 51.2 seconds. This resulted in spectral estimates averaged over 10 segments. The transfer 
function analysis (TFA) was calculated without attempts to unwrap the phase spectra, 
but the phase estimates were visually inspected for phase wrap around. TFA graphs were 
produced at each iteration during averaging. If any sudden change in phase in the LF range 
occurred (visual inspection), the data were excluded. Coherence was considered significant 
if it exceeded the 95% confidence interval (CI) level of ‘no linear association’: 1-(0.05)1/L-1,25 
where L is the number of data segments used in the averaging. This resulted in a significant 
coherence level of 0.28. Gain and phase parameters were calculated at the 0.1 Hz frequency 
(in case of significant coherence). All frequencies were rounded off to two decimal places. 
Mean values of gain and circular mean values of phase were also calculated in the LF range 
(0.06 - 0.14 Hz) by averaging the values from these bins, i.e. the mean of 5 bins.
Power Spectral Density (PSD: i.e., power normalized by frequency bin width) of BP, 
etCO2, and respiratory frequency signals were determined at 0.1 Hz. The total power in the 
LF frequency range was calculated by integration. For etCO2 analysis, bins that were above 
the Nyquist frequency (i.e. respiratory frequency/2) as a consequence of the interpolation 
procedure were excluded. The Nyquist frequency was usually between 0.1 and 0.15 Hz. 
Because it is unlikely that significant fluctuations in alveolar etCO2 above these frequencies 
occur frequently, we assumed  any effects of aliasing of little importance. ARI was calculated 
by transforming the real and imaginary parts of the TFA back to the time domain with inverse 
FFT. The impulse response function thus created was integrated to yield the step response 
function. The first 10 seconds of the step response function were compared with the original 
Tiecks curves and the best fitting curve was determined by implementing a least squares 
fitting procedure, resulting in a ARI ranging from 0-9.26
Statistics 
SPSS 16.0 and SAS 9.2 software were used. Repeated measures analysis of variance (ANOVA) 
tests with post-hoc correction (Bonferroni and Dunnet T3 tests) were used. The following 
post-hoc comparisons were done: R1 vs R2, PCLR1 vs PCLR2, R1 vs PCLR1 and R2 vs PCLR2. 
After logarithmic transformation, all transformed variables were normally distributed in 
this study. To assess any differences in variability the Levene statistics was used. Intraclass 
correlation coefficient (ICC) analysis was used to assess reproducibility. Differences in ICCs 
were assessed with a difference test based on the CI for two dependent ICCs.27 No formal 
power calculation was done. The relation between dCA estimates and independent variables 
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(BP, etCO2 and derivatives) was evaluated with multiple regression analysis using a stepwise 
forward strategy. We accepted a variance inflation factor of < 10 as evidence that the input 
variables were indeed independent (co-linearity diagnostics).   
resulTs
The PCLR maneuver was well tolerated by all 16 subjects with good quality measurements. 
Mean data and spectral data of all relevant variables during the experiment can be found in 
Table 1 and in Figure 1.
Coherence, PSD MAPB, gain and phase spectra for all measured frequency bins are depicted. Data 
of the first rest period (gray bars) and the first PCLR period (black bars) are shown (mean ± standard 
error of the mean). Left and right hemispheres were averaged. Note that coherence does not increase 
despite a clear increase in BP power in the frequency bins around 0.1 Hz. There is significant leakage 
into the 0.08 Hz bin, and to a lesser extent into the 0.12 Hz bin. Gain remains similar for all frequency 
bins, while for phase, a focal decrease is present at the 0.1 and 0.08 Hz frequency bins, but not 
elsewhere in the low frequency (LF) or very low frequency band. Statistics were performed on the LF 
band data only (Table 2).  
Abbreviations: BP indicates blood pressure; PCLR, passive cyclic leg raising, PSD MAPB, power spectral 
density mean arterial blood pressure.   
Figure 1
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Table 1 Physiological and spectral characteristics during different test periods
rest (1) pclr (1) rest (2) pclr (2) P value anova
Blood pressure (BP) (mmHg) 78.1  ± 13.1 81.6 ± 14.5 * 81.7 ± 13.7 # 84.1 ± 14.4 * <0.001
Mean CBFV (cm/s)                                   Left MCA
                                                                    Right MCA
57.1 ± 12.1









etCO2 (kPa) 4.56 ± 0.50 4.41 ± 0.50 * 4.46 ± 0.51 # 4.28 ± 0.53 *# <0.001
Heart rate (beats/min) 63.5 ± 7.1 64.2 ± 8.2 62.2 ± 7.4 64.2 ± 8.7 0.226
Respiratory frequency (RF) (cycles/min) 13.8 ± 3.4 15.2 ± 3.1 * 13.9 ± 3.3 15.4 ± 2.7 * 0.003
PSD  total BP (mmHg2 *10-3 )/Hz 18.2 ± 12.3 35.5 ± 49.4 * 18.5  ± 12.5 29.6 ± 31.3 * <0.001
PSD 0.1 Hz BP (mmHg2 *10-3 )/Hz 4.4 ± 2.5 11.2 ± 21.1 * 4.3 ± 3.1 11.5 ± 14.0 * <0.001
PSD BP peak frequency (Hz) 0.07 ± 0.02 0.10 ± 0.00 * 0.08 ± 0.02 # 0.10 ± 0.00 * <0.001
PSD  total CBFV (mmHg2 *10-3 )/Hz     Left MCA
                                                                     Right MCA
21.6 ± 8.9
22.5 ± 8.7
37.6 ± 45.9 * 
27.0 ± 35.6 *
18.2 ± 16.1
20.1 ± 15.0
36.3 ± 30.5 *
34.8 ± 37.8 *
0.019
0.040
PSD 0.1 Hz CBFV (mmHg2 *10-3 )/Hz    Left MCA
                                                                     Right MCA
5.5 ± 4.0
5.9 ± 3.2
13.0 ± 17.3 *
11.3 ± 12.1 *
4.8 ± 4.8
5.1 ± 5.4
14.0 ± 11.7 *
13.1 ± 17.2 *
0.003
0.005
PSD total etCO2 (kPa
2 *10-3)/Hz 3.7 ± 5.8 14.7 ± 44.1 * 5.6 ± 5.2 14.2 ± 32.7 * <0.001
PSD 0.1 Hz etCO2 (kPa
2 *10-3)/Hz 0.49 ± 1.4 2.6 ± 10.5 * 0.81 ± 0.97 3.0 ± 6.0 * <0.001
PSD total RF (cycles/min2 *10-2)/Hz 11.8 ± 15.4  44.1 ± 54.6 * 12.0 ± 13.5 25.5 ± 26.0 *# <0.001
PSD 0.1 Hz RF (cycles/min2 *10-2)/Hz 1.9 ± 2.0 11.1 ± 16.8 * 1.9 ± 3.9 5.6 ± 9.2 * <0.001
Physiological data are shown as mean ± standard deviation; Spectral data are expressed as median ± 
Inter Quartile Range (IQR) because of non-normal distributions.
Abbreviations: PSD indicates power spectral density; CBFV, cerebral blood flow velocity; MCA, middle 
cerebral artery.
# indicates p < 0.05 vs previous similar condition; * indicates p < 0.05 vs previous different condition 
(after correction for multiple comparisons). ‘Total’ refers to ‘total PSD in the 0.06 - 0.14 Hz range (low 
frequency)’.
Changes induced by PCLR 
Leg raising significantly increased the power of BP in the LF band. This was accompanied 
by a shift in the peak of BP power from around 0.07 to 0.08 Hz during rest to 0.1 Hz during 
PCLR. Absolute levels of BP changed slightly, albeit significantly. At 0.1 Hz, BP power markedly 
increased (median ± interquartile range (IQR); R1: 4.4 ± 2.5, PCLR1: 11.2 ± 21.1, R2: 4.3 ± 3.1, 
PCLR2: 11.5 ± 14.0, (mmHg2 *10-3)/Hz, p < 0.001). Mean CBFV remained unchanged during the 
experiment, but total LF and 0.1 Hz power increased significantly during PCLR. Absolute etCO2 
levels decreased significantly during leg raising, although only by a small amount. A much 
larger increase was observed in the total LF and 0.1 Hz power of etCO2 fluctuations (Table 1). 
An increase in absolute respiratory frequency occurred during PCLR. The total LF and 0.1 Hz 
power of the respiratory frequency curve also increased. The HR remained unchanged during 
the experiment. Data of a representative subject can be found in Figure 2. 
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Left panel represents rest period 1 and the right panel leg passive leg raising period (PCLR) 1. Only 
etCO2 is plotted on the secondary Y-axis, all other variables are plotted on the primary Y-axis. Note 
the increase in amplitude of BP and MCA CBFV fluctuations in both middle cerebral arteries. Also 
an increase in etCO2 and respiratory frequency oscillations during the PCLR maneuver can be seen. 
Abbreviations: MABP indicates mean arterial blood pressure; MCA-L/R, middle cerebral artery (flow 
velocity) left/right; RF, respiratory frequency.
Table 2 Transfer function and Autoregulation Index (ARI) results
rest 1 leg raising 1 rest 2 leg raising 2 P value anova
Mean LF phase (°)               L
R
42.4 ± 12.7
44.8 ± 11.9 
36.9 ± 9.6
38.4 ± 11.2 
40.1 ± 14.5
40.9 ± 14.4 












46.6 ± 16.1 
0.017
0.130















0.83 ± 0.34 
0.91 ± 0.26










6.1 ± 2.1 
6.4 ± 1.9
5.7 ± 2.2
6.4 ± 2.1 
0.935
0.385






0.62 ± 0.15 
0.61 ± 0.15
0.61 ± 0.15 
0.060
0.315
































0.15 ± 0.13 
0.25 ± 0.15
0.23 ± 0.16 
0.013
0.009
Data are presented as means ± standard deviation. 
Abbreviations: Coh. indicates coherence; BP, blood pressure; CBFV, cerebral blood flow velocity.
* Indicates p < 0.05 vs previous different condition (after correction for multiple comparisons).
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Dynamic cerebral autoregulation parameters (Table 2) 
Circular mean LF phase was not different between the four periods. The phase difference 
between BP and MCA CBFV at 0.1 Hz was different for the left hemisphere recording, with a 
significant difference between the first rest and first PCLR period (R1: 47.6° ± 11.2, PCLR1: 33.8° 
± 10.7, R2: 44.1° ± 12.7, PCLR2: 37.1° ± 14.5, p = 0.017, R1 vs PCLR1, p < 0.05), but not between other 
periods. Mean LF gain, gain at 0.1 Hz and ARI were not different between the four periods. 
Mean LF coherence and coherence at 0.1 Hz between BP and MCA CBFV were similar across 
all periods. However, coherence between etCO2 and MCA CBFV at 0.1 Hz was different with 
significant post hoc differences between R1 and PCLR1 (both hemispheres, p < 0.05, Table 
2). No significant differences were found for mean LF coherence between etCO2 and CBFV.  
Table 3 Intraclass correlation analyses
rest 1 vs 
rest 2 95% cI
pclr 1 vs 
pclr 2 95% cI













































*denotes a significant difference (p < 0.05) in intraclass correlations between the passive cyclic 
leg raising maneuver and rest conditions.
Abbreviations: 95%-CI indicates 95% confidence interval; PCLR, cyclic passive leg raising
Reproducibility and variability (Table 3)  
The ICC values for the rest period comparison were generally low for mean LF phase and 0.1 
Hz phase and did not improve during PCLR. The ICC values for mean LF and 0.1 Hz gain were 
low in the rest period comparison, but improved significantly during PCLR, especially for the 
0.1 Hz gain (left hemisphere: ICC for R1 vs R2: 0.43 and ICC for PCLR1 vs PCLR2: 0.84, p = 0.02); 
right hemisphere: ICC for R1 vs R2: 0.25 and ICC for PCLR1 vs PCLR2: 0.70, p = 0.05). The ICC 
values for ARI did not improve during PCLR. The variability was not different between the 
four periods (both hemispheres) for all dCA estimates (data not shown).
 
Relationship between variables 
Additional analyses were performed to explore the significant lower 0.1 Hz BP-MCA CBFV 
phase difference during PCLR1, while no such difference occurred for the 0.1 Hz gain. 
Absolute levels of BP and etCO2 as well as (the log-transformed) 0.1 Hz BP and etCO2 power, 
as well as  the 0.1 Hz coherence levels of BP-MCA CBFV and etCO2-MCA CBFV were entered 
as independent variables in the multiple regression model. Only the 0.1 Hz etCO2-MCA CBFV 
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coherence was significantly related to the 0.1 Hz phase difference (left hemisphere: p = 
0.048; right hemisphere: p = 0.007). Figure 3 shows the linear relationship between the 0.1 
Hz etCO2-MCA CBFV coherence and the 0.1 Hz phase. For the 0.1 Hz gain, only the 0.1 Hz BP 
power was significant correlated during both PCLR periods (data not shown). Figure 4 shows 
the relation between the 0.1 Hz gain and the 0.1 Hz BP power. 
Figure 3
Correlation plot of the 0.1 Hz etCO2-CBFV coherence and the 0.1 Hz BP-CBFV phase for both hemispheres 
during the first PCLR period. 
Abbreviations: CBFV indicates cerebral blood flow velocity; (MA)BP, (mean arterial) blood pressure; 
PCLR, passive cyclic leg raising.
dIscussIon
changes durIng The pclr maneuver
Coherence 
The results of this study show that the well tolerated PCLR maneuver increased the power 
of BP and MCA CBFV at 0.1 Hz significantly in healthy subjects. However, the BP-MCA CBFV 
coherence did not increase. This may be partly attributed to the fact that in the resting 
condition, the LF coherence was already quite high in our (relatively young) study population. 
Furthermore, during 0.1 Hz PCLR subjects started to breathe faster and more irregular with 
significantly increasing etCO2 fluctuations and 0.1 Hz etCO2-CBFV coherence. 
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Figure 4
This figure shows the relationship between 0.1 Hz BP-MCA CBFV gain and the PSD of BP fluctuations. 
Data of the first and second passive cyclic leg raising (PCLR1 and PCLR2) periods were used. A 
significant inverse relation existed, which was best described by non linear inverse functions. 
After logarithmic transformation of the PSD of BP fluctuations a linear inverse relation was the 
best fitting function, and these transformed data were used in the multiple regression analysis. 
Abbreviations: CBFV indicates cerebral blood flow velocity; (MA)BP, (mean arterial) blood pressure; 
PSD, power spectrum density. 
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Phase 
The 0.1 Hz BP-MCA CBFV phase tended to decrease during the PCLR maneuver, which would 
indicate impaired autoregulation. The 0.1 Hz etCO2-MCA CBFV coherence was negatively 
correlated with the phase estimate (Figure 3). We hypothesize that the decrease in phase 
was caused by the disruptive effect of increased etCO2 fluctuations during PCLR. During the 
second PCLR period, these effects were less pronounced, despite a similar increase in etCO2 
power. An increase in etCO2 fluctuations after BP fluctuation inducing maneuvers has also 
been described after repeated LF squat-stand maneuvers.16 In that study also a decrease in 
phase (with unaffected gain) was found. This was not interpreted as a CO2 effect, but rather 
as an alteration in cerebrovascular tone due to increase in shear stress caused by the large 
squat-stand BP fluctuations. However, the coherence between etCO2 and MCA CBFV was not 
assessed in the squat-stand study. Our findings might indicate that induced CO2 fluctuations 
disturb the phase estimate in the LF range significantly. 
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Gain and ARI
Gain and ARI estimates remained unchanged during PCLR. In our experiment the major 
determinant for gain was the BP power, with less influence of etCO2. Therefore, different 
factors seem to influence frequently used estimates to describe dCA. The relation between 
BP power and gain was present during PCLR, but not during rest. The decrease in gain with 
increasing BP power is best described by a ‘non linear inverse function’ (Figure 4). This 
may indicate two things. Firstly, a threshold phenomenon, with cerebral autoregulation 
becoming active above a certain BP threshold. Secondly, at higher BP fluctuation levels the 
variability of gain decreases. However, reduction in inter-individual variability could not be 
demonstrated with formal statistics, although intra-individual variability was lower (see 
section on reproducibility and variability).
Sensitivity of ARI to both static and dynamic etCO2 changes have been described before, 
using autoregressive moving average models with time varying estimates of ARI.28,29 We did 
not use a time varying estimate of ARI and this difference in analyzing technique might be a 
possible explanation for these different results. 
Reproducibility and Variability
Only the reproducibility of the 0.1 Hz gain estimate increased significantly with PCLR. Gain 
seems less sensitive to etCO2 fluctuations with reproducibility improving with increasing BP 
power. The fact that  the inter-individual variability remained unchanged despite increased 
reproducibility indicates that a large proportion of the total variability of dCA estimates is 
due to inter-individual variability. Reductions in dCA estimate variability with increasing BP 
fluctuations have been reported by others.21 The limited number of subjects in our study, 
and the fact that not every subject showed a large increase in BP power with PCLR can be 
another explanation for this discrepancy. 
Limitations
Several limitations deserve mentioning. Firstly, the physiological mechanism for the 
increase in BP power after PCLR is not entirely clear. Besides an increase in venous return, 
the altered breathing pattern may also have contributed to the increase in BP fluctuations. 
Breathing depth was not measured, so we were not able to analyze this option extensively. 
Secondly, in contrast to the LF band, limited coherence is more often problematic in the 
very low frequency (VLF) band (< 0.05 Hz).16 However, in this experiment we chose to focus 
on the LF band, because in this band BP (power) is considered to be the most important 
determinant for coherence.7 In the VLF band spontaneous oscillations in etCO2 and non 
linear system interactions have been shown to exert a significant influence on the BP-MCA 
CBFV coherence calculation.30,31,32 Thirdly, although we hypothesize that concomitant etCO2 
fluctuations significantly influenced reproducibility of phase and ARI during PCLR, we cannot 
exclude the possibility that limitations in methodology have contributed. Our methodology 
only provides a single estimate of dCA parameters for the entire recording period. Other 
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techniques such as autoregressive moving average modeling, phase synchronization, 
multimodal pressure-flow analysis or wavelet analysis provide multiple estimates over time 
and are less sensitive to non stationarities.33 Multivariate models may be able to correct for 
etCO2 changes. Alternatively, methods filtering out short lasting changes in dCA parameters 
caused by etCO2 changes may be developed. However, recent experiments have failed to 
show improvements in reproducibility with these methods and techniques.22 
Implications for clinical use and future directions
We aimed to obtain a practical bedside test that would increase BP power with minimal 
patient cooperation. Although the PCLR was well tolerated and significantly increased BP 
power, the first variability and reproducibility results of our selected dCA estimates were 
disappointing. Only the reproducibility for the gain estimate improved, most probably 
because it is less affected by (unexpected) concomitant etCO2 changes. Therefore, at present 
the clinical utility of PCLR to improve diagnostic properties for testing dCA status is limited. 
In cooperative patients the use of breathing instructions at a fixed pace could be considered 
and in mechanically ventilated patients there might be less risk of concomitant breathing 
and etCO2 changes. Alternatively, one could employ methods to ensure that etCO2 remains 
constant, such as sequential gas delivery breathing circuit devices that can accurately target 
and control etCO2.
34 The fact that etCO2 fluctuations have an important influence on dCA 
estimates further illustrates the need to incorporate or at least report etCO2 variability in 
future dCA analysis.30,31,35 
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absTracT
Background 
Blood pressure is one of the major vital parameters monitored in the stroke unit. The 
accuracy of indirect blood pressure measurement is strongly influenced by the position of 
both patient and arm during the measurement. Acute stroke patients are often nursed in 
lateral decubitus positions. 
Objective 
The effect of these alternating body positions in relation to affected body side on the 
outcome and reliability of blood pressure readings in acute stroke patients is unknown. 
Methods 
An automatic oscillometric blood pressure device was used. Blood pressure was measured in 
both arms in the (back) supine and both lateral decubitus positions. 
Results 
In total, 54 consecutive acute stroke patients were included. Thirty-five patients had right-
sided deficits and 19 left-sided deficits. Supine blood pressure readings were similar in right 
and left arms regardless of side of deficit. Measurements of blood pressure in the lateral 
decubitus positions resulted in significantly lower blood pressure readings in the uppermost 
arm (around 12 mmHg in both arms) and significantly higher readings in the right lowermost 
arm (around 6 mmHg) compared to the supine position. This effect seemed less pronounced 
when the left lowermost arm was measured. There was no relation between change of 
blood pressure readings in various lateral positions and side of stroke. 
Conclusions 
Alternating lateral decubitus positions according to nursing standards in acute stroke 
patients lead to a mean 18 mm Hg blood pressure fluctuation. This may largely be explained 
by hydrostatic pressure effects, partly by anatomical factors in the left lowermost arm, but 
not by the side of stroke. 
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InTroducTIon
There is increasing evidence that disturbance of vital parameters after stroke is associated 
with poor outcome.1 This has led to a strong focus on monitoring of vital parameters in stroke 
units and development of strategies to maintain physiological homeostasis.2 Changing body 
positions has been shown to prevent decubitus and pneumonia, and has led patients to be 
nursed in alternating supine and lateral decubitus positions.3,4 However, the changes of body 
position may also affect physiological homeostasis as illustrated by changes in oxygenation, 
changes in blood pressure (BP), in cerebral blood flow and in intracranial pressure.5,6 The 
effect of lateral decubitus positions on vital parameters in acute stroke patients has not yet 
been investigated.  
Not only can different body positions affect vital parameters, they can also affect the 
measurement itself. BP is one of the vital parameters most prominently monitored in the 
stroke unit setting and many stroke treatment guidelines take into account indirect BP levels. 
The accuracy of BP measurement strongly depends on both the number of measurements 
and the way the procedure is performed. One of the important confounders is the position 
of both patient and arm during the measurement, and the resulting hydrostatic gradients.7-9 
At present, guidelines about BP monitoring recommend measuring with the arm at heart 
level, but how to determine heart level in the lateral decubitus position is not specified.10,11 
Before the effect of body position on vital parameters in stroke patients can be assessed, 
information about the effects of different body positions on the methodological accuracy 
of BP measurements is needed. 
The aims of this study in admitted consecutive stroke patients in the first 24 hours were 
therefore to evaluate (1) the effects of lateral decubitus body positions on vital parameters 
accounting for affected body side, (2) the effects of lateral body position on BP readings.
meThods
Study participants 
This observational study was conducted in the University Medical Center Groningen, during 
the period January-August 2009. Consecutive patients with an ischemic stroke within 24 
hours of stroke unit admission without cardiac arrhythmias or hemodynamic instability were 
included. The measurements were done with the patient being installed on the stroke unit. 
Initial stroke severity was assessed with the National Institute of Health Stroke Scale (NIHSS). 
Stroke subtype was defined according to the Oxfordshire Community Stroke project.12 
Demographics, vascular risk factors, and medication were recorded. A noncontrast brain CT 
scan and routine hematologic and chemical analyses were carried out prior to treatment 
and admission in all patients. Patients received tissue plasminogen activator (tPA) treatment 
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according to protocols.13 The study was approved by the local medical ethics committee and 
all subjects gave informed consent.
Study Methods 
All measurements were carried out by one investigator (M.A.). A Philips Intellivue MP30 
(Philips Medical Systems, Best, The Netherlands) automatic oscillometric instrument was 
used. This oscillometric BP device measures oscillations from the blood vessel wall during 
cuff deflation. The pressure at which the oscillations are maximal is defined as mean arterial 
pressure (MAP). The device then calculates the systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) with an algorithm. Continuous peripheral oxygen saturation monitoring was 
performed with the Intellivue MP30 device withthe Fourier Artifact Suppression Technology 
(FAST) algorithm. The instruments are regularly calibrated. The cuff size was adapted to arm 
circumference. Heart rate (HR) was recorded from a diagnostic 6-lead electrocardiogram 
with multi-lead arrhythmia alarm. BP was measured in both arms in the supine and both 
lateral recumbent positions (Figure 1). The patients rested for 3 minutes after a change in 
position before a new measurement took place. The order of lateral turning was determined 
by coin toss. In the lateral position the back was supported by a firm pillow with the head 
resting on one pillow. The uppermost arms rested on the patients’ flank, and the lowermost 
arm rested on the mattress. The term supine is used with the patient on the back with both 
arms positioned at the phlebostatic level.
Overview of main Mean Arterial Pressure (MAP) differences in patients with right-sides (n = 35) 
and left-sides (n = 19)-sided deficits in the three body positions (supine (Sup), left lateral decubitus 
(LLD), and right lateral decubitus (RLD)) with changing of blood pressure (BP) cuff (left or right 
arm). Values between brackets represent corrected MAP differences (c∆) after adding covariates 
to the model.   
Figure 1
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Statistical analysis 
The outcomes in this study were MAP, SBP, DBP, HR (beats per minute (bpm)) and peripheral 
oxygen saturation (%) in each position. Values are presented as means  standard error (SE) 
unless presented otherwise. In a two-level model the body positions (supine, left lateral 
decubitus or right lateral decubitus) and cuff side (left arm or right arm) were evaluated. A 
multilevel model was chosen because measurements were nested in patients. The effects of 
the covariates age, sex, NIHSS, Oxford stroke classification, history of hypertension, cardiac 
disease, and atrial fibrillation were evaluated. The covariate age was centred at 37 years. A 
value of p < 0.05 was considered to indicate a significant effect. SPSS (16.0; SPSS Inc, Chicago, 
IL) was used for statistical analysis. Bonferroni adjustments for multiple comparisons were 
used in all the presented results. 
We performed a literature search using PubMed. A combination of the key words ‘blood 
pressure’ or ‘vital parameters’ and ‘lateral body position’ or ‘body position’ or ‘recumbent 
body positions’ or ‘lateral decubitus position’ was used.  
resulTs
Fifty-four patients were included. Thirty-five patients had right-sided deficits and 19 had left-
sided deficits. All patients had 18 measurements. Data on 31 measurements were incomplete 
or missing. Baseline characteristics are summarized in Table 1 and were comparable for 
both sides of deficit. Twenty-six patients (48%) were taking antihypertensive medication 
on admission, most of them because of a history of hypertension (39%). Table 2 shows the 
hemodynamic readings at different body and cuff positions in relation to side of deficit. The 
35 patients with right-sided deficits had lower MAP recordings than the 19 with left-sided 
deficit (difference, 7.4 mmHg (4.0); p = 0.07;  Figure 1, A). Both HR (2.1 bmp (3.6); p = 0.58)) 
and oxygen saturation (0.47% (0.5); p = 0.30) were similar. 
In both those with left- and those with right-sided deficit, the MAP – with HR and oxygen 
saturation - was not different in both arms in the supine position (p = 0.1; Figure 1, B and C). 
The supine MAP recordings were lower in the patients with right-sided deficits compared to 
the patients with left-sided deficits (estimate 5.2 mmHg (4.1); p > 0.99). The supine HR and 
oxygen saturation were not different (0.88 bmp (3.6); p > 0.99 and 0.65% (0.47); p > 0.99) 
between the two groups of patients. 
Studying both lateral decubitus positions, the MAP in patients with a right-sided deficit 
was 17.6 (1.0) mmHg higher in the right lateral decubitus position with the cuff on the 
right arm (right lowermost arm) than in the left lateral decubitus position with the cuff 
on the right arm (right uppermost arm; p < 0.001;  Figure 1, D) and 11.8 mmHg (1.0) higher 
in the left lateral decubitus position with cuff on the left arm (left lowermost arm) than in 
the right lateral decubitus position with the cuff on the left arm (left uppermost arm; p < 
0.001; Figure 1, E). For the group with a left-sided deficit these numbers amounted to 18.8 
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mmHg (1.2; p < 0.001) and 11.4 mmHg (1.3; p < 0.001), respectively (Figure 1 F and G).  The 
MAP in the left lateral decubitus position with the cuff on the right arm and right lateral 
decubitus position with the cuff on the left arm (both uppermost arms) were not different 
for both sides of deficit (0.3 mmHg (1.0), p > 0.99; and 1.7 mmHg (1.2), p > 0.99), yet the MAP 
in the left lateral decubitus position with the cuff on the  left arm (left lowermost arm) was 
significantly lower than in the right lateral decubitus position with the cuff on the  right arm 
(right lowermost arm; 6.1 mmHg (1.0), p < 0.001; and 6.0 mmHg (1.3), p < 0.001). Comparable 
results were found using SBP and DBP  recordings (Table 2).
Significantly lower HR were found in the left lateral decubitus position compared to the 
right lateral decubitus position (both groups, 1.3 bmp (0.4); p = 0.03) and compared to the 
supine position only for the patients with right sided deficits (1.9 bmp (0.3); p < 0.001). Only 
for patients with left-sided deficits, oxygen saturation was significant lower in the left lateral 
decubitus  position compared to the right lateral decubitus position (0.7% (0.2); p < 0.001). 
Adding covariates to the model did not change the results for all variables (for MAP, Figure 1). 
Table 1 Patient characteristics 




(n = 19) P value
Mean age (SD), y 69 (15) 71 (14) 67 (17) 0.35
Male 33 (61) 24 (69) 9 (47) 0.15
Baseline median NIHSS score 
[IQR] 8 [4-12] 8 [5-12] 7 [4-12] 0.39
History of hypertension 21 (39) 16 (46) 5 (26) 0.25
Cardiac disease 11 (20) 7 (20) (21) >0.99



















Diabetes Mellitus 11 (20) 6 (17) 5 (26) 0.49
Antihypertensive medication 26 (48) 18 (51) 8 (42) 0.58
Mean systolic blood pressure 
(SE) on stroke unit, mmHg 139 (4) 132 (4) 147 (5) 0.04
Mean diastolic blood pressure 
on stroke unit (SE), mmHg 66 (2) 63 (2) 68 (3) 0.21
Values are numbers (%), unless otherwise indicated. P values are not adjusted for multiple 
comparisons. 
Abbreviations: SD indicates standard deviation; SE, standard error; IQR, interquartile range; NIHSS, 
national institutes of health stroke scale; TACI/PACI/LACI/POCI total/partial anterior circulation/
lacunar infarction/posterior circulation infarction.
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Table 2  Absolute levels of Mean Arterial Pressure, Systolic and Diastolic Blood Pressure, Heart Rate 
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Abbreviations: BP indicates blood pressure; HR, heart rate; MAP, mean arterial pressure; Sat, 
saturation; SE, standard error.
dIscussIon
In the stroke unit, patients are often monitored in alternating lateral decubitus positions 
either spontaneously or as part of commonly used nursing protocols. These alternating 
lateral decubitus positions lead to major fluctuations in BP readings. Moreover, this effect 
seems to be muted when patients are measured in the left lateral decubitus position with 
the cuff on the left arm (left lowermost arm). Change of BP reading in lateral decubitus 
positions does not seem to be affected by side of deficit. HR and oxygen saturation were 
slightly lower in left lateral position.  
We were able to compare our results with 19 published studies (Table 3). All these 
studies were in nonstroke patients. Some of them lack data on the comparison of the two 
lateral decubitus positions or they lack measurements in both arms. Only 11 studies provide 
information about the angle of inclination. For all intraarterial BP studies, transducer height 
adaptations for the lateral positions are not clear. In the article of Bein et al, critically ill 
patients with intraarterial BP lines in the left or right brachial arteries were compared in 
the lateral  decubitus positions with the difference possibly explained by a selection bias.14 
Eventually, we were able to compare our results with five studies concerning cardiac, 
hypertensive or healthy subjects.15-19 In accordance with these studies, the BP difference 
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Table 3 Effect of lateral decubitus position on Blood Pressure measurements
study no of patients category  of patients
Type of
 measurement
both arms measured 
(in one patient)
cuff on uppermost(u)* 






Brachial cuff (auscultation method) 
or 
Intraarterial (with hydrostatic 
correction)
Yes U and L In the lateral positions, BP decreased in all patients in both U arms (> 10 mmHg). On average, BP increased slightly in L arms in the lateral position, but varied considerably among patients 
Newton,
198116 13 PTCA patients
Brachial cuff (ultrasound method) 
or
Intraarterial (both with hydrostatic 
correction)
Yes U and L Hydrostatic effects were the most likely cause of the drop in both U arms BP (14 mmHg; inclination 90˚). Both L arms BP were lower than expected
Kirchhoff et al, 
198323 29 Cardiac patients
Intraarterial
(with hydrostatic correction) Unknown Unknown In stable cardiac patients, the MAP for the supine and lateral position were comparable
Emerson et al, 
199417 120 CABG patients Brachial cuff (oscillometric method) Yes U and L
BP was significant lower in both U arms (4 mmHg) and higher in both L-arms (3 mmHg; 
inclination 45˚)   
Hallak et al, 
199724 30 Pregnant women Brachial cuff (mercury method) Yes U and L
BP in the L arms was comparable to U arms, indicating that hydrostatic pressure does not 
account for these changes in pregnancy
Bein et al, 
1996 14 12 Critically ill patients
Intraarterial (with hydrostatic 
correction) Yes L 
The MAP was lower in the right lateral (> 13 mmHg) compared to supine and left lateral 
position. (inclination 63˚)






(with hydrostatic correction) No Unknown
The MAP of 8 patients in the right lateral position (inclination 70° to 80°) was higher than 
the MAP of 7 patients in the left lateral position during urological surgery. No measurements 
in the supine position 
Cavelaars et al, 
200026 16
Hypertensive healthy 
patients Brachial cuff (oscillometric method) No U and L
The MAP in the U arms was significant lower (> 10 mmHg) than measured in the supine or L 
arm position 
Van der Steen et 
al,  200018 40
Hypertensive/
healthy patients Brachial cuff (oscillometric method) Yes U and L
In both groups, the MAP in both U arms was significant lower (16 mmHg) and higher (4 
mmHg) in both L arms in the lateral position (inclination 90˚) 
Schou et al, 
200127 12 Healthy subjects
Brachial cuff  (aneroid method) 
and Finapress recording (with 
hydrostatic correction)
No Unknown The MAP in the left lateral position was not different compared to the supine recordings taken after 30 minutes 
Pump et al, 
200228 8 Healthy subjects
Brachial cuff (oscillometric method, 
with hydrostatic correction) No U
The MAP in the U arm decreased significantly in the left lateral position (5 mmHg) compared 
to supine position 
Kinsella et al, 
200629 32 Pregnant women
Brachial cuff (mercury and 
oscillometric method) Yes U and L
The MAP in the U arm was lower (10 mmHg), and higher (6 mm Hg) in the L arm compared to 
supine. Only measurements in right lateral position (inclination 90˚)
De Laat et al, 
200730 55 CABG patients
Intraarterial
(with hydrostatic correction) Unknown Unknown
The MAP does not significant change (< 5 mmHg) much in the lateral position (inclination 
30˚) 
Jones et al, 
200431 32 Healthy subjects Brachial cuff (oscillometric method) Yes U
BP in U arms decreased significantly (> 10 mmHg) in both lateral position (inclination 90˚), 
more evident in the left lateral position
Clochesy,
1986 19 10 Healthy subjects Brachial cuff (oscillometric method) Yes U and L
BP in the both U-arm is significantly lower in both lateral positions (inclination 35°to 45°). 
The BP is in the L arm is only slightly lower (2 mmHg) in the left lateral position 
Stein, 195232 100 Cardiovascular disease Unknown Unknown Unknown
The MAP was found to be around 20 mmHg lower in the left lateral than in the sitting, 
supine and right lateral position, respectively
Thomas et al,
200733 34 Critically Ill patients 
Intraarterial (hydrostatic correction 
not clear ) No Not clear The MAP remained stable in the 90˚ lateral positions 
Gordon et al, 
200934 26 Healthy elderly Brachial cuff (aneroid method) No U
The MAP of U arms was significant lower in both lateral 90˚ positions. No difference 
between right and left lateral recordings
Almeida et al,
200935 11 Pregnant women Brachial cuff (mercury method) No U Systolic and diastolic BP is significant lower in the left lateral position
Abbreviations: CABG indicates coronary artery bypass graft; MAP, mean arterial pressure; PTCA, 
percutaneous trans coronary angiography; BP blood pressure (systolic and diastolic).
* Uppermost arm: The arm opposite to the patients’ lateral decubitus position.
# Lowermost arm: The arm on the same side of the patients’ lateral decubitus position.   
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Table 3 Effect of lateral decubitus position on Blood Pressure measurements
study no of patients category  of patients
Type of
 measurement
both arms measured 
(in one patient)
cuff on uppermost(u)* 






Brachial cuff (auscultation method) 
or 
Intraarterial (with hydrostatic 
correction)
Yes U and L In the lateral positions, BP decreased in all patients in both U arms (> 10 mmHg). On average, BP increased slightly in L arms in the lateral position, but varied considerably among patients 
Newton,
198116 13 PTCA patients
Brachial cuff (ultrasound method) 
or
Intraarterial (both with hydrostatic 
correction)
Yes U and L Hydrostatic effects were the most likely cause of the drop in both U arms BP (14 mmHg; inclination 90˚). Both L arms BP were lower than expected
Kirchhoff et al, 
198323 29 Cardiac patients
Intraarterial
(with hydrostatic correction) Unknown Unknown In stable cardiac patients, the MAP for the supine and lateral position were comparable
Emerson et al, 
199417 120 CABG patients Brachial cuff (oscillometric method) Yes U and L
BP was significant lower in both U arms (4 mmHg) and higher in both L-arms (3 mmHg; 
inclination 45˚)   
Hallak et al, 
199724 30 Pregnant women Brachial cuff (mercury method) Yes U and L
BP in the L arms was comparable to U arms, indicating that hydrostatic pressure does not 
account for these changes in pregnancy
Bein et al, 
1996 14 12 Critically ill patients
Intraarterial (with hydrostatic 
correction) Yes L 
The MAP was lower in the right lateral (> 13 mmHg) compared to supine and left lateral 
position. (inclination 63˚)






(with hydrostatic correction) No Unknown
The MAP of 8 patients in the right lateral position (inclination 70° to 80°) was higher than 
the MAP of 7 patients in the left lateral position during urological surgery. No measurements 
in the supine position 
Cavelaars et al, 
200026 16
Hypertensive healthy 
patients Brachial cuff (oscillometric method) No U and L
The MAP in the U arms was significant lower (> 10 mmHg) than measured in the supine or L 
arm position 
Van der Steen et 
al,  200018 40
Hypertensive/
healthy patients Brachial cuff (oscillometric method) Yes U and L
In both groups, the MAP in both U arms was significant lower (16 mmHg) and higher (4 
mmHg) in both L arms in the lateral position (inclination 90˚) 
Schou et al, 
200127 12 Healthy subjects
Brachial cuff  (aneroid method) 
and Finapress recording (with 
hydrostatic correction)
No Unknown The MAP in the left lateral position was not different compared to the supine recordings taken after 30 minutes 
Pump et al, 
200228 8 Healthy subjects
Brachial cuff (oscillometric method, 
with hydrostatic correction) No U
The MAP in the U arm decreased significantly in the left lateral position (5 mmHg) compared 
to supine position 
Kinsella et al, 
200629 32 Pregnant women
Brachial cuff (mercury and 
oscillometric method) Yes U and L
The MAP in the U arm was lower (10 mmHg), and higher (6 mm Hg) in the L arm compared to 
supine. Only measurements in right lateral position (inclination 90˚)
De Laat et al, 
200730 55 CABG patients
Intraarterial
(with hydrostatic correction) Unknown Unknown
The MAP does not significant change (< 5 mmHg) much in the lateral position (inclination 
30˚) 
Jones et al, 
200431 32 Healthy subjects Brachial cuff (oscillometric method) Yes U
BP in U arms decreased significantly (> 10 mmHg) in both lateral position (inclination 90˚), 
more evident in the left lateral position
Clochesy,
1986 19 10 Healthy subjects Brachial cuff (oscillometric method) Yes U and L
BP in the both U-arm is significantly lower in both lateral positions (inclination 35°to 45°). 
The BP is in the L arm is only slightly lower (2 mmHg) in the left lateral position 
Stein, 195232 100 Cardiovascular disease Unknown Unknown Unknown
The MAP was found to be around 20 mmHg lower in the left lateral than in the sitting, 
supine and right lateral position, respectively
Thomas et al,
200733 34 Critically Ill patients 
Intraarterial (hydrostatic correction 
not clear ) No Not clear The MAP remained stable in the 90˚ lateral positions 
Gordon et al, 
200934 26 Healthy elderly Brachial cuff (aneroid method) No U
The MAP of U arms was significant lower in both lateral 90˚ positions. No difference 
between right and left lateral recordings
Almeida et al,
200935 11 Pregnant women Brachial cuff (mercury method) No U Systolic and diastolic BP is significant lower in the left lateral position
Abbreviations: CABG indicates coronary artery bypass graft; MAP, mean arterial pressure; PTCA, 
percutaneous trans coronary angiography; BP blood pressure (systolic and diastolic).
* Uppermost arm: The arm opposite to the patients’ lateral decubitus position.
# Lowermost arm: The arm on the same side of the patients’ lateral decubitus position.   
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between both lateral decubitus positions while leaving the right cuff in position in our study 
is explained by the change in hydrostatic pressure. 
Measurements of BP in the lateral decubitus position results in a lower BP reading at 
the arm in top position (left lateral decubitus position with cuff on the right arm) and a 
higher BP reading in the lower arm (right lateral decubitus position with the cuff on the 
right arm). Several studies have shown that BP differences caused by a change of the arm 
relative to that of the right atrium correlate with differences in hydrostatic pressure.7-9 The 
five studies we retrieved from the literature, however, do not report significant differences 
between BP readings between both arms in the lateral decubitus position. We are the first 
to report significantly lower BP recordings in the left lateral decubitus position with the 
cuff on the left arm (left lowermost arm) in a group of stroke patients, regardless of side of 
deficit. Although the study was conducted in a small heterogeneous population admitted 
on the stroke unit and full standardisation of posturing was difficult, measurements had 
only small statistical errors and seemed consistent across the range. Comparing our cohort 
with stroke unit effectiveness trail cohorts revealed a slightly lower prevalence of history of 
hypertension in our patients.20 We found similar BP recordings in both uppermost arms (left 
lateral decubitus position with cuff on right arm compared to right lateral decubitus position 
with cuff on the left arm) and no major changes in HR and saturation. Heart displacement 
(with change of hydrostatic level) or compression, and different autonomic postural states 
are therefore unlikely explanations.21 A study concerning sleep position dimensions across 
age groups revealed a clear preference for the right side in elderly patients.22 Discomfort or 
altered cardiovascular functions were suggested. Postural compression of vascular structures 
in the left arm or shoulder region attenuated by a stroke may be hypothesized but, to our 
knowledge, are not supported by any literature. Further investigations will be required. In 
order to improve correct indirect BP measurements in stroke patients, it is important to 
recognise substantial hydrostatic pressure effects in lateral decubitus positions.8 Treatment 
decisions regarding optimal perfusion pressure should take these sources of BP variation into 
account. Practical advices for correct BP monitoring, including alternating lateral decubitus 
positions, should be added to BP monitoring guidelines. Moreover, every study reporting 
BP values should ideally mention body, arm and cuff (or intraarterial line, with or without 
height correction) position. 
In conclusion, we recommend performing indirect BP measurement in stroke patients in the 
back supine position. In case of frequent turning, we suggest measurements on the right arm 
while taking into account the hydrostatic effects  for optimal lateral decubitus BP readings. 
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absTracT 
Background 
Routine lateral turning of patients has become an accepted standard of care to prevent 
complications of immobility. The hemodynamic and oxygenation effects for patients in 
both lateral positions (45°) are still a matter of debate. We aimed to study the effect of 





Twenty stable intensive care unit patients with intraarterial blood pressure recordings in 
the supine and lateral positions with correction of hydrostatic height compared to a fixed 
reference point (phlebostatic level). A multilevel model was used to analyse the data. 
Results 
Mean arterial pressure readings in the lateral positions were, on average, 5 mmHg higher 
than in the supine position (p < 0.001). There were no significant differences between 
MAP recordings in the left and right lateral position (p = 1.0). No important differences 
in peripheral oxygenation saturation and heart rate were observed. After correction for 
covariates, the effects persisted. 
Conclusions 
Our study demonstrated an increase, albeit small, of blood pressure in the lateral positions. 
No major differences between the left and right lateral position were found. No important 
differences in oxygenation and heart rate were observed. 
Relevance to clinical practice 
Turning hemodynamically stable patients in the intensive care has no important effects on 
blood pressure measurements when continuous hydrostatic height correction is applied.
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InTroducTIon
Critically ill patients in the intensive care unit (ICU) are at high risk for complications of 
immobility such as pneumonia and pressure ulcers.1,2 Routine lateral turning of patients has 
become the standard of care to prevent these complications. Whenever blood pressure (BP) 
is measured in varying body positions, the location on a vertical axis of BP measurement 
compared to the right atrium (RA) needs to be accounted for. This need for hydrostatic height 
correction in ICU invasive BP measurements is generally recognised.3 However, whether 
lateral turning has hemodynamic and oxygenation effects beside these hydrostatic effects 
is still partly unclear. Several studies found contradictory effects of turning in different 
patient groups. In 1951, Stein introduced the term ‘left lateral hypotension’ syndrome,4 and in 
1996 Bein et al. advised to avoid the hypotensive right lateral position in critically ill patients.5 
Different hemodynamic or physiological explanations including hydrostatic, mechanical, 
hormonal or body side-specific sympathetic nervous modulations were suggested.5-7 
Our objective was to quantify the hemodynamic (intraarterial (IA) BP, heart rate (HR)) and peri-
pheral oxygenation saturation effects of 45˚ lateral turning in a general stable ICU population. 
meThods
Study participants
This observational prospective study was conducted in the 47-bed mixed ICU with 2900 
admissions per year in a 1300-bed tertiary referral hospital with transplant, trauma, 
neurosurgical and thoracic programs. Twenty patients were included in the period June till 
August 2009. Demographic data, vascular risk factors, sedation, side of IA line, ventilation 
conditions and medication (analgesics, vasopressors and antihypertensives) were recorded. 
Exclusion criteria were a diagnosis of (severe) traumatic brain injury or subarachnoid 
haemorrhage, hemodynamic instability (systolic BP < 90 mmHg and/or mean arterial 
pressure (MAP) < 60 mmHg), cardiac dysrhythmias, difficult ventilation (plateau pressures 
above 25-cm H2O and inspired oxygen fraction > 0.5), inability to lie in the lateral body 
position, restlessness or delirium, and a left-right arm difference of MAP > 8 mmHg (mean 
value of three brachial cuff measurements) in the supine back position. The study was 
approved by the local medical ethical committee. 
Invasive BP recordings with transducer reference 
The BP values were obtained from a bedside IA BP monitor (model Philips Intellivue MP70; 
Philips Medical Systems, Best, The Netherlands). This monitor displays electrocardiogram 
(ECG), arterial waveforms, systolic and diastolic pressures, MAP and HR measurements. 
The MAP was determined by time averaged mean calculation. The monitors are routinely 
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calibrated. In all patients, a 20-gauge catheter was placed in the radial artery and connected 
to a pressure tubing with a physiological transducer that was electrically connected to the 
monitor. The transducer was fixed to the bed. The RA was considered as the reference point 
for the transducer (continuous hydrostatic height correction). In the supine position, the 
RA level was consistently measured at the phlebostatic level, the junction between the 
transverse plane of the body along the fourth intercostal space and the midline between 
the anterior and posterior chest (coronal plane). No alterations of the transducer level 
were made in the lateral positions. The monitor was zeroed at atmospheric pressure and 
electronically calibrated at bedside before every measurement. The arterial waveform was 
observed for artefact or dampening. A finger pulse oximeter (Massimo SET, Intellivue model; 
Philips Medical Systems) was used to obtain continuous arterial oxygenation levels. All 
measurements were carried out by first and second author of this manuscript. 
Body positions 
The patients were studied in the supine and lateral body positions. In one patient, supine 
recordings were not possible because of painful sacral decubitus. The patients rested for 
3 minutes after a change in position before the measurements. In the lateral position (45˚) 
the back was supported by a wedge shaped firm pillow with the head resting on one soft 
pillow. The uppermost arm rested on the patient’s flank, and the lowermost (dependent) 
arm rested on the mattress. When supine, both arms rested on the mattress. The order of 
lateral turning was determined by coin toss. The next ten values were recorded for systolic 
and diastolic BP, MAP, HR and peripheral oxygen saturation. If patients were mechanically 
ventilated, the recordings were all done at the end-expiratory stage.
Statistical analysis 
The outcomes in this study were BP, expressed as MAP, systolic and diastolic BP (mmHg), HR 
(beats/minute) and oxygenation (%) in each position. The primary outcome was MAP. Values 
are presented as means ± standard error (SE). Because of nested measurements in patients, 
a multilevel model was employed evaluating the effects of different body positions (supine, 
right lateral and left lateral) with and without accounting for side of IA line. Age, sex, history 
of hypertension and cardiac disease, positive end expiratory pressure (PEEP), morphine and 
BP medication were incorporated as covariates. The covariate age was centered at 37 years. 
A value of p < 0.05 was considered to indicate a significant effect. SPSS 16.0 was used for 
statistical analysis. Bonferroni adjustments were used for all multiple comparisons. Taking 
into account inaccuracy of BP measurements and possible effects of different arm (body) 
positions with fixed transducer level, we considered a MAP difference of less than 10 mmHg 
due to position change as clinically unimportant.8, 9 
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Results
Twenty patients were included. The clinical characteristics are given in Table 1. Nine patients 
had a right-sided IA line. These patients had more noradrenalin support and administration of 
morfine, and higher HRs compared to patients with left IA line. Ten patients were ventilated 
during the measurements. Table 2 shows the mean hemodynamic absolute values in the 
three body positions. MAP readings in the lateral positions were, on average, 4.5 mmHg 
higher than in the supine position (p < 0.001). There were no significant differences between 
MAP recordings in the left and right lateral position (p = 1.0). The systolic BP increased more 
than 5 mmHg in the lateral positions (p = 0.001), with no significant difference between 
both lateral positions (p = 1.0). The effects were less pronounced for the diastolic BP. The HR 










Male (%) 13 (65) 7 (78) 6 (55) 0.28
Age (y), mean (SD) 59 (12) 61 (11) 58 (13) 0.63
Ventilation (%) 10 (50) 4 (44) 6 (54) 0.65
Inspiration pressure, mean (SD) * 15 (3) 9 (9) 9 (8) 0.98
PEEP, mean (SD) * 7 (1) 4 (4) 4 (4) 0.78
Oxygen support, mean (SD) * 43 (13) 41 (18) 37 (18) 0.68
Noradrenalin support (%) 6 (30) 5 (56) 1 (9) 0.02
Morphine (%) 11 (55) 8 (89) 3 (27) 0.01
Propofol (%) 4 (20) 1 (11) 3 (27) 0.37
Midazolam  (%) 4 (20) 2 (22) 2 (18) 0.82
Epidural anaesthesia (%) 3 (15) 1 (11) 2 (18) 0.66
BP medication (%) 10 (50) 4 (45) 6 (55) 0.65
History of hypertension (%) 7 (35) 5 (56) 2 (18) 0.08
History of cardiac disease (%) 6 (30) 4 (44) 2 (18) 0.20
Data represent numbers (percentages) or mean (standard deviation).
* n= 10 (ventilated patients). 
Abbreviations: SD indicates standard deviation; IA, intraarterial; BP, blood pressure; PEEP, positive 
end expiratory pressure.
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decreased two bpm in the left lateral position compared to supine (p = 0.37), and three beats/
minute compared to right lateral position (p = 0.06). No significant changes in oxygenation 
levels between the three positions were seen (all p = 1.0). Because the covariate analysis had 
similar results, only the univariate analysis is shown. Table 3 shows the mean hemodynamic 
absolute values in the three body positions for patients with the IA line on the right or left 
side. For right IA line patients the effects of turning on BP values diminished but increased 
for left IA line patients with significantly higher values in both lateral positions. Comparable 
responses for HR and saturation were observed in both patient groups.  
dIscussIon
Our study shows that intraarterial BP recordings in the (45˚) lateral positions are higher by 
around 5 mmHg in a stable ICU population, with no differences between measurements on 
the left or right lateral side. No clinically important changes for HR and oxygenation were 
observed in the different positions. Our results are in line with two small cardiac studies and 
one with hemodynamically unstable patients.10, 11
In these studies, no clinically important hemodynamic changes in the lateral position were 
observed, yet it was unclear, unfortunately, whether both lateral positions or both arms 
were measured (Table 4).10,11 Likewise, Bein et al. found a 13 mmHg lower mean MAP in the 
right lateral position (inclination 63°) but it remains unclear whether only the dependent 
(lowermost) arm was used for comparison.5 The reported differences may be fully explained 
by different patient characteristics instead of posture or body side specific effects. Fujise et al. 
compared the hemodynamic changes during laparoscopic urological surgery between eight 
patients in the right and seven in the left lateral position. Different baseline measurements 
Table 2 Mean absolute values (SE) during different body positions
parameter supine right lateral left lateral
MAP (mmHg) 80.8 (3.1) 85.3 (2.9) 85.2 (3.1) 
Systolic BP (mmHg) 124.1 (4.9) 129.3 (4.8) 130.8 (5.2)
Diastolic BP (mmHg) 60.2 (2.5) 64.7 (2.4) 63.5 (2.4)
Heart rate (beats/minute) 96.1 (3.9) 97.2 (3.7) 94.2 (3.8)
Oxygenation (%) 97.1 (0.4) 97.1 (0.3) 97.2 (0.5)
Abbreviations: SE indicates standard error; MAP, mean arterial pressure; BP, blood pressure.
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and different responses to induced pneumoperitoneum were observed. Insufficient patient 
characteristics were presented to determine whether these observations were related 
to patient characteristics or body position.12 Stein found that the average systolic BP was 
22 mmHg lower in the left lateral than the sitting, supine or right lateral positions of 100 
patients. However, an unequal distribution of side of IA lines without height correction could 
fully explain these clinically important differences.4    
Some limitations of this study deserve mentioning. Firstly, the study had a small sample 
size. While this generally limits sensitivity and generalisability of the study results, the small 
standard errors render it unlikely that clinically important effects were missed. Secondly, an 
angle of inclination was chosen that was different from previous studies (Table 4). While that 
makes comparison to previous studies difficult, the angles of inclination chosen represent 
the effects of turning as carried out in daily practice. 
Blood pressure measurement is one of the most frequently performed clinical procedures 
Table 3  Mean hemodynamic absolute values (SE) during different body positions concerning side of 
IA line 
position right Ia line (n = 9) left Ia line (n = 11)
MAP
Supine 80.3 (4.9) 81.3 (3.7)
Left lateral 82.2 (5.0) 88.3 (3.7)
Right lateral 83.2 (4.5) 87.3 (3.6)
Systolic BP
Supine 121.2 (7.2) 127.0 (7.0)
Left lateral 124.9 (7.9) 136.8 (6.8)
Right lateral 124.7 (6.5) 133.9 (7.1)
Diastolic BP
Supine 62 (4.4) 58.5 (2.5)
Left lateral 63.5 (4.3) 63.4 (2.2)
Right lateral 64.4 (4.0) 65.0 (2.6)
Heart rate
Supine 104.4 (5.5) 87.9 (5.5)
Left lateral 102.0 (4.9) 86.4 (5.9)
Right lateral 105.1 (5.0) 89.4 (5.4)
Saturation
Supine 96.9 (0.6) 97.4 (0.5)
Left lateral 97.3 (0.6) 97.1 (0.7)
Right lateral 97.4 (0.4) 96.8 (0.5)
Abbreviations: SE indicates standard error; IA, intraarterial; BP, blood pressure; MAP, mean arterial 
pressure.
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on the ICU to guide optimal perfusion therapy. With the transducer for hydrostatic correction 
continuously fixed at around the right atrial level the BP in our study shows acceptable changes. 
These absolute changes are comparable with IA recordings in a small group of supine healthy 
volunteers in whom the position of the arm above and below the fixed transducer were varied.9 
conclusIon
For daily practice with routine turning of hemodynamically stable ICU patients, no clinically 
important changes of BP in the lateral positions are encountered. Our results show no major 
differences between the left and right lateral position. Also, no important differences in 
oxygenation and HR were observed. Comparison with previous literature suggests that 
hemodynamic effects may vary with hemodynamic status of patient groups which may 
explain observations in the past. 
6
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absTracT 
Background and purpose 
The effects of early upright positioning in the acute phase of ischemic stroke on both blood 
pressure and functional outcome have not been previously examined. 
Methods 
Prospective investigation of mean arterial pressure, heart rate and peripheral oxygen 
saturation in the supine, sitting and (if achievable) active standing position 1, 2 and 3 days 
after an acute stroke was performed. Also investigated was the presence of significant 
postural BP rise and fall using orthostatic definitions and the relation to functional outcome 
after 3 months.
Results 
One hundred sixty-seven patients were included (mean age, 68.5 ± 15.2 years; median 
National Institutes of Health Stroke Scale, 7). About 60% of the patients were able to stand. 
On average the mean arterial pressure increased when patients moved from the supine to 
sitting (Day 1: ∆ 3.9 mmHg; p < 0.001) and from sitting to an active standing position (Day 
1: ∆ 4.6 mmHg; p < 0.001). Changes were most pronounced within the first 24 hours after 
stroke. Blood pressure decreased significantly (fall) upon standing in 13% of patients and 
increased significantly (rise) in 20% of the patients. The latter was independently associated 
with favorable outcome (p = 0.003). Moving to the standing position was accompanied by 
an increase of heart rate. No difference in  peripheral oxygen saturation was observed in the 
various positions over the period of investigation.
Conclusions 
We found that a significant blood pressure rise during early upright positioning in acute 
stroke patients was independently associated with favorable outcome. No contraindication 
to early mobilization was found in this study.
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InTroducTIon 
Early mobilization and rehabilitation (in and out of bed) is increasingly applied in the setting 
of acute stroke, although largely based on low levels of evidence.12 Such early mobilization 
may prevent venous thrombosis, cardiopulmonary deconditioning, and may improve early 
plasticity of the brain.3-5 However, it may also increase metabolic demands of the damaged 
brain and decrease penumbral perfusion. Especially, the upright positioning in the setting of 
early mobilization after stroke may be detrimental to perfusion.6 In healthy subjects, upright 
positioning leads to a transient period of decreased blood pressure (BP; < 30 seconds), but 
intact cerebral autoregulation maintains a constant cerebral perfusion through increased 
cardiac output and cerebral vasodilatation.7 In acute stroke patients however, the responses 
to upright positioning may be disturbed due to (1) diminished or overactive cerebral 
autoregulation;8 (2) ischemic lesions that disturb autonomic nervous function;9 and (3) 
a potential correlation between stroke and orthostatic hypotension through shared risk 
factors such as old age, diabetes, and the use of antihypertensive medication. 
There is increasing evidence that disturbed cerebral autoregulation affects the outcome 
of stroke, especially in the setting of cervical artery disease.10 Also, various strategies in 
the stroke unit are geared towards monitoring and optimizing physiological parameters, 
partly in an attempt to salvage penumbra.11,12 However, there is only 1 study that reports BP 
responses to upright positioning in acute stroke patients.13 That study reports a 10% rate of 
postural hypotension in acute stroke patients, yet BP increases upon upright positioning in 
most patients. The relation to outcome is not addressed. It is unclear how postural changes 
in hemodynamic parameters affect the average patient in the acute stroke unit, when 
mobilized to the upright position within 24 hours of symptom onset. The aim of our study 
was to address how changes in physiological parameters upon upright positioning affect 
outcome after 3 months of an acute stroke.
meThods 
Patients 
This study was conducted in the stroke unit of a large teaching hospital from August 2008 
to June 2010. Inclusion criteria were the diagnosis of an acute stroke, age > 18 years, and 
admission to the stroke unit within 24 hours. Exclusion criteria were decrease of consciousness, 
decreased cooperation, hemodynamic instability, and fever. Baseline stroke work-up with 
baseline brain Computed Tomography (CT) scanning, electrocardiogram, duplex carotid 
ultrasound and laboratory investigation were performed. Use of any medication, especially 
anti-arrhythmic and antihypertensive medication, were registered. Discontinuation of 
preadmission antihypertensive medication was registered. Initial and follow-up stroke 
severity was assessed with the National Institute of Health Stroke Scale (NIHSS). The stroke 
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subtype was classified using the Oxfordshire Community Stroke Project classification.14 
Functional outcome at 3 months was assessed with the modified Rankin Scale by a trained 
person blinded to BP data.15 A favorable outcome was defined as a modified Rankin Scale 
score <_ 1. The study was approved by the local medical ethics committee.
Measurements 
Measurements of vital parameters in the different body positions were performed in a 
standardized fashion by a single physician. The first postural measurements were taken a 
few hours after admission in the stroke unit (Day 1, < 24 hours after ictus). BP and heart 
rate (HR) readings were taken with an automatic oscillometric device (Philips Intellivue 
MP30 monitor, Philips Medical Systems, Best, The Netherlands). This BP device measures 
oscillations from the blood vessel wall during bladder deflation. The pressure at which the 
oscillations are at a maximum is defined as mean arterial pressure (MAP). The device then 
calculates systolic blood pressure (SBP) and diastolic blood pressure (DBP) with an unknown 
patented algorithm. Continuous peripheral oxygen saturation (SpO2) monitoring was 
performed with the Intellivue MP30 device with the Fourier Artifact Suppression Technology 
(FAST) algorithm. The aim was to repeat the measurements at Days 2 and 3 at the same time 
of the day. Potential confounders for correct BP recordings were avoided,16 the instruments 
were regularly calibrated, and the size of the bladder within the cuff was adapted to arm 
circumference. 
Body positions 
To mimic the stroke unit mobilisation process patients were always brought in the sitting 
position first before carefully moving to the active standing position. Stroke patients who 
were unable to stand independently or with minimal help (e.g., because of their neurological 
deficits) were not investigated in the standing posture. The ability to stand was evaluated 
daily. Hypotensive symptoms during the sitting or standing phases were noted. In both 
sitting and standing positions the cuff was positioned close to the armpit approaching 
the level of the right atrium. In the supine position, the arm used for BP measurement was 
routinely supported by a pillow to keep it halfway the distance between the sternum and the 
bed. In the sitting position the patient was upright in bed (approximately 70˚) with the legs 
in the horizontal position. Both arms were depending besides the thorax with the forearms 
in the lap. In the standing position, the arms were depending next to the body. 
Measurements 
After 3 minutes of supine rest the supine BP was measured twice bilaterally to screen for 
important (> 8 mmHg) differences between both arms, in which case patients were excluded. 
The 4 supine BP readings were averaged. The cuff was left on the arm with the mean highest 
supine value. Three separate measurements were then averaged after 3 minutes of rest in 
the sitting position. This procedure was then repeated with the subjects in the standing 
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position. The incidence of significant postural fall as defined by  20 mmHg systolic or  10 
mmHg diastolic drop was determined by calculating the difference between standing after 
3 minutes and supine values. Similarly significant postural rise was defined as a systolic 
increase of  20 mmHg.17 HR and SpO2 were also measured in the 3 positions.
Statistical analysis 
It was calculated (paired means) that around 150 subjects were needed to detect a within 
group BP change of > 5 mmHg with a power of 80% at the 5% significance level, given that the 
standard deviation (SD) of the supine to standing systolic BP difference in elderly hospitalized 
stroke patients is  20 mmHg.13 The outcomes in this study were MAP, SBP, DBP (all mmHg), 
HR (beats/minute), and SpO2 (%) in each position. Values are presented as means ± standard 
error (SE) unless otherwise indicated. In a 2-level model, the body positions (supine, sitting, 
and standing) and days after stroke (Day 1, 2, and 3) were evaluated. A multilevel model 
was chosen because measurements were nested in patients. The effects of the covariates 
age, sex, NIHSS, history of hypertension, history of diabetes mellitus, discontinuation of 
antihypertensive medication and supine SBP (Day 1) were evaluated. The covariate age was 
centered at 37 years. To investigate whether significant BP rise or fall was independently 
associated with favorable outcome, the same covariates as in the multilevel model were 
entered in a logistic regression model where all covariates were treated simultaneously and 
on equal footing. These covariates have previously been associated with outcome of stroke or 
orthostatic hypotension. P < 0.05 was considered statistically significant. Statistical Package 
for the Social Sciences (version 16.0; SPSS Inc, Chicago, IL) was used for statistical analysis. 
Bonferroni adjustments for multiple comparisons were used in all presented results.
resulTs
Patient characteristics 
In total 167 patients were included of which 156 patients were measured on Day 1, 132 on Day 
2 and 101 on Day 3. Demographic and clinical characteristics are shown in Table 1. Median 
NIHSS was 7 with more than half (52%) being mildly affected (NIHSS < 7) and 23% being 
severely affected (NIHSS > 12). Mean supine SBP and DBP on Day 1 were 140 ± 24 mmHg and 
69 ± 14 mmHg, respectively. Mean HR was 77 ± 15 beats/minute and SpO2 97 ± 1.6%. On Day 
one 52% was able to stand, increasing to 66 and 68% on Days 2 and 3, respectively. Forty-
three percent of the patients had a favorable outcome.  
Hemodynamic parameters in various positions in the first three days after stroke 
Mean SBP, DBP, MAP, HR and SpO2 values over the first 3 days in the supine, sitting and 
standing position are presented in Table 2. SpO2 remained stable during mobilisation in 
almost all patients. BP increased going from the supine to the standing position. This was 
7
90  c e r e b r a l  h e m o d y n a m i c s  i n  s t r o k e  a n d  t r a u m a t i c  b r a i n  i n j u r y 
most pronounced on Day 1 after stroke (e.g., mean MAP change 8.5 mmHg; p < 0.001, and 
mean HR change 12 beats/minute; p < 0.001 on Day 1). The Figure also shows this increase 
of BP on attaining an upright position. It also shows that the MAP is highest on day one 
and tends to decrease over the next days. In comparison to BP, the HR response is relatively 
stable over the 3 days (Table 2). Adding covariates to the model did not influence the results. 
Only 1 stroke patient developed dizziness on standing and had a systolic fall of > 25 mmHg. 
In total 107 patients had supine and standing measurements on at least one day. The overall 
frequency of a significant BP fall in this group was 13.1% (n = 14). Ten individuals (9.3%) 
showed a postural SBP fall of 20 mmHg. In addition, 6 individuals (5.6%) had a postural 
DBP fall of 10 mmHg. Two patients fulfilled both criteria. The percentage of patients with a 
Table 1 Patient Characteristics (n = 167)
variable
Age, mean (SD), y 68.5  (15.2)
Male (%) 91  (54.5)
Median NIHSS [IQR] 7.0  [4-12]
Stroke-subtype (%)
  Total Anterior Circulation Infarct
  Partial Anterior Circulation Infarct
  Lacunar Circulation Infarct







  Small-vessel disease
  Cardioembolism
  Unknown
  Dissection 
34   (20.4)
38   (22.8)
42   (25.1)
51   (30.5)
2    (1.2)
Left-sided impairment (%)  64   (38.3)
Mean SBP (SD), mmHg # 140   (24.0)
Mean DBP (SD), mmHg # 69   (13.6)
Median glucose (SD), mmol/l* 6.7   (3.1)
Mean total cholesterol (SD), mmol/l w 5.1   (1.2)
Prior medical history (%)
  Hypertension
  Diabetes Mellitus
  Hyperlipidemia
  Myocardial infarction
  Atrial fibrillation
  Previous stroke
  Prior use of antihypertensives
87   (52.1)
29   (17.4)
37   (22.2)
27   (16.2)
26   (15.6)
32   (19.2)
90  (53.9)
Data are numbers with either standard deviation (SD) or percentages (%) in parentheses.
*  Five missing values.
w  Six missing values.
#   All baseline blood pressure measurements were carried out in the stroke unit.
Abbreviations: NIHSS indicates national institutes of health stroke scale; IQR, interquartile range; 
SBP, systolic blood pressure; DBP, diastolic blood pressure; SD standard deviation.
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significant postural SBP fall was 1.2%, 3.5% and 10.4% on Days 1, 2 and 3, respectively. The 14 
patients with this significant BP fall more often had a history of hypertension (78.6% versus 
49.5%; p = 0.04) and their antihypertensive medication was more frequently discontinued at 
admission (50% versus 20.4%; p = 0.04). HR responses did not differ between the group with 
significant BP drops compared to the rest (p = 0.42). A SBP rise > 20 mmHg occurred in 19.6% 
of patients. On Day 1, 10 patients had a significant BP rise (12.2%) and during the following 
days these percentages decreased to 10.5% and 6.0%, respectively. Patient characteristics 
were similar for those with and without this BP rise of > 20 mmHg. HR responses did not 
differ significantly either (p = 0.28).
Change in hemodynamic parameters and outcome 
Patients with a significant SBP rise had a significantly better outcome with 81% favorable 
outcome rates versus 51% in the group without this response (p = 0.01). In the multivariate 
analysis significant BP rise was an independent predictor of favorable outcome (odds ratio 
(OR) 7.95; 95%-confidence interval (CI) 2.02-31.28; p = 0.003; Table 3). There was no significant 
relationship between significant BP fall and outcome.
Table 2  Blood pressure, heart rate and oxygenation in different body positions in the first 3 Days after 
stroke
position change (no.) sbp, mmhg dbp, mmhg map, mmhg hr, beats/minute spo2(%)
Day 1 Supine 140  (24) 69  (15) 85  (14) 77  (15) 97  (2)
Supine-Sitting (156) -4.0  (0.8)# -4.4  (0.5)# -3.9  (0.5)# -1.3  (0.5) -0.1  (0.1)
Supine-Standing (82) -6.7  (1.0)# -9.1  (0.7)# -8.5  (0.7)# -12.0  (0.6)# -0.3  (0.1)
Sitting-Standing (82) -2.7  (1.1) -4.8  (0.7)# -4.6  (0.7)# -10.7  (0.7)# -0.2  (0.1)
Day 2 Supine 135  (22) 67  (14) 84  (15) 74  (14) 97  (2)
Supine-Sitting (132) -2.6  (0.9) -5.0  (0.6)# -4.5  (0.6)# -1.8  (0.6) -0.1  (0.1)
Supine-Standing (86) -4.1 (1.0)* -7.9  (0.7)# -7.4  (0.7)# -11.7  (0.7)# -0.1  (0.1)
Sitting-Standing (88) -1.5  (1.0) -2.9  (0.7)# -2.9  (0.7)* -9.9  (0.7)# -0.0  (0.1)
Day 3 Supine 135  (21) 69  (13) 85  (14) 73  (15) 97  (2)
Supine-Sitting (101) -1.5  (1.0) -3.3  (0.7)# -3.4  (0.7)# -2.8  (0.7)# -0.3  (0.1)
Supine-Standing (67) 1.3  (1.2) -5.6  (0.8)# -3.8  (0.8)# -10.8  (0.8)# -0.5 (0.1)*
Sitting-Standing (69) 2.7  (1.2) -2.3  (0.8) -0.4  (0.8) -8.0  (0.8)# -0.3  (0.1)
Rows in gray show supine values for SBP, DBP, MAP, HR and SpO2. SD is mentioned in parentheses. 
Other rows show changes of these values in response to various position changes. SE is mentioned in 
parentheses. A negative value indicates an increase upon the position change. All data are adjusted 
for multiple comparisons (Bonferroni).
Abbreviations: SBP indicates systolic blood pressure; DBP, diastolic blood pressure; MAP, mean 
arterial pressure; HR, heart rate; SpO2, oxygen saturation. 
# p < 0.001.
* p < 0.05.
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Table 3 Prediction of favorable outcome (Defined as mRS 0-1; n = 107)
variable or 95% cI P value
Sex (male) 0.77 0.31-1.91 0.57
Age, y 0.98 0.95-1.02 0.35
NIHSS per point increase 0.82 0.72-0.93 0.002
History of DM 0.44 0.13-1.53 0.20
History of  HT 0.51 0.17-1.53 0.23
Significant postural BP rise 7.95 2.02-31.28 0.003
Mean supine SBP (Day 1) 1.01 0.99-1.03 0.30
Discontinuation of  AHT 1.32 0.43-3.99 0.63
Abbreviations: OR indicates odds ratio; CI, confidence interval; NIHSS, national institutes of 
health stroke scale; DM, diabetes mellitus; (S)BP, (systolic) blood pressure; HT, hypertension; AHT, 
antihypertensive medication; mRS, modified Rankin score.  
Figure 1
Blood pressure and heart rate on Days 1, 2 and 3 in supine, sitting, and standing position. Bars 
represent standard errors of the mean (SEM). Temporal trends were calculated and the asterisk 
(*) represents significance (p < 0.001) over the following 3 Days.
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dIscussIon
In this prospective study, we evaluated the influence of the supine, sitting and active 
standing body positions on indirect BP, HR and SpO2 over the first 3 days of acute ischemic 
stroke patients. The results demonstrated increases of mean SBP, DBP and MAP upon 
sitting and standing, especially on Day 1. Moving to the standing position was accompanied 
by an increase of HR, which was only slightly more pronounced on admission. SpO2 was 
not different in the various positions over the days. The incidence of significant postural 
BP fall and rise were approximately 13% and 20%. Interestingly, a significant BP rise was 
independently associated with a favorable outcome 3 months after stroke.   
This is the first study to demonstrate a relationship between hemodynamic responses to 
various body positions and outcome in stroke patients. Our findings are in agreement with a 
previous study of 40 elderly stroke patients with DBP and MAP increasing significantly upon 
sitting and active standing on admission and 1 week after stroke. The incidence of significant 
postural BP fall in that group was approximately 10%.13 Later the same group reported that 
the use of antihypertensive medication in the acute phase does not contribute to significant 
postural BP fall.18 Although the results are comparable to ours, patients in both studies 
were asked to move directly from the supine to the active standing position, bypassing the 
sitting position. Their approach allows a formal assessment of the presence of orthostatic 
hypotension according to published criteria.19 Our more gradual approach does not allow 
such a formal assessment, but is a better simulation of the actual physiological challenges to 
the patient when mobilized at the stroke unit. Two other stroke studies used passive tilt table 
investigation in the acute and chronic phase of stroke. Again, the physiological response on 
tilting is different from our active standing protocol making comparison difficult.9,20 
The incidence of significant postural BP fall was very low in our cohort on Day 1 (1.2%) and 
increases to approximately 10% which is comparable to the known incidence of orthostatic 
hypotension in the normotensive and hypertensive elderly.13,21,22 The incidence of significant 
postural BP rise was around 12% on admission and decreased slowly over the next days. 
Interestingly, this acute hypertensive postural response was an independent predictor for 
favorable outcome. To our best knowledge this direct relationship with outcome has not been 
reported in acute stroke patients previously. Chronic orthostatic hypertension in Japanese 
patients with essential hypertension has been associated with silent cerebrovascular 
ischemia and infarction,23 but this is most probably a different phenomenon than the one 
we observed in the acute phase of stroke.
An acute hypertensive response defined as an elevation of BP above normal within the 
first 24 hours of symptom onset is reported in > 60% of stroke cases.24 Spontaneous reduction 
in the initial BP over the next few days in most patients supports the role of a transient 
and stroke-specific mechanism. Spontaneous reduction of BP after vessel recanalisation 
also implies stroke-specific mechanisms.25 Several underlying mechanisms like damage to 
cardiovascular and autonomic brain centers,26 an excessive reaction to venous pooling in the 
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legs,27 an increased sympathetic nervous system and/or reduced parasympathetic activity, 
an impaired cardiac baroreceptor sensitivity and raised levels of circulating catecholamines 
may all contribute to this hypertensive response.28,29 Our results relate favorable outcome 
to an exaggerated postural BP increase without important contributions of HR. The effect 
persisted after correction for known confounders (such as medical history, NIHSS, age or BP 
medication).30 It is known that BP changes on tilting reflect sympathetic nervous system 
function.31 All together this suggests a positive role of an intact or enhanced sympathetic 
autonomic function in recovery after stroke by allowing adequate responses to physiological 
challenges such as early mobilisation.29,32 
 Because not all patients were included consecutively, we assessed external validity by 
comparing baseline characteristics to those of the stroke registry of our centre (Table S1) and 
data published.33 The only important difference was a higher NIHSS in our study population. 
Patients with early complete or nearly complete recovery may have been less likely included. 
Patients dropped out on Days 2 and 3 due to transfers to other hospital or discharge, which 
may have influenced changes seen from Days 1 to 3. The impact of this is likely limited as 
patient characteristics for drop-outs were comparable to those who finished the study and 
main results were similar excluding patients who failed all repeat measures (Table S2 and 
Figure S1). Furthermore, in our study, upper extremities were depending instead of horizontal 
when BP was measured in the sitting and standing position because of paresis or fatigue of 
extremity. However, attention should be paid to the position of the BP cuff to the right atrial 
level to obtain correct measurements.34 BP measurement will result in higher values if the 
cuff is below the right atrium. Favorable outcome was defined as modified Rankin Scale 
score of 0 to 1. This seems appropriate for the active standing stroke group with mild to 
moderate disability (median NIHSS of 5 [4-8], n = 107).  
conclusIon 
The present study shows that upright positioning as part of early mobilization in mildly 
to moderately affected acute stroke patients does not lead to important decreases in BP, 
HR or SpO2. This constitutes an additional argument for the safety of early mobilization 
after stroke.35 Exaggerated postural BP rises seem to be related to favorable outcome in 
the acute phase of ischemic stroke. It is an underappreciated, yet easily diagnosed, clinical 
phenomenon. Further studies to confirm and explain these findings in the setting of acute 
stroke are required. Greater attention for postural BP changes seems warranted when 
designing and interpreting acute stroke hypertension treatment and mobilization trials.36,37
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supplemenTal maTerIal
Table  S1  Patient Characteristics of study cohort and Stroke database registry Groningen  
(period 2010-2011)
study 




Age, mean (SD), y 68.5  (15.2) 69.3 (14.7)
Male (%) 91  (54.5) 148 (51)
Median NIHSS [IQR] 7.0  [4-12] 4.0 [2-10]                          N=229
Stroke-subtype (%)
  Total Anterior Circulation Infarct
  Partial Anterior Circulation Infarct
  Lacunar Circulation Infarct









18 (12)                                 N=150
Stroke etiology (%)
  Atherosclerosis
  Small vessel disease
  Cardio-embolism
  Unknown
  Dissection 
34   (20.4)
38   (22.8)
42   (25.1)
51   (30.5)





4 (3)                                    N=144
Left-sided handicap (%)  64   (38.3) 65 (40)                               N=161
Mean SBP (SD), mmHg 140   (24.0)# 152 (26)$                            N=242
Mean DBP (SD), mmHg 69   (13.6)# 81 (17)$                               N=242  
Median glucose (SD), mmol/l 6.7   (3.1)* 6.4 (2.8)                             N=229
Mean total cholesterol (SD), mmol/l 5.1   (1.2)w 5.3 (1.4)                              N=229
Prior medical history (%)
  Hypertension
  Diabetes Mellitus
  Hyperlipidemia
  Myocardial infarction
  Atrial fibrillation
  Previous stroke
  Prior use of antihypertensives
87   (52.1)
29   (17.4)
37   (22.2)
27   (16.2)
26   (15.6)
32   (19.2)
90  (53.9)
147 (60)
60   (24)
84   (35)
36   (15)
43  (17)
51  (22)
146 (60)                              N=242
Data are numbers with either SD or percentages (%) in parentheses.
Abbreviations: NIHSS indicates national institutes of health stroke scale; IQR, interquartile range; 
SBP, systolic blood pressure; DBP, diastolic blood pressure; SD, standard deviation.
*    5 missing values.
w 6 missing values.
#  All baseline blood pressure measurements were carried out in the stroke unit. 
$  All baseline blood pressure measurements were carried out in the emergency ward.  
Blood pressure on Days 1, 2 and 3 in supine, sitting, and 
standing  position without the patients who failed all repeat 
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Table S2  Prediction of favorable outcome (Defined as mRS 0-1; n = 93) without the patients who failed 
all repeat measures
variable or 95% cI P value
Sex (male) 0.67 0.25 - 1.70 0.42
Age, y 0.98 0.95 - 1.02 0.34
NIHSS per point increase 0.84 0.73 - 0.96 0.01
History of DM 0.38 0.10 - 1.50 0.17
History of  HT 0.48 0.14 - 1.60 0.24
Significant postural BP rise 9.70 2.07 - 45.3 0.004
Mean supine SBP (Day 1) 1.01 0.99 - 1.04 0.27
Discontinuation of  AHT 1.01 0.32 - 3.20 0.30
Abbreviations: OR indicates odds ratio; CI, confidence interval; NIHSS, national institutes of 
health stroke scale; DM, diabetes mellitus; SBP, systolic blood pressure; HT, hypertension; AHT, 
antihypertensive medication; mRS, modified Rankin score. 
chapTer 8
The ImpacT of uprIghT posITIonIng In bed on cerebral 
blood flow velocITy afTer acuTe sTroke. 
ImplIcaTIons for safeTy of early mobIlIzaTIon afTer sTroke
M.J.H. Aries, J.W. Elting, R.E. Stewart, J.H.A. De Keyser, 
H.P.H. Kremer, P.C.A.J. Vroomen
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absTracT 
Background 
International guidelines recommend mobilisation of acute stroke patients in and out of bed 
as soon as their clinical condition permits. Little is known about the influence of different 
body positions on real time cerebral flow variables in the acute ischemic stroke phase. We 
aimed to assess whether cerebral blood flow velocity (CBFV) changes significantly after 
upright positioning in bed and related this to changes in neurological status, functional 
outcome and dynamic autoregulatory status.
Methods 
We investigated postural changes in neurological status and simultaneously recorded 
bilateral Transcranial Doppler (TCD), near-infrared spectroscopy, end-tidal CO2 and non-
invasive continuous blood pressure (BP) data in patients with first ever acute middle 
cerebral artery ischemic stroke. Postures included supine, half sitting (45°), sitting (70°) and 
Trendelenburg (-15º) position. Dynamic autoregulation was evaluated by estimating phase, 
gain and autoregulation index (ARI) of TCD flow velocity correlations with spontaneous BP 
fluctuations in the supine position. Using multilevel analyses, we compared postural changes 
between hemispheres, follow-up measurements, and outcome groups and between stroke 
patients and 20 controls.  
Results 
The final analysis included 52 patients, 47 and 33 within 24 h and 72 h after symptom 
onset, respectively. Mean age was 62.0 ± 15 years and median National Institutes of Health 
Stroke Scale score (NIHSS) on admission was 7 (IQR 5-14). During the upright positioning, no 
neurological worsening or improvement (using motor NIHSS) was observed in any of the 
patients. Mean CBFV decrease upon sitting (70°) was comparable between controls and 
stroke patients, with a mean difference of 4% on Day 1 for the affected hemisphere (95% 
CI: -11% to 3%, p=1.0) and 1% (95% CI: -8% to 6%, p=1.0) on Day 3. No significant differences 
were found between affected and unaffected stroke hemispheres and between patients 
with unfavorable and favorable outcome. Dynamic cerebral autoregulation was impaired in 
stroke patients which showed a bilateral decrease in phase and ARI estimates. No correlation 
between bilateral impaired autoregulation status and positional mean CBFV changes was 
found. 
Conclusions 
Upright positioning in bed of mildly to moderately affected stroke patients appears to be 
safe during the first 3 days on the stroke unit, despite a bilaterally impaired dynamic cerebral 
autoregulation. Supine or Trendelenburg positioning did not seem to augment real time flow 
variables or improve neurological status.    
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InTroducTIon 
Brain ischemia is a potentially reversible process that is dependent on restoration of 
cerebral blood flow (CBF) within a time window of cellular viability that varies according 
to the severity and duration of the flow cessation.1 Any activity that alters CBF during the 
acute phase of ischemic stroke may directly contribute to extension of the ischemic core 
and compromise clinical outcome. International guidelines recommend mobilisation in and 
out of bed as early as possible (depending on clinical condition) after stroke.2-5 Such early 
upright positioning prevents venous thrombosis, cardiopulmonal deconditioning and may 
improve early plasticity of the brain.5,6 However, there is insufficient evidence in support 
of early activity in and out of bed after acute stroke.7 Also, there is fear of gravity-induced 
diminished CBF to ischemic brain tissue by upright positioning in the setting of a (potentially) 
disturbed cerebral autoregulation.8,9 As a result, stroke physicians do not universally accept 
early mobilisation.
Little is known in acute stroke patients about the influence of different body positions on 
systemic blood pressure (BP), or, more importantly, on real time CBF variables.9 Transcranial 
Doppler (TCD) of the middle cerebral artery (MCA) may be used to assess cerebral blood 
flow velocity (CBFV) at the bedside in the stroke unit. Wojner et al. reported that different 
recumbent head of bed (HOB) positions (30º to 0º) augmented MCA CBFV by 20% on the 
affected side in 20 patients with severe acute stroke with improvement of deficits in a 
proportion. They advised to nurse stroke patients ‘heads down’.10 If such relatively minor 
changes in HOB position have such impact on CBFV and neurological status, the question 
arises what the consequences of early in bed upright HOB positioning in acute stroke patients 
would be in terms of cerebral perfusion. In this study we sought to assess whether MCA 
CBFV changes significantly after upright HOB positioning, in affected as well as unaffected 
stroke hemispheres. Any changes were compared between positions, hemispheres, follow-up 
measurements and between patients and controls. Any effect of in bed upright positioning 
on neurological status, and outcome was determined. 
While this bedside evaluation addresses the hemodynamic and clinical effects of upright 
positioning, it cannot serve as a formal evaluation of cerebral (pressure) autoregulation. For 
evaluation of static cerebral autoregulation (CA), larger fluctuations of BP would need to be 
induced than would normally occur during upright positioning in the stroke unit.11 However, 
challenges such as tilt table testing and pharmacological manipulation of BP are not feasible 
in the setting of acute stroke. An alternative method to formally evaluate autoregulation and 
which is feasible at the bedside of the patient is the assessment of dynamic CA (in response to 
spontaneous BP fluctuations). Dynamic CA was evaluated to assess how hemodynamic and 
clinical effects of postural changes in stroke are related to disturbances in autoregulation.
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meThods
Study design and patients 
This study was conducted in the stroke unit of a large teaching hospital between August 
2008 and May 2011. Patients aged over 18 years with a first ever ischemic stroke in the MCA 
territory, admitted to the stroke unit within 24 h after stroke onset were considered eligible. 
Patients had to be conscious, cooperative, and hemodynamically stable without fever. These 
factors were incorporated into the final clinical and nursing judgment whether patients 
were deemed too severely affected by the stroke or too severely ill to position upright and 
be included in this study. Brain CT, electrocardiography, bilateral duplex carotid ultrasound, 
and laboratory investigations were performed. Thrombolytic therapy was administered 
according to (inter)national guidelines. Use of any medication, especially antiarrhythmics 
and antihypertensive medication, was registered. The National Institute of Health Stroke 
Scale score (NIHSS) was used to determine initial (on admission) and Day 3 neurological 
deficit. Neurological deterioration or improvement after 72 h was defined as any change 
on the NIHSS score. The stroke subtype was classified using the Oxfordshire Community 
Stroke Project (OXFORD) classification,12 and stroke cause according to Trial of Org 10172 in 
Acute Stroke Treatment definitions.13 The modified Rankin Scale (mRS) score at 3 months 
was determined by a certified assessor by telephone interview, who was blinded to the 
physiological data.14 The study was reviewed by the local medical ethics committee that 
allowed execution. All participants or next of kin gave informed consent. Twenty age and sex 
matched controls were recruited and their medical history was reviewed. 
Sample size calculation 
In the literature, the standard deviation (SD) of the intraindividual supine to sitting MCA 
CBFV difference is estimated to be around ± 5% for elderly hospitalized patients,15 and ± 20% 
for severe stroke patients going from 30º to 0º.10 To detect a difference in CBFV of more than 
6 cm/s (10% to 20%) between supine and sitting upright in bed with a probability (power) of 
90% when testing at a two-sided significance level of 5%, a sample size of 45 subjects was 
required. 
Procedures 
BP was measured with a finger servo-controlled plethysmograph (Finometer-Pro, Finapress 
Medical Systems, Amsterdam, The Netherlands). The cuff was applied to the middle finger 
of the non-dominant or paretic hand placed at the heart level with the arm across the 
chest and supported by a sling. Mean arterial pressure at the MCA level (MAPmca, mmHg) 
was automatically calculated from the MAP measured at heart level and the vertical finger-
to-TCD probe distance. TCD was performed by the same neurosonographer (MA) over the 
temporal bone window on both sides. Subjects were evaluated for an adequate temporal 
window for insonation of the MCA. MCA wave forms were identified at a depth range of 40 
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to 60 mm and a stable forward waveform with good intensity was selected for monitoring. 
Using the time-averaged mean velocities of the maximum velocity outlines of the Doppler 
spectrum, the mean flow velocity (MCA CBFVmean, cm/s) was calculated (Nicolet Pioneer 
TC8080, Carefusion Corporation, San Diego, USA). Patients with permanent MCA occlusion 
on TCD were excluded. TCD probes (2.0 MHz) were mounted by a head frame to ensure a 
constant angle of insonation throughout the positioning procedure. End-tidal CO2 (etCO2, kPa) 
was measured by a mask using an infrared CO2 analyzer (Capnomac Ultima, GE Healthcare, 
Chalfont St Giles, UK) as an approximation of partial arterial CO2 pressure. The beginning and 
ending time-points of the postural transitions were marked. These data periods (± 30 sec) 
were not used for analysis. 
From 2010 onwards, the data collection protocol was changed. Firstly, bifrontal near- 
infrared spectroscopy (NIRS) recording was added. Secondly, all signals (including the 
positional marks) were captured synchronously at 250 Hz using a A/D converter. This 
allowed calculation of dynamic CA estimates in the baseline supine position (see later) 
with Labview software (Labview 9.0, National Instruments, Austin, USA. The INVOS 5100C 
NIRS device (Somanetics Corp, Detroit, MI) has a sampling frequency of 0.2 Hz for regional 
cerebral oxygenation (rSO2, %) calculation. Adhesive optodes were placed on each side of the 
forehead, high enough to avoid muscle artifact and sufficiently lateral to avoid the superior 
sagittal sinus.
Data analysis 
The recorded signals were visually inspected for artifacts and ectopy. Occasional artifacts 
of short duration, visible as narrow spikes in the TCD, BP or rSO2 signal, were removed by 
linear interpolation. Using the high frequency data, beat to beat data were obtained by 
triggering on the ascending slope during BP systole. The data were resampled at 10 Hz by 
spline interpolation to create a uniform time base. This was followed by mean normalization 
and subtraction of 1 to create zero mean signals. A Hanning window was applied to the data, 
and the Welch method of spectral estimation was used with 50% overlap on data segments 
of 51.2 seconds. This resulted in spectral estimates averaged over 10 segments in the baseline 
supine position.16  
The coherence and transfer function analysis (TFA) estimates were calculated at the low 
frequency (LF) range (0.06 to 0.14 Hz) without attempts to unwrap the phase spectra. The LF 
was taken because in this range coherence is high in healthy volunteers using spontaneous BP 
fluctuations.17 The coherence between BP and CBFV was considered significant if it exceeds 
the 95% confidence interval (95% CI) level of ‘no linear’ association: 1-(0.05)1/L-1,18 where L is 
the number of data segments used in the averaging, resulting in a significance level of 0.28. 
Transfer functions were calculated for each subject over the frequency range meeting the 
significance coherence criterion and averaged to obtain mean values. The phase shift (º) is 
a measure of the extent of which each frequency component of the respective time series 
leads the BP time series, and it represents continuous, early counter regulation of CBFV 
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against rise and fall of BP. By dividing the CBFV by the BP spectra the amplitude frequency 
response or gain (cm/s mmHg-1) can be calculated quantifying the damping effect of the 
system on the magnitude of spontaneous BP fluctuations. This means that higher phase 
shift and lower gain in de LF range indicates better dynamic CA.19
The autoregulation index (ARI) was calculated by transforming the real and imaginary 
parts of the transfer function back to the time domain with inverse Fast Fourier 
transformation. The impulse response function thus created was integrated to yield the step 
response function. The first 10 seconds of the step response function were compared with 
the original Tiecks curves and the best fitting curve was determined by implementing a least 
squares fitting procedure. This resulted in a score ranging from 0 to 9, with 0 representing 
total absence of dynamic CA and 9 the most effective CA.11 
Positioning protocol
 After admission to the stroke unit, patients were instrumented. Subjects were requested 
to abstain from moving and talking in order to minimize artifacts and activity related CBFV 
changes. Great care was taken to keep the head in the neutral midline position (without 
shifting of the headband) and the BP cuff at heart level during positioning. A test run was 
performed. After 10 min of supine rest (baseline supine) the subjects were passively tilted by 
changing HOB angles to 45º (half sitting), 70º (sitting) and -15º (Trendelenburg) position for 
3 to 5 minutes each. Patients were brought in the sitting position twice. Periods of tilts were 
interspaced with 3 to 5 min of supine rest to re-establish control values (supine position). 
The first measurement was performed within 24 h after symptom onset and the second (if 
possible) 48 h later. Before and after establishing each position the motor NIHSS (affected 
arm and leg) was evaluated. Control subjects were recorded in a quiet, temperature 
controlled research room using the same positioning protocol.
Statistical analysis 
We calculated a mean hemodynamic value for every position period. To compare responses 
in each position, percentage changes in the variables (MCA CBFVmean, rSO2, MAPmca, heart rate 
(HR), etCO2) were calculated as the differences between the positions after normalization to 
the mean baseline supine value. We averaged these percentage changes to obtain a mean 
percentage change for each of the four different positions: supine, half sitting, sitting and 
Trendelenburg. For control subjects, the mean of both MCA CBFVmean and rSO2 signals was 
taken. To account for, and to take advantage of the correlation between repeated measures 
in the same individual, a multilevel model was used to estimate the effects of positioning, 
affected hemisphere and day of recording on changes in the main variables (MCA CBFVmean 
and rSO2).
20 The relation between MCA CBFVmean and outcome (dichotomized as mRS 0-2 
for favorable outcome) was analysed in a similar way. Significant carotid stenosis, stroke 
subtype, NIHSS, age and sex were used as potential confounding covariates in stroke group 
comparisons. Age, sex and history of hypertension, cardiac disease and diabetes were used 
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as covariates for healthy control and stroke group comparisons. Bonferroni adjustments for 
multiple comparisons were used for all results presented. Dynamic CA data were explored 
using analysis of variance. Simple correlation analysis was used to compare CBFVmean response 
upon sitting and dynamic CA estimates (in baseline supine period). Statistical analysis was 
done with SAS (version 9.2).
resulTs 
In total we enrolled 52 acute stroke patients in the study. We measured 47 patients within 
24 h (Day 1 measurement) and 33 patients within 72 h (Day 3 measurement) after symptom 
onset. Twenty-eight patients had measurements on both days (Day 1 and 3 measurements). 
Five patients were measured on Day 3 only. Table 1 shows the demographic characteristics 
of the study sample. Mean patient age was 62.0 ± 15 years and median baseline NIHSS was 
7 points [IQR 5-14 points]. NIRS recordings and calculation of dynamic CA parameters were 
done in 34 patients (65%) and 17 controls (85%). 
Figure 1 shows that systemic and cerebral hemodynamic changes were most pronounced 
when moving from supine to sitting position (70°) for both patients and controls. The results 
presented, including Table 2 and 3, therefore focus on changes from supine to sitting position, 
with information on other positions, unaffected hemisphere and additional comparisons 
available as supplemental material (SM; Table S1-S11). In the sitting position on Day 1 for 
both affected and unaffected hemisphere MCA CBFVmean decreased in 28 patients (60%) 
and rSO2 decreased in 18 patients (55%). On Day 3 these percentages were 64% and 57%, 
respectively. None of the univariate results presented below were different after adjustment 
for predefined covariates, except for the outcome analysis.
Positional changes, neurological status and outcome for all positions 
We observed no neurological worsening or improvement during the postural changes 
in any of the patients. Eighteen patients (64%) had improved neurologically on Day 3. In 
total 3 patients had deteriorated (11%) with a NIHSS decline of 1 point (due to recurrent 
embolic stroke), 3 points (due to progression from carotid stenosis to occlusion) and 2 points 
(due to edema) on Day 3. There was no significantly greater MCA CBFVmean decrease upon 
positioning in patients with unfavorable compared to favorable outcome after correction for 
confounding covariates (mean difference upon sitting, for the affected hemisphere on Day 
1: -5%, 95% CI -14% to 5%, p = 1.0). There were no significant differences between large and 
small vessel strokes (using OXFORD classification) on both days and hemispheres concerning 
MCA CBFVmean changes upon sitting (all p = 1.0).  
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Positional CBFV changes upon sitting in stroke patients and controls 
MCA CBFVmean dropped slightly more (but not significantly) in controls compared to stroke 
patients on Day 1 (for affected hemisphere: -4%, 95% CI -11% to 3%, p = 1.0) and Day 3 (for 
affected hemisphere: -1%,  95% CI -8% to 6%, p = 1.0) (SM: Table 7 and 8). 
Positional CBFV changes upon sitting in affected and unaffected hemisphere 
MCA CBFVmean was not different between the affected and the unaffected hemisphere in 
the sitting position (on both days: -2%, 95% CI -5% to 2%, p = 1.0) (SM: Table 5 and 6). 
Figure 1
Image showing the changes of MCA CBFVmean in the different bed positions on Day 1 (Figure 
A) and Day 3 (Figure B) following acute ischemic stroke, for both patients (affected hemisphere) 
and healthy controls. Changes in rSO2 in the different bed positions on Day 1 (Figure C) and Day 3 
(Figure D) following acute ischemic stroke for both patients and controls are also shown. Data were 
normalized with regard to the baseline supine position. Error bars represent standard error of the 
mean (SEM).  
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Table 1 Patient characteristics 
measure patientsday 1 (n = 47)
patients
day 3 (n = 33)
control subjects 
(n = 20)
Age, mean (SD), y 62 (15) 60 (15) 52 (20)
Male (%) 32 (70) 21 (66) 11 (55)
Affected right hemisphere  (%) 24 (52) 16 (50) -
Median NIHSS score on admission [IQR] 7 [5-14] 6 [3-11] - 
History of hypertension  (%) 21 (46) 15 (47) 7 (35)
History of cardiac disease  (%) 17 (37) 10 (31) 0 (0)


















  Total Anterior Circulation Infarct
  Partial Anterior Circulation Infarct
  Lacunar Circulation Infarct









History of Diabetes Mellitus (%) 8 (17) 3 (9) 0 (0)
Antihypertensive medication on admission (%) 25 (54) 16 (50) 6 (30)
IV Thrombolysis treatment received (%) 20 (44) 14 (44) -
Mean Arterial Pressure (SD), mmHg 84 (21) 81 (19) 78 (13)
Mean Heart rate (SD), beats/minute 77 (18) 71 (13) 64 (7)
Data are absolute numbers with either SD or percentages (%) in parentheses. 
Abbreviations: SD indicates standard deviation; IQR, interquartile range; NIHSS, national institutes 
of health stroke scale. 
Table 2 Changes of MCA CBFVmean and rSO2 in supine (0°) and sitting (70°) position on Days 1 and 3 
mca cbfvmean 
supine (0°) ∆ mca cbfvmean P value
# rso2
supine (0º)
∆ rso2 P value#
Affected Hemisphere








(-0.03 to -0.01) 0.006
Unaffected Hemisphere 


















(-0.05 to -0.01) 0.002
Affected Hemisphere








(-0.05 to -0.01) 0.004
Unaffected Hemisphere 








(-0.04 to -0.01) 0.02
Data are normalized values with 95% CI in parentheses. 
Abbreviations: MCA CBFVmean indicates middle cerebral artery cerebral blood blow velocity; rSO2, 
regional cerebral oxygen saturation.
*Thirty-two and twenty-two patients had appropriate near-infrared spectroscopy recordings on 
Days 1 and 3, respectively. 
#p values with (Bonferroni) correction for multiple comparisons. 
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Positional CBFV changes upon sitting on Days 1 and 3 
MCA CBFVmean decreased significantly with moving to the sitting position on Day 1 (-4%, 95% 
CI -6% to -3%, p = 0.005) and Day 3 (-7%, 95% CI -10% to -3%, p < 0.001) for the affected 
hemisphere (Table 2). MCA CBFVmean in the sitting position was not different between Day 1 
and Day 3 (for affected hemisphere -3%, 95% CI: -7% to 1%, p = 0.29) (SM: Table 4).
Positional changes of rSO2, MAP and etCO2 upon sitting 
rSO2 decreased significantly with moving to the sitting position on Day 1 (-2%, 95% CI -3% to 
-1%, p = 0.006) and Day 3 (-3%, 95% CI: -5% to -1%, p = 0.004) for the affected hemisphere 
(Table 2). In agreement with MCA CBFVmean, the small rSO2 positional responses were not 
significantly different between both hemispheres, between measurements on the two Days 
and between patients and controls (SM: table 4-8). MCA CBFVmean and rSO2 were positively 
correlated for the affected hemisphere on Day 1 (r = 0.33, p = 0.01).  
In stroke patients MAPmca decreased on average by 15% on Day 1 (95% CI -19% to -10%, 
p < 0.001) and 17% (95% CI -22% to -12%, p < 0.001) on Day 3, similar to controls (-17%, 95% 
CI -24% to -11%, p < 0.001). MAPmca increased during the course of the experiment, for both 
patients and controls, looking at MAPmca values during the supine rest periods (Table 3). The 
postural responses were accompanied by only minor HR changes. EtCO2 decreased with 
moving to the sitting position on Day 1 (-3%, 95% CI -5% to -1%, p < 0.001) and Day 3 (-4%, 
95% CI -7% to -2%, p < 0.001) for the patients (Table 3). 
Dynamic autoregulation estimates 
Because of absence of significant coherence, dynamic CA estimates were not available in 5 
patients on Day 1 (16%). Results of the averaged different estimates are shown in Table 4 with 
Table 3  Changes of MAPmca, HR and etCO2 in supine (0º) and sitting (70º) position (normalized 
values) on Days 1 and 3 
mapmca








∆ etco2 p value#
Stroke 
patients 





































































Data are normalized values with 95% CI in parentheses. 
Abbreviations: MAPmca indicates mean arterial pressure at circle of Willis level; HR, heart rate; 
etCO2, end-tidal CO2.
*Thirty-two and twenty-two patients had appropriate near-infrared spectroscopy recordings on 
Days 1 and 3, respectively.
# p values with (Bonferroni) correction for multiple comparisons.
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evidence of bilaterally significant lower ARI and phase on both days in stroke patients (Table 
4). In the baseline supine position etCO2 levels were significantly lower for stroke patients in 
comparison to controls on both days (for Day 1; 4.0 versus 4.6 kPa, p = 0.002). Parameters of 
dynamic CA were more impaired in large vessel strokes with some improvement on Day 3 
for the unaffected hemisphere (Figure 2 and 3). This phenomenon persisted after exclusion 
of the 4 patients with symptomatic carotid stenosis. Interestingly, there is no correlation 
between MCA CBFVmean response upon sitting and any of dynamic CA estimates (for example 
on Day 1 for the affected hemisphere: ARI r = 0.16, p = 0.43; phase  r = -0.31, p = 0.14; gain r = 
-0.14, p = 0.44).  
Figure 2
Dynamic autoregulation estimates (ARI, gain and phase) on Day 1. Data are divided into non affected 
and affected hemisphere, stroke subtype (large vessel (PACI together with TACI, n = 17) versus small 
vessel (LACI, n = 10) strokes) and compared to controls (average value of both hemispheres, n = 17). 
Analysis of variance shows that significant lower ARI and phase estimates are present for large 
vessel strokes for both hemispheres compared to controls (* p < 0.05 in posthoc testing) (Figure 2 
A and B). Error bars represent standard error of the mean (SEM). In Figure 2 D the averaged supine 
mean arterial pressure (MAP) and etCO2 (secondary y-axis) levels are depicted. 
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dIscussIon 
Our study showed that following acute ischemic stroke in MCA territory early upright 
positioning in bed resulted in minor average changes in the CBFVmean only. The postural 
responses were not significantly different between the affected and unaffected 
hemispheres, between follow-up measurements, and between patients and controls. 
Passive upright positioning was not accompanied by worsening of the (motor) stroke 
Figure 3
Dynamic autoregulation estimates (ARI, gain and phase) on Day 3. Data are divided into non affected 
and affected hemisphere, stroke subtype (large vessel (PACI together with TACI, n = 13) versus small 
vessel (LACI, n = 10) strokes) and compared to controls (average value of both hemispheres, n = 17). 
Analysis of variance shows that significant lower ARI and phase estimates are still present for 
large vessel strokes compared to controls (* p < 0.05 in posthoc testing), with suggestions for some 
improvement of dynamic autoregulation in the non affected hemisphere (Figure 3 A and B). Error 
bars represent standard error of the mean (SEM). In Figure 3 D the averaged supine mean arterial 
pressure (MAP) and etCO2 levels (secondary y-axis) are depicted.
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severity score. No improvement was noticed in the flat supine and Trendelenburg positions. 
The relative postural hemodynamic and etCO2 changes were largely comparable between 
patients and controls, although etCO2 was lower in the patients in the supine position. 
This study suggests that upright positioning compromises neither flow nor neurological 
function in the affected MCA territory in mild to moderately affected acute stroke patients. 
No correlations between flow changes (upon sitting), outcome and dynamic autoregulatory 
status were found. The effects of upright positioning were even less pronounced on Day 1, 
suggesting effective local or systemic hemodynamic adjustments to overcome gravitational 
force during postural changes in the acute phase of mild to moderate stroke. The potential 




Although CBFV measurements cannot be used to calculate CBF volume, the observed 
relative CBFV changes can be considered proportionate to CBF changes as long as the angle 
of insonation and the MCA diameter remain constant during the brief test interval. The 
MCA diameter is thought to remain constant over a ± 30 mmHg range of BP and ± 2 kPa 
of CO2.
22 This requirement was fulfilled in our study. TCD is prone to several errors because 
the measurements are operator-and patient-dependent. Even small probe position changes 
may alter the CBFV readings. However, frontal cerebral oxygenation (rSO2) followed MCA 
CBFVmean changes in size and direction in the affected hemisphere, which further strengthens 
our findings. Assuming a constant arterial O2 content and cerebral metabolic rate during 
Table 4 Dynamic autoregulation estimates in low frequency range on Days 1 and 3
arI phase (°) gain (cm/s mmhg-1) coherence
Affected hemisphere Day 1
(n = 27) 4.4 (2.6)* 33 (21)* 0.86 (0.28) 0.55 (0.24)
Unaffected hemisphere Day 1
(n = 26)$ 4.4 (2.4)* 34 (18)* 0.86 (0.27) 0.51 (0.23)
Control subjects
(n = 17) 6.4 (2.0) 49 (8) 0.86 (0.14) 0.55 (0.15)
Affected hemisphere Day 3
(n = 23) 3.7 (2.3)* 32 (17)* 0.89 (0.26) 0.61 (0.15)
Unaffected hemisphere Day 3
(n = 21)$ 4.3 (2.1)* 41 (12)* 0.91 (0.23) 0.53 (0.14)
Data are mean ± standard deviation. 
Abbreviation: ARI indicates autoregulation index.
*There was a significant (p < 0.05, ANOVA) difference between patient hemisphere and controls 
(both sides averaged). 
# Sixteen patients had measurements on both days. 
$ On Day 1 one and on Day 3 two patients had artefacts and low coherence for the non affected 
hemisphere measurements.  
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the measurement, rSO2 is predominantly a function of local CBF.
23,24 Furthermore, TCD 
monitoring is the only noninvasive method to monitor CBF changes continuously in stroke. It 
is generally accepted that CBF changes are closely reflected by TCD readings.25 
  
Stroke population 
Patients in our study predominantly had mild to moderate strokes. Patients with MCA 
occlusion were excluded. It was left to clinical and nursing judgment whether patients were 
deemed too severely affected by the stroke or too severely ill to be positioned upright for 
this study.5 Although NIHSS was not found to be a confounder for postural CBFV changes, 
too few patients with severe stroke (NIHSS > 16) were included to be able to generalize our 
findings to patients with severe strokes. Furthermore, fully ambulatory patients at Day 1 
may have been less likely to be included. The practical implication of the latter drawback in 
generalization is probably limited. When mild to moderate strokes are unlikely to be affected 
by upright positioning, very mild strokes are even less likely affected. Patients dropped out 
on Day 3 due to transfers to other hospital or discharge, which may have influenced changes 
seen from Days 1 to 3. The impact of this appears limited as patient characteristics were 
comparable on Day 1 and 3 (Table 1). 
  
Postural effects on CBFV in acute stroke 
Three studies have investigated the postural effects on MCA CBFVmean in acute stroke.
10,26,27 
Wojner et al. found 20% CBFVmean increase on average in the supine position in 20 patients 
with an acute MCA occlusion. However, a wide range of individual flow improvements was 
present (5% to 96% from baseline), with no data from the unaffected hemisphere being 
available.10 A small study with 8 subjects found important postural flow changes in 4 severely 
affected patients with incomplete MCA recanalization on 24 h follow-up imaging (affected 
hemisphere).26 A more than 15% higher MCA flow in the supine position in 18 large stroke 
patients with intracranial pressure (ICP) monitoring on the ICU was found. This effect was 
only present in the affected hemisphere.27 Our study did not show relevant postural changes 
despite the larger position changes (70° instead of 30°). This is probably largely due to our 
predominant focus on mild to moderately affected stroke patients. Also, in our study changes 
in all variables were related to the individual baseline supine level (by normalization), reducing 
the effects of large variation of measured parameters and difficulties with standardization 
of the used techniques (TCD, NIRS and BP). In none of the 3 studies, flow data were recorded 
simultaneously with NIRS and etCO2. Furthermore, there might be an effect of anesthesia, 
vasopressors, hypothermia and decompressive craniectomy on cerebral vasoregulation used 
in the ICP monitoring stroke positioning study.28 Our results are in line with subarachnoid 
hemorrhage patients in whom MCA CBFVmean remained constant in supine and 45° HOB 
positions, regardless of the development of vasospasm.29     
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Cerebral blood flow and autoregulation 
Early upright positioning of stroke patients might challenge autoregulation.9 We show 
that the impact of this on cerebral hemodynamics and neurological status is limited. This 
observation, however, does not allow a conclusion on whether cerebral CA is disturbed. 
Because a formal evaluation of static (pressure) CA is unfeasible in the stroke unit setting, we 
used an alternative method of assessing CA. For assessment of dynamic CA, phase relation or 
transfer magnitude (gain) or both between BP and CBF are computed using spontaneous BP 
fluctuations. These techniques are based on a high-pass filter model of CA, which assumes 
that (spontaneous or induced) variations in CBF caused by changes in BP are effectively 
damped in the LF range but not in the high-frequency range, in which changes in pressure 
are directly transferred to changes in CBF. Using the transfer function method in the baseline 
supine position, we were able to show bilateral impairment of dynamic CA in the (sub) acute 
phase of stroke. However, this was not correlated with the relative MCA CBFVmean changes 
upon sitting. The gain estimates were not different between strokes and controls but this 
discrepancy has been reported before.19 A more global dynamic autoregulatory dysfunction 
has been demonstrated in the first days after ischemic stroke.9,30 Such changes were not 
uniformly detected for static CA.31 The reasons for this general dynamic impairment is not 
clear but it is not likely to be a direct or exclusive effect of the acute infarction.30 It rather 
reflects pre-existing endothelial dysfunction with multiple vascular risk factors. This may 
exacerbate shortly after larger cortical stroke. It would lead to the conclusion that dynamic 
CA is disturbed in most strokes but fortunately the hemodynamic and practical consequences 
of this seem limited with upright positioning. 
With the upright position there was a consistent decrease in etCO2. This decrease in 
etCO2 is a common finding that might be a consequence of maintained alveolar ventilation 
with reduced CO2 return to the lungs as venous return decreases with tilt. It is well established 
that reductions in arterial etCO2 will cause an increase in vascular resistance. Thus, regulation 
of CBF on going to the head-up position is the sum of the complex interactions of altered 
pressure gradient, cerebral vessel dilation to counter the reduction in perfusion pressure, 
increased cerebral venous return, and vasoconstriction resulting from lower arterial etCO2. 
Patients had lower etCO2 levels in the baseline supine position. However, several studies 
reported improved dynamic and static CA with hypocapnia and therefore seems unlikely to 
explain the found differences.32 
  
Upright positioning in acute stroke 
It is widely believed that a sudden BP reduction can affect CBF and render elderly subjects 
or patients with cerebrovascular disease vulnerable to orthostatic symptoms.33 Especially 
with impaired cerebral CA, the sitting position is thought to be dangerous to acute stroke 
patients because of susceptibility of the penumbral regions to local hypoperfusion. However, 
our results indicate that sitting is well tolerated in mildly to moderately affected patients 
with acute stroke and seems independent of dynamic autoregulatory impairment. This 
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may be due to the counterbalancing effects of BP elevation (with adequate hydration), ICP 
reduction and increased venous return to stabilize cerebral perfusion pressure in the acute 
phase of stroke. There is also evidence for increased sympathetic activation in acute stroke 
patients.34-36 Replication of this study should be considered using more sophisticated and 
direct methods that measure CBF and cerebral oxygen metabolism.37 Follow-up studies 
several days after stroke may be warranted because systemic compensatory mechanisms 
may become exhausted or cerebral autoregulation may deteriorate.38 Our results do 
not hold for early sitting to the standing (out of bed) mobilisation, which may provoke 
different (probably larger) hemodynamic responses.3 In the paucity of results for the early 
out of bed mobilisation stroke trails,39 we suggest to continue early upright positioning of 
stroke patients in the stroke unit and propose that continuous CBF measurements during 
early activity out of bed could be the next investigation to reassure safe stroke unit early 
mobilisation. 
conclusIon
In conclusion, upright positioning in mildly to moderately affected ischemic stroke patients 
in the stroke unit appears to be safe during the first 3 Days on the stroke unit, despite 
suggestions of a disturbed dynamic CA. Supine or Trendelenburg positioning seems not to 
augment MCA CBFVmean or improve neurological status.    
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AH indicates affected hemisphere; UH, unaffected hemisphere. 
# P values with (Bonferroni) correction for multiple comparisons. 
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Supplemental Table 5  Comparison of postural CBFVmean and rSO2 changes (normalized values) 




































































































# P values with (Bonferroni) correction for multiple comparisons. 
Supplemental Table 6  Comparison of postural CBFVmean and rSO2 changes (normalized values) 




































































































# P values with (Bonferroni) correction for multiple comparisons. 
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Background and purpose 
There is uncertainty whether bilateral near-infrared spectroscopy (NIRS) can be used for 
monitoring of acute stroke patients.
Methods 
The NIRS responsiveness to systemic and stroke-related changes was studied overnight 
by assessing the effects of brief peripheral arterial oxygenation (SpO2) and mean arterial 
pressure (MAP) alterations in the affected versus nonaffected hemisphere in 9 patients with 
acute stroke.
Results 
Significantly more NIRS drops were registered in the affected compared to the nonaffected 
hemisphere (477 drops versus 184, p < 0.001). In the affected hemispheres nearly all SpO2 
drops (n = 128; 96%) were detected by NIRS; in the nonaffected hemispheres only 23% (n 
= 30; p = 0.17). Only a few MAP drops were followed by a significant NIRS drop. This was 
however significantly different between both hemispheres (32% versus 13%, p = 0.01). 
Conclusions 
This pilot study found good responsiveness of NIRS signal to systemic and stroke related 
changes at the bedside but requires confirmation in a larger sample.  
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InTroducTIon
In patients on stroke units, parameters like blood pressure (BP) and peripheral arterial 
oxygenation (SpO2) are continuously monitored. It would probably be more relevant to 
be informed bedside on cerebral perfusion and metabolism. Near-infrared spectroscopy 
(NIRS) allows noninvasive measurement of regional cerebral oxygen saturation (rSO2) with 
high time resolution. NIRS measurements are derived from a sample volume of one third 
of arterial blood and intra- or extracellular tissue, and two thirds of venous blood. Relative 
contributions vary depending on several systemic (e.g., BP and oxygenation) and local stroke 
related factors (e.g., ischemia and autoregulation).1 As such, NIRS may provide a useful 
summary measure of factors that determine blood oxygenation in the early cerebral venous 
phase. A first requirement for use of NIRS in stroke unit monitoring would be that NIRS 
measurements are responsive to such systemic and stroke-related changes. 
In this pilot study, NIRS responsiveness was studied by assessing the effects of brief SpO2 
and BP alterations in the affected versus nonaffected hemisphere. Obstructive sleep apnea 
syndrome, highly prevalent in acute stroke patients, serves as an attractive in vivo model 
for such changes. Questions addressed in this study in the first 24 hours after stroke are: 
(1) does bilateral frontal NIRS change after nocturnal SpO2 change and relative hypotension 
(responsiveness to systemic changes) (2) can NIRS demonstrate differences between 




After local ethics committee approval and with informed consent, 9 patients were studied 
overnight within 24 hours after anterior circulation stroke. Patients with severe aphasia 
and hemodynamic instability were excluded. All patients received standard stroke unit care 
and work-up including ultrasound examination of extracranial vessels. Measurements were 
started from 10.00 pm onwards, ending the next morning or at the patient’s request.    
Near-infrared spectroscopy 
The INVOS 5100C device (Somanetics Corp, Detroit, MI) was used with a sampling frequency 
of 0.2 Hz. Adhesive optodes were placed on each side of the forehead according to the 
manufacturer’s recommendations. NIRS was incorporated into a continuous overnight 
monitoring system with noninvasive BP (Portapres; Finapres Medical Systems, Amsterdam, 
The Netherlands) and SpO2 measurement (derived from Vitaport 4; TEMEC Instruments, 
the Netherlands). Data signals were digitized and collected at 40 Hz (Labview, National 
Instruments, Texas, USA). BP was measured unilaterally using 2 finger cuffs in alternation. 
9
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Beat-to-beat values were normalized over the period of 1 finger measurement (15 minutes) 
to overcome variance caused by cuff switch. For NIRS and SpO2, a drop of 4% was defined 
as significant, for mean arterial pressure (MAP) a drop of 20%.2 The correlations between 
significant NIRS signal decrease and BP or SpO2 decreases were evaluated at or up to 30 
seconds prior to the NIRS drop. All patients received overnight polygraphy including 
nasal airflow, thoracoabdominal movement and SpO2 measurement (Vitaport 4, TEMEC 
Instruments, The Netherlands) to screen for periods of hypopnea or apnea. NIRS hemispheric 
signals were compared by Wilcoxon Rank sum tests.      
resulTs
Nine patients were included with a total overnight recording time of 2.898 minutes (range, 
115-580 minutes) representing 49 hours. Patient characteristics are presented in Table 
1. Ultrasound bedside examination demonstrated flow in both middle cerebral arteries 
insonated at a depth of 40 to 50 mm in all patients. Table 2 provides individual nocturnal 
Table 1  Patient characteristics (n = 9)
variable
Gender: male 3 (33)
Admission median NIHSS [IQR] 6 [3-13]
Age, y, mean ± SD 71 ± 10
 rSO2, %, mean ± SD 
   Affected hemisphere
   Nonaffected hemisphere
68.4 ± 6
72.6 ± 7
MAP, mmHg, mean ± SD
Heart rate, beats/minute, mean ± SD





  Large artery atherosclerosis
  Cardioembolism




Carotid artery abnormalities 1  (11)
BMI, mean ± SD 30  (6)
Median O2 supply overnight, l/min [IQR] 2  [1-2]












Values are numbers (%), unless otherwise indicated.
Abbreviations: NIHSS indicates national institutes of health stroke scale; IQR, interquartile range; 
MAP, mean arterial pressure; BMI, body mass index; SD, standard deviation
# In 1 patient, the polygraphy data were lost.
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changes in NIRS and its relation with significant SpO2 and MAP drops. Two patients had 
problematic SpO2 measurements. Overall, 133 significant SpO2 and 414 significant MAP drops 
were recorded. Significantly more NIRS drops were registered in the affected compared to 
the nonaffected hemisphere (477 drops versus 184, p < 0.001). In the affected hemispheres 
96% of 133 SpO2 drops were detected by NIRS; in the nonaffected hemispheres only 23% 
of 133 (p = 0.17). Only a few MAP drops were followed by a significant NIRS drop; 32% in 
affected versus 13% in nonaffected hemisphere (p = 0.01; Table 2). In comparison to lacunar 
stroke, the difference in NIRS drops between affected and nonaffected hemisphere was 
more pronounced in cortical stroke (127 versus 70 and 350 versus 114 drops, respectively). No 
correlation between overnight disability score change and NIRS drops was found (Table 2). 






























































































Values are numbers (%). 
Abbreviations: NIRS indicates near-infrared spectroscopy; AH, affected hemisphere; NAH, 
nonaffected hemisphere; SpO2, peripheral arterial oxygen; MAP, mean arterial pressure; TACI, total 
anterior circulation infarction; PACI, partial anterior circulation infarction; LACI, lacunar circulation 
infarction; NIHSS, national institutes of health stroke scale. 
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dIscussIon
In this pilot study, 96% of systemic desaturations were rapidly followed by local cerebral 
desaturations as measured by NIRS. Also, BP drops were more likely to be followed by NIRS 
drops in the affected than in the nonaffected hemisphere. Local nocturnal cerebral desatu-
rations were more than twice as likely in the affected hemisphere.  
NIRS is noninvasive and easy to employ in a stroke unit setting, although experience in acute 
stroke is limited. In 1 study, different rSO2 patterns in both hemispheres were demonstrated 
for patients with space-occupying stroke. Real-time NIRS assessment may be used to man-
age brain swelling and planning of hemicraniectomy.3 Our results suggest that NIRS can also 
be employed for detection of less severe complications, such as systemic events that could 
harm the ischemic brain. Nearly all SpO2 drops (96%) were detected by NIRS. A similar posi-
tive correlation between SpO2 changes and cerebral rSO2 during sleep has been reported in 
OSA patients with clear improvement after CPAP treatment.4 These results support the sen-
sitivity of NIRS to SpO2 in an acute stroke population. Our data suggest that NIRS measure-
ments reflect responses that are specific to the affected hemisphere, especially for cortical 
stroke. This responsiveness to stroke related changes makes NIRS an attractive technique 
when studying vulnerability of ischemic brain tissue to changes in the internal environment. 
A limitation of our study is the small patient sample. Also, a large proportion of the NIRS 
drops was not explained by periods of SpO2 drop and/or relative hypotension, pointing to 
the complex multifactorial contributions to the NIRS signal.5 More studies are needed to 
understand the interplay between local rSO2 changes and cerebral perfusion pressure, SpO2, 
intrathoracal pressure changes, CO2 levels, collateral flow and local oxygen consumption and 
distribution patterns. 
In summary, this pilot study found good responsiveness of NIRS signal to systemic chal-
lenges and stroke related changes albeit in a small sample. After confirmation in a larger 
sample, further studies would need to (1) delineate the exact meaning and prognostic sig-
nificance of NIRS changes in ischemic brain and (2) elucidate the mechanisms behind  NIRS 
changes not explained by systemic desaturations. 
references
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spectroscopy. Stroke. 2006;37:2720-2725.
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Background 
Guidelines for the management of traumatic brain injury (TBI) call for the development of 
accurate methods for assessment of the relationship between cerebral perfusion pressure 
(CPP) and cerebral autoregulation and to determine the influence of quantitative indices 
of pressure autoregulation on outcome. We investigated the relationship between slow 
fluctuations of arterial blood pressure (BP) and intracranial pressure (ICP) pulse amplitude 
(an index called PAx) using a moving correlation technique to reflect the state of cerebral 
vasoreactivity and compared it to the index of pressure reactivity (PRx) as a moving 
correlation coefficient between averaged values of BP and ICP.
Methods 
A retrospective analysis of prospective 327 TBI patients (admitted on neurocritical care unit 
of a university hospital in the period 2003 to 2009) with continuous BP and ICP monitoring. 
Results 
PAx was worse in patients who died compared to those who survived (-0.04 ± 0.15 vs -0.16 
±0.15, χ2 = 28,  p < 0.001). In contrast to PRx, PAx was able to differentiate between fatal and 
nonfatal outcome in a group of 120 patients with ICP levels below 15 mmHg (-0.04 ± 0.16 vs 
-0.14 ± 0.16, χ2 = 6, p = 0.01).
Conclusions 
PAx is a new modified index of cerebrovascular reactivity which performs equally well as 
established PRx in long-term monitoring in severe TBI patients, but importantly is potentially 
more robust at lower values of ICP. In view of establishing an autoregulation-oriented CPP 
therapy, continuous determination of PAx is feasible but its value has to be evaluated in a 
prospective controlled trail. 
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InTroducTIon
The latest Brain Trauma Foundation guidelines for the management of traumatic brain 
injury (TBI) call for the development of ‘minimally invasive, efficient and accurate methods 
for determining the relationship between cerebral perfusion pressure (CPP) and cerebral 
autoregulation’ and conclude ‘there is a need for randomised trials of the influence on 
outcome of basing optimal CPP […] on quantitative indices of pressure autoregulation’.1 
Among such indices of cerebral autoregulation, the most commonly used in neurocritical 
care units (NCCU) is the pressure reactivity index (PRx), which reflects the capability of 
smooth muscle tone in the wall of cerebral arterioles to react to changes in transmural 
pressure.2,3 Several studies confirmed the prognostic significance of PRx and highlighted the 
opportunity of individualised optimisation of CPP based on bedside PRx monitoring.4 The 
PRx technology is based on continuous monitoring of the robust signals intracranial pressure 
(ICP) and arterial blood pressure (BP) and their computer integration by means of a simple 
calculation algorithm. The physiological principle of PRx is based on the following: when 
cerebral pressure reactivity is intact, a slow increase in BP will lead to vasoconstriction, with 
a subsequent reduction in cerebral blood volume (CBV) and therefore a decrease in ICP. Or 
to put in other words, when cerebral pressure reactivity is intact, BP and ICP are negatively 
correlated. On the other hand, when cerebral pressure reactivity is compromised, cerebral 
vessels dilate or collapse passively in response to changes in BP, and therefore ABP and ICP 
are positively correlated. The calculation is based on a major assumption: that changes in 
cerebrovascular resistance must be reflected in changes in CBV and, more importantly for the 
paper at hand, that changes in CBV must be reflected in changes in ICP.5,6 This assumption 
holds true when intracranial compliance is low, which is the case for higher ICP values. Yet, 
what happens when intracranial compliance artificially increases due to medical therapies 
or, much more dramatically, by surgical interventions such as decompressive craniectomy? 
The limited evidence available showed that PRx initially worsened after decompressive 
craniectomy.3,7 This finding could either be a genuine account of changes in cerebrovascular 
dynamics following decompression or, equally likely, could be an artefact caused by the fact 
that changes in CBV are not reflected in changes in mean ICP.8,9 
The pulsatile component of ICP (often referred to as ICP pulse amplitude) reflects beat-to-
beat changes in CBV and carries significant clinical and pathophysiological information.10-13 
Cardiac pulses in BP produce pulsatile expansions of the walls of the cerebral arteries (and 
thus pulsation in CBV) which in turn are the cause of the pulsatile component of pressure 
in the surrounding brain and cerebral spinal fluid (CSF). This transmission depends most of 
all on the compliance of the cerebral vessels, which is a function of the vascular tone and 
therefore is modulated by the state of the cerebrovascular reactivity. Therefore, it is assumed 
that even with low levels of ICP changes in vascular tone brought about by slow waves in 
BP will be reflected by changes in the BP to ICP pulse transmission. In a recent study with 
293 TBI patients with intermittent transcranial Doppler (TCD) recordings the autoregulation 
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index Mx correlated strongly with a new index, termed PAx,  reflecting pressure reactivity 
via the correlation coefficient between fluctuations of BP and ICP pulse amplitude, using a 
technique similar to the one used for the PRx index.14 
In this study the relationship between the PAx and PRx indices was investigated in TBI 
patients with long-term monitoring. We hypothesised that the PAx index would reflect the 
state of cerebral vasoreactivity in a similar way to PRx, but would be more robust at low 




We analysed retrospectively recordings of BP and ICP waveforms from 327 patients with 
severe TBI, admitted to the NCCU of Addenbrooke’s hospital in Cambridge in the period 2003 
to 2009. Anonymised digital recordings of physiological parameters and clinical outcomes 
were stored in a password-protected computer database. During monitoring all patients 
were sedated, intubated and mechanically ventilated with etCO2 maintained in the mild 
hypocapnia range (4-4.5 kPa). A CPP/ICP driven protocol was used aiming for a CPP around 65 
- 70 mmHg and ICP below 25 mmHg.15 The baseline neurological status of each patient was 
determined using the Glasgow Coma Score (GCS). The post resuscitation GCS was used in 
patients who allowed sedation discontinuation immediately following hospital admission.16 
In patients who were deemed too unstable to undergo formal neurological assessment on 
admission the GCS collected on scene was used. Clinical outcome was assessed at 6 months 
using the Glasgow Outcome Scale (GOS). All data were recorded as part of standard clinical 
care. Patient’s representatives were individually consented for using computerized data 
recorded with approval of our Local Ethical Committee and the permission to use anonymized 
clinical audit data was obtained from the NCCU User’s Group.
Methods
BP was monitored invasively through radial or femoral artery using a standard pressure 
monitoring kit (Baxter Healthcare Corp, CardioVascular Group, Irvine, CA USA). ICP was 
monitored using an intraparenchymal probe (Codman ICP MicroSensor, Codman & Shurtleff 
Inc., Raynham, MA, USA) inserted via a cranial access device (triple bolt).17 All signals were 
digitised using an A/D converter (DT9800 series, Data Translation, Marlboro, Mass. USA), 
sampled at a frequency of 100 Hz and recorded using a laptop PC with ICM+ software 
(Cambridge Enterprise, Cambridge, UK, http://www.neurosurg.cam.ac.uk/icmplus). The 
same software was used for the retrospective analysis of physiological monitoring data. 
Time-averaged values of ICP, BP and CPP (CPP = ICP - ABP) were calculated using waveform 
time integration over 60 second intervals. 
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Cerebrovascular reactivity indices
PRxwas calculated as a short-term moving Pearson correlation coefficient between changes 
in 30 consecutive, 10 second averages of BP and corresponding ICP signals (with 80% overlap 
of data).2 Averaging over 10 seconds was used to suppress influence of the pulse wave 
and the respiratory wave. The same algorithm was used for PAx calculation except that 
mean ICP was replaced by pulse amplitude of the ICP signal. The ICP pulse amplitude was 
calculated as the fundamental harmonic of the pulse component in a fast Fourier Transform 
decomposition of the ICP signal. 
Statistical analysis
All the data were expressed as mean or median values with their range or standard deviation 
(SD) where appropriate. To evaluate the relationship between CPP, ICP and the vasoreactivity 
indices in all patients, 1 hour averages were used. For correlation with outcome analysis, 
one mean value of the variables PRx, PAx, CPP and ICP was calculated for each patient. 
Nonparametric statistical methods were used where variables failed the normality test. 
Partial rank-correlation coefficients as well as analysis of variance (ANOVA, Kruskal-Wallis 
test) were used to investigate statistical relationships between the studied (continuous) 
variables: baseline GCS, patients’ age and GOS at 6 months. Multivariate logistic regression 
analysis was used to identify independent associations between the pressure indices and 
outcome. A receiver operating characteristic (ROC) curve was calculated to compare the 
accuracy in predicting mortality using PRx, PAx and ICP using non-parametric methods for 
estimating standard errors (SE) and applying the method described by DeLong et al. for 
comparisons between two (correlated) parameters.18 Tests were considered statistically 
significant for  values p < 0.05. Statistical analysis was performed using SPSS (version 16.0; 
IBM Inc., Chicago IL, USA).
resulTs
Patients
The database population included 327 patients, (246 males, 75%), ranging in age from 15 to 87 
year old (median age: 36 years). The median baseline GCS score was 6 and ranged from 3 to 15; 
25% of patients had a baseline GCS > 8, but their condition subsequently deteriorated, requiring 
neurocritical care and warranting invasive monitoring. The initial GCS score and GOS score 
were missing in 7 (2%) and 5 (1.5%) patients, respectively. Outcomes were grouped as follows: 
good recovery, n = 51 (16%); moderate disability, n = 82 (25%), severe disability, n = 105 (32%), 
persistent vegative state, n = 9 (3%) and death, n = 75 (23%). Patients in persistent vegative 
state were excluded from further outcome analysis because this group is disproportionally 
smaller than other outcome groups, leaving 313 patients for outcome analysis. Duration of 
data recording ranged between 1 and 28 days per patient with a mean of 4 days.
 
10
136  c e r e b r a l  h e m o d y n a m i c s  i n  s t r o k e  a n d  t r a u m a t i c  b r a i n  i n j u r y 
General exploratory correlations
Spearman partial rank correlation coefficients between averaged (for every patient) values 
of PRx, PAx, ICP, ABP, CPP, baseline GCS, and age are presented in Table 1. Lower baseline GCS 
was significant associated with lower age. There was no correlation between baseline GCS 
and any of the other variables. Higher age correlated only with higher PRx (0.17, p = 0.004) 
and PAx (0.35, p < 0.001). PRx and PAx correlated positively with ICP, negatively with CPP and 
ABP. Patients who died had significant higher ICP (22.6 ± 14 versus 15.8± 5, χ2 = 21, p < 0.001) 
and lower CPP (73.6 ± 12.2 versus 78.4 ±6.6, χ2 = 12, p = 0.001).  
Comparison between PAx and the PRx
Mean PRx was 0.03 (SD 0.17, range 1.11) and mean PAx -0.13 (SD 0.16, range 1.07). PAx showed 
a significant correlation with PRx (R = 0.63, p < 0.001) (Table 1). The correlation decreased 
somehow in patients with mean ICP below 15 mmHg (R = 0.59, p < 0.001, n = 120) and 
improved in patients with ICP levels above 15 mmHg (R = 0.68, p < 0.001, n = 207). Both 
indices presented similar changes during recording intervals. In an example of refractory 
intracranial hypertension, both PAx and PRx were capable of detecting severe (not reversible) 
impairment of vasoreactivity (Figure 1a). During plateau waves in ICP both indices of PAx and 
PRx were temporarily assuming values close to +0.5, indicating impairment of vasoreactivity 
(Figure 1b). Figure 1c shows an example of ICP, CPP and vasoreactivity indices before and 
after decompressive craniectomy. PAx improved immediately after surgery and seemed 
more stable in comparison to PRx (Figure 1c). 
Table 1   Spearman partial Rank correlation coefficients and their significance levels calculated 
between the analyzed parameters (n = 327)
age gcs cpp Icp bp prx
GCS 0.17p =  0.004
CPP 0.07p = 0.23
0.07
p = 0.24
































Control variables used for partial correlation test: age, GCS, ICP, ABP and PRx (or PAx).
Abbreviations: GCS indicates Glasgow Coma Scale; CPP, cerebral perfusion pressure; ICP, intracranial 
pressure; BP, blood pressure.










































































































































































































































































































































































































































































































































































































































































Pressure reactivity indices (PRx and PAx) versus cerebral perfusion pressure (n = 327). Below 60 
and above 80 mmHg the cerebrovascular pressure reactivity deteriorates. Error bars represent 95% 
confidence intervals. 
This figure shows ICP and CPP recordings for several days in a severe TBI patient. The PRx/CPP and 
PAx/CPP plot allows retrospective assessment of optimal CPP, i.e. the CPP value for which pressure 
reactivity (PRx or PAx) has the most negative value. For this patient the optimal CPP seems to be 
between 77.5 and 82.5 mmHg (arrows).
Comparison of pressure indices with CPP
 ANOVA plots of PRx and PAx versus mean CPP are presented in Figure 2. Looking at both PRx 
and PAx the lowest (optimal) pressure reactivity is achieved around a CPP of 70 mmHg in 
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Figure 4a Figure 4b
Distribution of PRx and PAx across different outcome groups (n = 313). Outcome was assessed 6 
months after the injury. Vertical bars represent 95% confidence intervals. Outcome: G Good; M 
Moderate; S.D. Severe Disability; D Dead. A. The PRx values increased with worse outcome (ANOVA, 
F = 5.75, p < 0.001). B. The mean PAx value is the same in all outcome groups with the exception of 
patients who died (ANOVA, F = 10.9, p < 0.001). 
10
our patient cohort. For both PRx and PAx a nearly linear association between worse pressure 
reactivity and higher CPP levels, starting from 80 mmHg, can be seen. At low CPP levels (< 
60 mmHg) a sharp increase in the both PRx and PAx values is seen with higher absolute 
mean values. Figure 3 shows an example of a pressure reactivity index (using both PRx and 
PAx) versus CPP plot in a patient recording of several days that allows determination of the 
individual optimal CPP (retrospectively). 
Comparison of pressure indices with outcome
Figure 4 demonstrates distributions of PRx (a) and PAx (b) across the four outcome groups. 
Mean PRx was worse in patients who died compared to those who survived (0.10 ± 0.21 vs 
0.01 ± 0.15, respectively; χ2 = 12, p = 0.001). The same was true for PAx but the association 
was stronger (-0.04 ± 0.15 versus -0.16 ±0.15, χ2 = 28, p < 0.001). Figure 5 demonstrates that 
in contrast to PRx, PAx is still able to differentiate between fatal and non-fatal outcome in 
patients with mean ICP levels below 15 mmHg (-0.04 ± 0.16 versus -0.14 ± 0.16, χ2 = 6, p = 
0.01, n = 120). In a stepwise multivariate analysis, PAx (odds ratio (OR) 114, 95%-confidence 
interval (CI) 9.0-1418, p < 0.001) and PRx (OR 9.8, 95%-CI 1.5-64, p < 0.001) were very strong 
independent predictors of mortality. Other independent predictors for mortality were 
higher age, higher ICP and lower GCS score, while low CPP was not. In the model with PAx or 
PRx only ICP and baseline GCS were independent predictors of favorable outcome defined 
as good recovery and moderate disability (GOS 4-5). Estimating the area under the curve in 
ROC analysis, PAx had the highest diagnostic value for mortality in comparison to PRx and 
ICP (Figure 6). The differences were small and only for the comparison between PAx and PRx 
significant (differences between areas 0.07, 95%-CI 0.005-0.13, p = 0.04).
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Figure 5
Figure 6
Error bar plots of dichotomized (fatal) outcome using PRx and PAx for patients with low to normal 
(< 15 mmHg) and intermediate to high (> 15 mmHg) mean ICP levels. In contrast to PRx, PAx is able 
to differentiate between the two outcome groups independent of the level of ICP. Statistics were 
calculated using the Kruskal-Wallis test.
Receiver Operating Characteristic analysis of predictive power of ICP, PRx and PAx for mortality 
showing highest AUC (area under the curve) values attributed to PAx and thus confirming its 
strongest link to mortality.
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dIscussIon
In this retrospective analysis, we tested the hypothesis that PAx, a novel index for the continuous 
assessment of cerebral vasoreactivity based on the analysis of ICP pulse amplitude, was more 
robust than the established parameter PRx. The results showed that in this series of more than 
300 TBI patients with continuous bedside monitoring PAx was indeed a stronger independent 
predictor of fatal outcome than PRx. In contrast to PRx, PAx could also differentiate between 
fatal and non-fatal outcome in patients with normal to low ICP levels (Figure 5).    
Background of PAx
Despite being widely validated,3,19 a potential limitation of the PRx methodology is in its 
dependence on the pressure-volume characteristic of the brain. Essentially, fluctuations in 
Figure 7
Explanation of the mechanism how PAx can express cerebrovascular reactivity at lower mean ICP 
(mICP) levels (flat part of the pressure-volume curve ) (1). The hypothesized mechanism is that slow 
changes in mean arterial pressure (MAP), with reactive vessels (2), produce proportional changes 
in arterial smooth muscle tension, therefore causing an inverse change in the arterial compliance 
(Ca) (3). Changes in the compliance results in direct change of passive transmission of MAP pulse 
to ICP pulse amplitude (ICP pulse AMP). In this way, with reactive vessels, slow decrease in MAP 
produces increase in the compliance of cerebral arteries (vasodilatation with increasing arterial 
blood volume (CaBV) at time point B.) promoting stronger passive transmission of the pulse wave 
to ICP (4, 5), indicating a negative corellation index PAx (6). For PRx at the same levels of mICP the 
correlation between mICP and MAP changes may be less predictable (flat pressure-volume curve) 
(7, 8). 
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ICP are treated as surrogates of fluctuations in CBV, which in turn respond to changes in BP. 
When the pressure-volume curve is flat (such as in the case of decompressive craniectomy 
or, in general, with elevated intracranial compliance) vasogenic changes in CBV may not 
result in sufficiently significant changes in ICP to warrant reliable calculation of PRx.8,9 
In order to overcome the problem of weak transmission of volume to pressure at low ICP 
values, a feature of ICP signal was studied which more directly reflects the vascular tone, its 
pulse amplitude. When the pressure-volume curve is steep (at higher ICP values with low 
intracranial compliance), ICP pulse amplitude changes in the same direction as mean ICP 
changes (linear behaviour).8,9,20 and therefore we expect PAx to behave in the same way as 
PRx. 
On the other hand, we hypothesized, that at low levels of ICP, when the link between mean 
BP and mean ICP is diminished by the flat pressure-volume curve, the relationship between 
mean BP and ICP pulse amplitude should be maintained by the active adjustment of the 
vascular compliance. Our model is explained in Figure 7. With reactive vessels, a significant 
decrease in mean BP will lead to active smooth muscle relaxation and subsequent increase 
of the vascular compliance (less stiff vessels). Increased compliance of the cerebral vessels 
augments transmission of BP pulse to ICP pulse and as a result ICP pulse amplitude increases 
with decreasing BP.21,22 This dynamic relationship does not rely on the pressure-volume 
characteristic of the brain and therefore is independent of the level of ICP. For non-reactive 
vessels the negative relationship between mean BP and ICP pulse amplitude is abolished 
due to the inability of cerebral vessels to actively change their tone, and therefore vascular 
compliance as a response to fluctuations of BP.6, 21
PAx compared to PRx
A linear relationship between ICP pulse amplitude and mean ICP has been found in healthy 
animals and humans, at least up to mean ICP between 30 and 60 mmHg,8,20,23 so we were 
not surprised to find a good correlation between PRx and PAx, particularly at higher ICP 
levels. Similarly to PRx, PAx when plotted against CPP forms a U-shaped curve defining a 
CPP value at which pressure reactivity is optimal or in other words that too low or too high 
CPP values are unsuitable to maintain adequate cerebral blood flow (Figure 2). Interestingly, 
higher (more positive) absolute values of both PRx and PAx are seen with lower CPP levels 
compared to high CPP levels, which suggests that cerebral vessels compensate hypertension 
more easily than hypotension (Figure 2). Similarly to PRx, PAx allows for the identification of 
individual optimal CPP ranges (Figure 3). Both indices identified consistent values of optimal 
CPP. PAx correlates with outcome after severe TBI. It differentiates patients with fatal 
outcome from those who survive at 6 months. In contrast to PRx, this correlation seemed to 
be maintained for PAx in patients with mean normal to low ICP levels (Figure 5). This finding 
could suggest that PAx is a more robust estimator of cerebrovascular pressure reactivity in 
TBI patients. The correlation of PAx with patient outcome is independent of mean ICP: in the 
multivariate analysis both variables were included in the model. 
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Why a new index?
Several ‘autoregulation’ and ‘vascular reactivity’ indices were reported in the past. With 
intermittend TCD monitoring, autoregulation can be assessed, according to its definition, as 
a correlation between blood flow velocity and CPP. Unfortunately, with current TCD probe 
holders, monitoring over longer period is not feasible. Techniques involving near-infrared 
spectroscopy (NIRS) are easier for continuous monitoring but still need more accurate 
evaluation.24 Their link to outcome following TBI is still not very well established. Unknown 
limited sample volume (hypothetically frontal cortical tissue) makes interpretation of the 
data difficult in cases of multifocal injuries. Indices derived from ICP and BP signals seem to 
be more robust. These modalities, fundamental in brain monitoring and management of TBI, 
are relatively artefact-free and can be monitored over long period. PRx has been accepted in 
many different centres and its analysis, particularly for assessing ‘optimal’ CPP seems feasible 
in many scenarios.4 Unfortunately the index is rather ‘noisy’. This may be partially due to 
the pressure-volume curve dependent link between CBV and mean ICP. Thus in scenarios 
involving high brain compliance, such as for example after decompressive craniectomy,  PAx 
monitoring should potentially work better and be studied in near future. 
Limitations
Several limitations deserve to be mentioned. Prospective data on a pressure reactivity-
guided intensive care therapy are missing from the literature. This is also a major limitation 
of our own results given that all the analyses were performed retrospectively and some 
data like pupil reactivity on admission (as a strong prognostic factor for outcome of TBI) 
were not recorded. A further limitation of this study is the use of a very specific, although 
standard, intensive care management strategy with patients having different monitoring 
periods. Furthermore, we cannot rule out the impact of treatment on cerebral dynamics 
in the patients, in whom medications impacting vascular dynamics are commonly used. 
In such a large database, it is difficult to analyse changes caused by alterations in specific 
medications, regime of ventilation, core temperature control, and an influence of all complex 
environment of highly technologically dependent NCCU. These variables should be thus 
treated as unavoidable ‘background noise’ and the only remedy to minimize its influence is 
averaging large volumes of data. Furthermore, the present study did not have data regarding 
any ‘static’ autoregulatory measures with (BP) interventions, so validation of bedside PAx 
with more complex static rate of autoregulation is lacking at the moment. 
conclusIon
PAx is a new modified index of cerebrovascular reactivity which performs equally well as 
established PRx in long-term monitoring in severe TBI patients, but importantly is potentially 
independent of the level of ICP.  
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absTracT
Objectives 
We have sought to develop an automated methodology for the continuous updating of 
optimal cerebral perfusion pressure (CPPopt) for patients after severe traumatic head injury 
(TBI) using continuous monitoring of cerebrovascular pressure reactivity. We then validated 
the CPPopt algorithm by determining the association between outcome and the deviation of 
actual CPP from CPPopt. 
Design and setting
Retrospective analysis of prospectively collected data. Neurosciences critical care unit of a 
university hospital. 
Patients
A total of 327 TBI patients admitted between 2003 and 2009 with continuous monitoring of 
arterial blood pressure (BP) and intracranial pressure (ICP).
Measurements and Main Results
BP, ICP, and CPP were continuously recorded and pressure reactivity index (PRx) was 
calculated online. Outcome was assessed at 6 months. An automated curve fitting method 
was applied to determine CPP at the minimum value for PRx (CPPopt). A time trend of CPPopt 
was created using a moving 4-hr window, updated every minute. Identification of CPPopt was, 
on average, feasible during 55% of the whole recording period. Patient outcome correlated 
with the continuously updated difference between CPP and CPPopt (χ
2 = 45, p < 0.001; 
outcome dichotomized into fatal and nonfatal). Mortality was associated with relative 
‘hypoperfusion’ (CPP < CPPopt), severe disability with ‘hyperperfusion’ (CPP > CPPopt) and 
favorable outcome was associated with smaller deviations of CPP from the individualized 
CPPopt. While deviations from global target CPP values of 60 and 70 mmHg were also related 
to outcome, these relationships were less robust. 
Conclusions 
Real-time CPPopt could be identified during the recording time of majority of the patients. 
Patients with a CPP close to CPPopt were more likely to have a favorable outcome than 
those in whom mean CPP was widely different from CPPopt. Deviations from individualized 
CPPopt were more predictive of outcome than deviations from a common target CPP. CPP 
management to optimize cerebrovascular pressure reactivity should be the subject of future 
clinical trial in severe TBI patients.
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InTroducTIon
Survival after traumatic brain injury (TBI) is dependent on the control of intracranial 
hypertension and the provision of hemodynamic support to achieve an ‘adequate’ cerebral 
perfusion pressure (CPP). However, the idea of a single value (or even a single range) of CPP 
being adequate for the diverse group of TBI patients is an oversimplification.1-3 Age and pre-
morbid arterial blood pressure (BP) are examples of factors likely to influence individual 
CPP targets, with elderly, hypertensive patients requiring a higher CPP compared to young, 
normotensive patients. Although multimodal brain monitoring, including continuous brain 
tissue oxygenation, near-infrared spectroscopy, transcranial Doppler ultrasonography and 
microdialysis provide valuable information at the bedside regarding the adequacy of CPP, 
these technologies are costly and restricted to a relatively small number of specialised 
neurocritical care units (NCCU). The 2007 Brain Trauma Foundation guidelines advocated 
randomized controlled trials to verify the feasibility and the impact on outcome of 
strategies based on individualised CPP management following severe TBI.4 A method for 
individualization of  CPP oriented management based on determination of cerebrovascular 
reactivity (using the pressure reactivity index (PRx); a moving correlation coefficient 
between slow waves of intracranial pressure (ICP) and BP)5 was proposed in 2002.6 It was 
shown that a narrow CPP target (CPPopt) could be identified by defining the level of best 
cerebrovascular reactivity using PRx. The deviation from CPPopt was associated with worse 
outcome. However, the CPPopt range was calculated retrospectively from recordings of the 
whole period of ICP monitoring. The findings, therefore, are not necessarily applicable to 
a prospective interventional strategy, which would require more rapid and repetitive 
assessments of CPPopt. Further, the determination of CPPopt in that study was done by visual 
inspection of PRx measurements stratified across CPP ranges, an impediment to regular 
updating.  
The objective of this study was to develop and validate an algorithm for the objective, 
automated and continuous updating of CPPopt, derived  from  a clinically useful time window 
of 4 hrs. Such an algorithm is necessary for a prospective trial of PRx monitoring to guide 
individualized CPP management after TBI. The algorithm presented in this manuscript 
was validated by measuring the observed association between outcome and continuous 
deviation of CPP from calculated CPPopt. 
maTerIals and meThods
Monitoring of BP and ICP in patients following TBI has been an integral part of the routine 
clinical management. The computerised data storage protocol was reviewed and approved by 
the local ethics committee of Addenbrooke’s Hospital, Cambridge University and the NCCU 
User’s Group. With individual consents from patient representatives, we retrospectively 
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analysed anonymized digital recordings of BP and ICP waveforms from 327 consecutive 
patients with severe TBI, admitted to the NCCU at Addenbrooke’s Hospital between 2003 
and 2009. All patients were sedated, intubated, and mechanically ventilated during the 
recording period. A CPP/ICP-oriented protocol for management of head injury was used 
with CPP maintained > 60 mmHg and ICP < 20 mmHg.7 The baseline neurological status of 
each patient was determined using the Glasgow Coma Score (GCS). The postresuscitation 
GCS was used in patients who had sedation discontinuation immediately following hospital 
admission. In patients who were deemed too unstable to undergo formal neurological 
assessment on admission the GCS collected on scene was used. The clinical outcome was 
assessed at 6 months using the Glasgow Outcome Scale (GOS).8 All monitoring modalities 
recorded in the study were used as standard clinical care. 
Data acquisition and Processing
BP was monitored invasively through the radial or femoral artery using a standard pressure 
monitoring kit (Baxter Healthcare Corp, CardioVascular Group, Irvine, CA USA). BP was 
zeroed at the level of the right atrium. ICP was monitored using an intraparenchymal probe 
(Codman ICP MicroSensor, Codman & Shurtleff Inc., Raynham, MA, USA) inserted into the 
frontal cortex. All signals were digitised using an A/D converter (DT9801, Data Translation, 
Marlboro, Mass. USA), sampled at a frequency of 100 Hz and recorded using a laptop PC 
with ICM+ software (University of Cambridge, Cambridge Enterprise, Cambridge, United 
Kingdom, http://www.neurosurg.cam.ac.uk/icmplus). The same software was later used 
for the retrospective analysis of all stored signals. Time-averaged values of ICP, BP and CPP 
(CPP = BP - ICP) were calculated using waveform time integration over 60-sec intervals. 
Cerebrovascular pressure reactivity (PRx) was calculated as a moving Pearson correlation 
coefficient between 30 consecutive, 10-sec averaged values of BP and corresponding ICP 
signals (with 80% overlap of data).9 Averaging over 10 secs was used to suppress the influence 
of the pulse- and respiratory-frequency wave components. Positive correlation between 
BP and ICP at low frequency is indicative of passive cerebral vasculature and impaired 
autoregulation. Zero or negative correlation between BP and ICP at the same frequency is 
indicative of reactive vasculature and intact autoregulation.10-12 Artefacts were identified 
and excluded manually from analysis after the data collection. 
Data analysis
For determination of CPPopt  in individual patients, a 5-min median CPP time trend was 
calculated alongside PRx. These PRx values were divided and averaged into CPP bins spanning 
5 mmHg. An automatic curve fitting method (see Appendix for details) was applied to the 
binned data to determine the CPP value with the lowest associated PRx value. A time trend 
of CPPopt calculated in this way, was recorded from a moving 4-hr time window (so called 
CPPopt) updated every minute. The first CPPopt curve could be generated when at least 50% of 
the required data points of PRx were available, i.e., after a minimum of 2 hrs of monitoring. 
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An illustrative example from an individual patient is shown in Figure 1. Note that when the 
fitted curve does not include the convex point the estimated ‘optimal’ value will be either 
underestimated (ascending curve) or overestimated (descending curve) depending on the 
shape of the fitted part (Figure 1 B and C). In addition, the optimal CPP for the whole monitoring 
period (so called CPPopt total, as in Steiner et al) was calculated.
6 For exploratory analysis (Table 
1), values of measured variables from each patient were averaged over the whole monitoring 
period, so every patient was represented by one set of data containing mean arterial 
pressure (MAP), ICP, CPP, and PRx. In individual patients, the differences between CPPopt and 
median CPP for the moving window periods were calculated continuously (∆CPP = median 
CPP – CPPopt). The ∆CPP was averaged for every patient for the whole monitoring period, 
separately for CPP above and below CPPopt. Additionally, the difference between CPPopt total 
and median CPP for the whole monitoring period was calculated (∆CPPtotal = median CPPtotal – 
CPPopt total). We calculated the number of patients with CPPopt total values above, below or close 
(± 5 mmHg) to the median CPP. 
Outcome was dichotomized in two ways: First as favorable (good recovery, moderate 
disability) vs unfavorable outcome (severe disability, persistent vegative state, and death), 
second as fatal outcome (death) versus nonfatal outcome (persistent vegetative state, 
severe disability, moderate disability and good recovery). Groups were compared using the 
nonparametric Kruskal-Wallis test because the values in the majority of groups were not 
normally distributed. 
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resulTs
Demographics and grand averages of monitored modalities 
The database population included 327 patients with 246 male (75%), ranging in age from 15 
to 87 yrs old (median age, 36 yrs). The median GCS score at the scene was 6 and ranged from 
3 to 15; 25% of patients had an initial score > 8, but their condition subsequently deteriorated, 
requiring intubation and neurocritical care. The initial GCS score and GOS score were missing 
in 7 (2%) and 5 (1.5%) patients, respectively. The outcome was distributed as follows: good 
recovery, n = 51 (16%), moderate disability, n = 82 (25%), severe disability, n = 105 (32%), 
persistent vegative state, n = 9 (3%) and death, n = 75 (23%). Patients in persistent vegative 
state were excluded from further outcome analysis because this group is disproportionally 
smaller than other outcome groups. Sixteen patients were excluded because they had 
recordings shorter than 6 consecutive hours making CPPopt calculation unreliable. Finally, 
data of 299 patients were available for outcome analysis (Table 1). 
Figure 2
Pressure reactivity index (PRx) versus cerebral perfusion pressure using 1-hr averages for all 
patients (n = 327).
PRx-CPP relationship in the whole cohort 
Figure 2 shows the relationship between PRx and CPP with 1-hr averages of CPP plotted in 
10-mmHg bins for 327 patients monitored continuously. The U-shaped plot suggests that 
both too-low (ischemia) and too-high CPP (hyperemia and secondary increase in ICP) are 
associated with worse pressure reactivity. The plot suggests that, for our TBI cohort as a 
whole, CPPopt would be around 75 mmHg (Figure 2). The ‘U’-shape is asymmetrical, suggesting 
that a CPP below the averaged optimal level can impair cerebral pressure reactivity much 
more than CPP above the averaged optimal level.
11
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CPP optimal with 4 hours moving window in individual patients 
The mean recording time per patient after artefact removal was 4 days (range, 1 day - 28 days). 
Overall determination of an individual CPPopt was possible in all 299 patients. A CPPopt curve was 
on average present during 55% (range, 1% - 91%) of the whole recording period. In 10 patients 
determination of the CPPopt curve was impossible for > 20% of the recording time. In 69% of 
time a U-shaped curve was present, and in 22% and 9% ascending and descending curves were 
generated, respectively. On average, per patient, in our retrospective data set CPPopt stayed be-
low the actual CPP values during 62% (range 0 - 100) of total recording time (thus suggesting 
potential hyperperfusion), while in 38% (range 0 - 100) of the recording time the patients were 
potentially hypoperfused (CPPopt above the actual CPP level). 
Figure 3 demonstrates the relationship between the mortality rate (GOS score 1), favorable 
outcome (GOS score 4-5), unfavorable outcome (GOS score 1 and 3) and the severe disability 
rate (GOS 3) and continuous median CPP-CPPopt difference. The mortality increased steadily 
with the median CPP shifting below the threshold of CPPopt and decreases slightly with values 
above CPPopt (Figure 3 A). The likelihood of severe disability increased monotonically when CPP 
was above CPPopt (Figure 3 C). An asymmetrical inversed U-shaped curve with the highest fa-
vorable outcome rate with CPP approaching CPPopt is seen (Figure 3 B). Respectively, unfavorable 
outcome showed U-shaped curve, with a rate increasing below and above CPP optimal (Figure 
3 D). Additional analysis was performed with fatal versus nonfatal outcome dichotomization. 
Using CPPopt as an individual threshold, the rate of fatal outcome was < 20% in patients with 
median CPP values around or above CPPopt (median CPP > CPPopt - 2 mmHg) (χ
2 = 45, p < 0.001). In 
comparison, for fixed CPP thresholds of 60 or 70 mmHg, suggested by current guidelines, less 
discriminative values were obtained (χ2 = 13, p < 0.001 and χ2 = 21, p < 0.001, respectively). All 
above comparisons were repeated using a 12-hr moving time window, yielding similar results. 
Table 1  Patient demographics, clinical variables, and outcome (GOS, n = 299)
gos n age* m/f gcs* map Icp* cpp* prx*




0 - - - - - - -
Severe 
disability 101 39 (15) 74/27 6 (3) 95 (7) 16 (4) 78 (6) 0.02 (0.16)
Moderate 
disability 79 33 (14) 66/13 8 (4) 94 (7) 15 (4) 79 (6) 0.01 (0.14)
Good 
recovery 48 34 (17) 31/18 7 (3) 95 (6) 16 (4) 79 (7) -0.01 (0.13)
Total 299 38 (16) 230/70 7 (3) 95 (7) 17 (7) 78 (8) 0.03 (0.16)
Values are shown as means (standard deviation). MAP, ICP, CPP and PRx were averaged in each 
patient over the whole monitoring period.
Abbreviations: GOS indicates Glasgow outcome scale; M/F, males/females; GCS, Glasgow coma 
score at the scene; MAP, mean arterial pressure; ICP, intracranial pressure; CPP, cerebral perfusion 
pressure; PRx, pressure reactivity index. 
* Significant difference (p < 0.001) between groups of GOS (analysis of variance). 
c e r e b r a l  h e m o d y n a m i c s  i n  s t r o k e  a n d  t r a u m a t i c  b r a i n  i n j u r y  153
11
Figure 3
Graphs of the relationship between mortality rate (Glasgow outcome Scale (GOS) score 1), 
unfavorable outcome (GOS scores 1 - 3), severe disability rate (GOS score 3)  and difference between 
continuous calculation of median cerebral perfusion pressure (CPP) and CPPopt using the moving 
window of 4 hrs (n = 299);  A. The mortality increases steadily when CPP is increasingly below 
the threshold of CPPopt, and decreases slightly with increasing values above CPPopt; B. This graph 
shows the asymmetrical inversed U-shaped curve between favorable outcome and the difference 
between the median CPP – CPPopt; C. A nearly linear relationship between median CPP values above 
the CPPopt threshold and severe disability rate can be seen; D. A U-shaped curve demonstrating that 
the smallest incidence of unfavorable outcome was associated with median CPP around CPPopt. 
CPP optimal for total monitoring period in individual patients 
Determination of an individual CPPopt total was possible in 249 patients (83%) with 172 (70%) 
patients demonstrating a U-shaped curve, 53 (21%) and 24 (9%) demonstrating ascending 
and descending curves, respectively. The proportion of patients in whom no CPPopt total was 
detected did not differ significantly between the categories of outcome. In 100 patients 
(40%) median CPPtotal was below CPPopt total and in 149 patients (60%) was above CPPopt total. 
Figure 4 shows the distribution of patients (%) into the categories of the GOS with median 
CPPtotal above, below, or close to the CPPopt total for the whole recording period. The distribution 
was significantly different between the outcome groups (χ2 = 45, p < 0.001). More patients 
with good recovery and moderate disability were treated close to the individualized CPPopt 
total. Around 50% of patients with fatal outcome were treated below CPPopt total (median CCPtotal 
< CPPopt total - 5 mmHg). Patients treated above the CPPopt total threshold (median CCPtotal > CPPopt 
total + 5 mmHg) (Figure 4) were more likely severely disabled (60%) than patients with lower 
median CPPtotal.
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dIscussIon
We have developed and validated an automated methodology for the continuous calculation 
of optimal CPP using pressure reactivity monitoring. The method presented is applicable to a 
randomized clinical trial of individualized CPP following severe TBI. We were able to calculate 
CPPopt continuously during, on average, 55% of the ICP monitoring time. We confirmed a 
significant correlation between outcome and the difference between actual CPP and the 
calculated CPPopt, supporting the concept and the feasibility of a trial evaluating individualized 
CPP optimization based on continuous monitoring of cerebrovascular reactivity following 
severe TBI. Given that CPP is a modifiable target in intensive care of TBI patients, a great deal 
of effort has been expended in optimizing CPP. The selection of an optimal CPP is possible in 
theory, as confirmed by our Figure 2, but in practice many uncertainties remain. Cerebral blood 
flow and metabolism are regionally and temporally heterogeneous after TBI. It is not known 
whether these differences in flow and metabolism also correspond to individual differences 
in the lower limit of autoregulation, or CPP-optimization ranges. Different regions of the brain 
may therefore require different levels of CPP and different levels of CPP may be needed at 
different time points after injury.1 Although optimal CPP is essentially an imaginary number, 
Figure 4
Distribution of patients (%) into the categories of the Glasgow Outcome Score with median cerebral 
perfusion pressure (CPP) above, below, or close to a mean CPPopt for the whole recording period.
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brain- monitoring techniques of pressure regulation provide complementary information 
about the lower and upper limits of CPP for an individual patient over time. 
Our study confirms earlier findings of our group in a smaller cohort of 114 severe TBI 
patients in a different study period (1997-2000). By using the method of visual inspection of 
PRx curves demonstrated that patients with a mean CPP close to CPPopt total were more likely 
to have a favorable outcome than those whose mean CPP was different from CPPopt total.
6 In 
that article, we proposed to calculate CPPopt as a moving average to guide treatment and 
shorten the period to define CPPopt by artificial manipulation of MAP. In the present study, 
we adapted the software to calculate CPPopt continuously at the bedside, and investigated 
whether spontaneous CPP changes over a period of 4 hrs would yield reliable values of 
CPPopt. This method is more practical for the treating physicians and nurses allowing early 
initiation of CPPopt targeted management after only 2 hrs of continuous ICP and BP recording. 
Additionally, the presented method allows adjustment of the target CPP according to the 
changing clinical state. In < 20% of our patients we were unable to define CPPopt total. In 
contrast to Steiner et al, we also accepted ascending and descending curves (Figure 1 B and 
C) in addition to U-shaped curves. Both additional patterns allow identification of the best 
vasoreactivity (and thus approximation of CPPopt) in the available CPP range. It is important to 
note that taking both edges of the curves instead of only the turning point (vertex) introduces 
some overestimation (with ascending curves) or underestimation (with descending curves) 
of CPPopt in those cases. Furthermore, descending curves indicate the need to raise the CPP, 
with the converse being true for ascending curves. Therefore, the one-sided curve gives 
appropriate clinical guidance of CPP to some extent. Interestingly, the overall distribution of 
curve types was not different using the calculation window of 4, 12 hrs or total monitoring 
period, which might indicate that the current TBI CPP treatment regime at our centre does 
not allow for studying the full range of CPP values. Only when the data from all patients 
were pooled together the full autoregulatory range of CPP is revealed (Figure 2).   
Optimal CPP as a threshold for autoregulation oriented therapy 
The need to define optimal CPP for individual TBI patients has been stressed by several 
authors.1-4,13,14 The Brain Trauma Foundation guidelines (2007) for management of severe 
TBI recommended that CPP should be managed within the range of 50 - 70 mm Hg (level 
III evidence). The Foundation concluded that a critical threshold for ischemia generally 
lies in the realm of 50 -  60 mmHg and breaching such a threshold should be avoided.4 
Furthermore, maintaining the CPP at levels that are too high (> 70 mm Hg) might also have 
a negative influence on outcome. A previous study of our group, including patients from the 
period 1992 to 2001, suggested that higher CPP levels were associated with increased severe 
disability rate.15 However, this was not found consistently and probably does not apply to all 
patients.16-19 Another evidence of a serious detrimental systemic effect of aggressive CPP 
therapy is acute respiratory distress syndrome.16 
 Because both inadequate and excessive CPP can be deleterious, it is necessary to study 
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not only the absolute difference between CPP and CPPopt, but also to differentiate periods of 
hypoperfusion (CPP < CPPopt) and hyperperfusion (CPP > CPPopt). Our results show that using a 
value around CPPopt (CPPopt - 2 mmHg) as an individual lower threshold for CPP management 
has a better discriminative value than a fixed threshold of 60 or 70 mmHg. Furthermore, 
we demonstrated that mortality rate increased with relative ‘hypoperfusion’ (CPP < 
CPPopt), severe disability with ‘hyperperfusion’ (CPP > CPPopt) and thus favorable outcome 
was maximal with CPP around individualized CPPopt (Figure 3). Based on these findings we 
propose that for clinical purposes CPPopt should be used as a continuously adjusted individual 
target value for CPP management.2,6,16,17,19-28 In 2010 Jaeger et al demonstrated that CPPopt 
represents the lower breakpoint of autoregulation on the classic S-shaped autoregulation 
curve, with the partial pressure of brain-tissue oxygen as a CBF surrogate.29 Similar findings 
have been described in a recent experimental study in piglets.30 
However, treatment too far above this threshold will provide oxygen and CBF in excess 
of oxygen demand (hyperaemia) and may promote secondary transcapillary water leak 
aggravating, brain edema, elevated ICP and eventually neuronal death.16,31-33 Especially in 
patients with impaired autoregulation, the ICP response to BP elevations is less predictable 
and so attempts to maintain CPP at higher levels should be avoided.17-19 
Limitations 
Although this study has a large sample size, it is a retrospective observation. The limitations 
of optimal CPP estimation based on PRx monitoring include a range of artifacts that can 
degrade the signal to noise ratio of the data collected, and intrinsic, systematic limitations 
of the linear PRx methodology. Artifacts are either related to malfunction of probes or 
transducers, or are caused by active maneuvers such as ventricular draining, coughing and 
changes of ventilator parameters affecting carbon-dioxide levels. Although such artifact 
could be theoretically avoided in a prospective study (PRx calculation could be stopped 
during EVD draining or nursing maneuvers), these are in practice dealt by means of semi-
automated artifact-recognition algorithms with acceptable success. On the other hand, the 
intrinsic limitations of the technology derive from a series of assumptions made in order to 
calculate PRx. First, PRx is a global index and therefore represents the grand-average of all 
intracranial vascular territories. It is not unreasonable to assume that different territories 
might require different perfusion pressures (i.e., uninjured brain requiring normal CPP, 
while pericontusional areas require perfusion pressures that are different from this ‘normal’ 
level). Second, it is assumed that slow ICP pressure waves are predominantly vasogenic in 
nature. This may  not always be true. Thirdly, CPP may be too stable within the period of 
calculation and so not probing enough of the autoregulatory curve. Last, the calculation of 
PRx requires of the presence of spontaneous fluctuation of BP. While such fluctuations are 
present in the majority of patients following TBI, their magnitude may be insufficient to 
produce significant ICP changes. In such cases the value of PRx will be unreliable. However, 
this loss of precision can be compensated by the continuous nature of the recording. 
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Further prospective studies are needed to support our hypothesis that managing at about 
CPPopt will be beneficial in severe TBI patients. This can be only done with a randomized 
multicenter prospective trial, and can only be done with standardized interventions for PRx 
monitoring results. Continuous calculation of CPPopt with regular updating (i.e., hourly) is a 
necessary step to perform such standardization. In addition, performance of the proposed 
cerebrovascular pressure reactivity-guided optimization of CPP should be tested in specific 
TBI treatments like decompressive craniectomy, barbiturate coma, hyperventilation or 
therapeutic hypothermia.34,35 With our bedside method we were able to calculate CPPopt in 
around 55% of monitoring time. Future attempts should be undertaken to increase these 
numbers by testing flexible individual time windows to extend the CPP ranges. Furthermore, 
our concept should be validated by analyzing its relationship with other brain-monitoring 
techniques and various patterns of injury on diagnostic imaging.1,3 
conclusIon
Our data suggest that online calculation of CPPopt based on a 4-hr moving time window is 
feasible in severe TBI patients. We have also been able to show that there is an association 
between outcome and the difference between the CPP at which the patient was managed 
and the continuously calculated CPPopt. Based on our results we suggest that the concept 
of CPPopt as an individual target value should be tested in a prospective randomized CPP 
oriented therapy trial.
appendIx
The PRx data were first processed using Fisher Transform in order to achieve normal 
distribution eliminating the ceiling effect of the maximum PRx value of 1.0.36 The data were 
then binned according to CPP values subdivided into 5-mmHg sections. CPP values < 40 
mmHg and > 120 mmHg formed the two extreme bins. For each bin corresponding values of 
PRx were assembled. The mean value and standard deviation of each bin were then plotted 
against the bins’ mean CPP values in order to create the error bar chart representing the 
relationship between PRx and CPP. Theoretically, this relationship should form a smooth 
U-shaped curve, i.e., with cerebrovascular pressure reactivity getting worse (PRx increasing) 
for CPP values further away from the curve center. An algorithm was therefore devised to fit 
such a curve to the PRx-CPP error bar plot to estimate the value of the ‘optimal CPP’, i.e., the 
CPP value for which PRx achieves the smallest value. A summary of the processing steps are 
listed below.
1 Discard the first and the last CPP bin, as these contain outlier values.  
2 Discard CPP bins that contain < 2% of data points.
3 Identify the CPP bin with the minimum PRx value (labelled as ‘CPPbest’)
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4 Fit a second-order polynomial representing a convex parabola to the plot. The fitted 
curve must fulfil the following criteria: 
 a  In the first attempt the curve part fitted is expected to include the convex point (i.e., 
point of sign change of the first derivative from negative to positive). If such a curve 
cannot be found or it does not fulfil all the remaining criteria then the monotonically 
ascending or descending part of the curve can be used. The curve must however 
follow the convex shape to some extent.
 b  The sequence of the mean PRx values of the last two bins at each edge of the curve 
must follow the correct, expected order depending on the part of the parabolic 
curve fitted (i.e., descending at the left edge and ascending on the right when fitting 
a parabolic curve including a clear minimum). The edge bins that do not fulfil this 
criterion are excluded and the fitting process is repeated.
 c  Data corresponding to the bins used in successful curve fitting (i.e., after various 
exclusions mentioned above) must represent at least:  i. represent 50% of all the data 
points in the analysed window period, ii. cover at least 50% of the range of PRx data 
available in that period and iii. Represent 20 mmHg of CPP fluctuation, so the number 
of bins used for data fit must be at least 4.
 d  The fitted part of the curve must span the range of PRx values of at least 0.2, in other 
words curves that are too ‘flat’ are rejected.
 e  The fitted part of the curve must include the ‘CPPbest’ value as defined above.
5 If all the criteria/restrictions are fulfilled the fitting procedure is stopped and the ‘optimal 
CPP’ is automatically returned. This will be the value corresponding to the minimum point 
of the fitted curve that lies within the covered range of CPP values (range of CPP bins used 
for the fit). Note that when the fitted curve does not include the convex point (i.e., point 
of sign change of the first derivative from negative to positive) the estimated ‘optimal’ 
value will be either underestimated (ascending curve) or overestimated (descending 
curve) depending on the shaped of the fitted part.
6 If all attempts have been exhausted and no satisfactory curve was fitted, the procedure 
returns an invalid value (i.e., Not-A-Number value) for the selected period.
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InTroducTIon
Advances in measurement techniques and methods have made it possible to study static 
and dynamic changes in blood pressure (BP) and cerebral blood flow (CBF). In this thesis 
these techniques have been further explored, with specific attention for their potential use 
in stroke and traumatic brain injury (TBI) subjects. First, we have outlined that measurements 
of BP, CBF, regional cerebral oxygen saturation (rSO2) and intracranial pressure (ICP) and their 
interaction (called autoregulation or vasoregulation) are important in stroke and TBI research 
(chapter 2, 3 and 4). Second, we have considered that simple postural BP changes in the stroke 
unit could form a physiological challenge to the cerebral vasoregulation and vulnerable brain 
(chapter 5, 6 and 7). This will not only improve our knowledge of the complex autoregulation 
or vasoregulation process, but also directly relates it the pressing question regarding safe 
early upright positioning and early (in and out of bed) mobilisation of stroke patients (chapter 
7 and 8). Third, vasoregulation or autoregulation results have been proposed to be capable of 
providing feedback to treatment interventions. We investigated new methods to calculate a 
continuous updated target cerebral perfusion pressure (CPP) in severe TBI patients with ICP 
monitoring that might result in better survival (chapter 10 and 11).
This chapter will provide a summary of the findings in this thesis, followed by a general 
discussion. 
summary
Part 2. CliniCal and methodologiCal baCkground
Chapter 2. 
This chapter introduces the concept of cerebral vasoregulation/autoregulation. It provides a 
clinical background underlining its relevance in early detection of cerebral (hypo) perfusion 
at the individual level with follow up over time. Several methods to analyse and quantify 
cerebral vasoregulation/autoregulation and cerebral CO2 vasoreactivity are described. Some 
vasoregulation techniques inform the clinician about subtle local regulation disorders 
(‘snapshot assessment’). Other techniques are suitable for long term monitoring of 
vasoregulation (‘monitoring assessment’) where the updated results can serve as feedback 
for treatment interventions. We conclude that monitoring cerebral autoregulation/ 
vasoregulation can be used in a variety of clinical scenarios and may be helpful in delineating 
optimal therapeutic strategies and prognostication. However, so far prospective research is 
lacking.  
Chapter 3. 
In the third chapter we consider the interaction between stroke and cerebral autoregulation. 
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Transcranial Doppler ultrasonography (TCD) in combination with continuous BP 
measurements allows non-invasive continuous bedside investigation with high temporal 
resolution of the dynamic and the steady-state components of cerebral autoregulation. We 
reviewed all relevant TCD studies on cerebral autoregulation in ischemic stroke. TCD studies 
have shown impairment of cerebral autoregulation in various subtypes of ischemic stroke 
with progressive deterioration in the first 5 days after stroke and recovery over the next 
3 months. Impaired cerebral autoregulation was related to neurological deterioration, the 
necessity for decompressive surgery, and poor outcome. To improve the synthesis of data 
from various research groups, there is urgent need for standardization of methodology of 
TCD studies in cerebral autoregulation. 
Chapter 4. 
Calculation of dynamic cerebral autoregulation (dCA) estimates require slow BP fluctuations 
of sufficient amplitude. We tested if reproducibility and variability of three dCA estimates 
improved with a passive cyclic leg raising (PCLR) maneuver in 16 healthy subjects. Middle 
cerebral artery cerebral blood flow velocity (MCA-CBFV), BP and end-tidal CO2 (etCO2) were 
obtained twice at rest and twice during PCLR at 0.1 Hz. The maneuver significantly increased 
the power of BP fluctuations at 0.1 Hz. However, an increase in etCO2 fluctuations around this 
frequency also occurred, as a result of irregular breathing. Reproducibility of dCA estimates 
phase and autoregulation index (ARI) was low and did not improve with the PCLR maneuver. 
Reproducibility of dCA gain increased significantly with the maneuver. Variability was not 
reduced by PCLR for all dCA estimates. We conclude that the utility of PCLR for autoregulation 
testing is limited because of the simultaneous changes in etCO2. This limits reproducibility 
of the most important dCA estimates. Future research on reproducibility and variability of 
dCA parameters should therefore incorporate CO2 variability or find methods to keep CO2 
constant. 
Part 3. blood Pressure, Cerebral Perfusion and vasoregulation in different 
body Positions in aCute stroke and CritiCally ill Patients
Chapter 5. 
This chapter introduces BP as one of the major vital parameters monitored in the stroke unit. 
Routine lateral turning of (critically) ill stroke patients has become an accepted standard of 
care to prevent complications of immobility. We investigated the effect of alternating body 
positions in relation to affected body side on the outcome and reliability of BP readings in 54 
acute stroke patients. The indirect BP was measured in both arms in the supine back and both 
lateral decubitus positions (45°). Supine BP readings were similar in the right and left arms 
regardless of side of deficit. Measurements of BP in the lateral decubitus positions resulted 
in significantly lower BP readings in the uppermost arm (around 12 mmHg in both arms) 
and significantly higher readings in the right lowermost arm (around 6 mmHg) compared to 
12
164  c e r e b r a l  h e m o d y n a m i c s  i n  s t r o k e  a n d  t r a u m a t i c  b r a i n  i n j u r y 
the supine position. This effect seemed less pronounced when the left lowermost arm was 
measured. There was no relation between change of BP readings in various lateral positions 
and side of stroke. We conclude that alternating lateral decubitus positions according to 
nursing standards in acute stroke patients lead to a mean 18 mmHg BP fluctuation. This may 
largely be explained by hydrostatic pressure effects, partly by anatomic factors in the left 
lowermost arm, but not by the side of stroke.
Chapter 6. 
In intensive care routine lateral turning of critically ill patients has become an accepted 
standard of care to prevent complications of immobility. We studied the effect of these 
positions on intraarterial BP (with height correction), heart rate (HR) and peripheral arterial 
oxygenation saturation measurements in 20 general intensive care unit (ICU) patients. 
BP readings in the lateral positions were, on average, 5 mmHg higher than in the supine 
position (p < 0.001). There were no significant differences between BP recordings in the left 
and right lateral position (p = 0.99). No important differences in oxygenation saturation 
and HR were observed. After correction for covariates, the effects persisted. We conclude 
that there is an increase, albeit small, in BP in the lateral positions. Turning hemodynamically 
stable ICU patients has no important effects on intraarterial BP measurements when 
continuous hydrostatic height correction is applied.
Chapter 7. 
In this chapter we extended the earlier postural BP data (chapter 5) by studying the effects 
of early upright positioning in the acute phase of ischemic stroke on both BP and functional 
outcome. The indirect BP, HR, and peripheral oxygen saturation in the supine, sitting, and (if 
attainable) active standing position 1, 2, and 3 days after acute stroke was measured in 167 
patients. Approximately 60% of the patients were able to stand. On average the BP increased 
when patients moved from the supine to sitting (Day 1: ∆ 3.9 mmHg; p < 0.001) and from 
sitting to an active standing position (Day 1: ∆ 4.6 mmHg; p < 0.001). Changes were most 
pronounced within the first 24 hrs after a stroke. BP decreased significantly (orthostatic fall) 
on standing in 13% of patients and increased significantly (orthostatic rise) in 20% of the 
patients. The latter was independently associated with a favorable outcome (p = 0.003). 
We conclude that BP changes upon upright positioning are most pronounced in the first 
24 hrs after stroke and that a significant BP rise during early upright positioning out of bed 
in patients with acute stroke is independently associated with a favorable outcome. No 
contraindication to early mobilization was found in this study.
Chapter 8. 
In this study we assessed whether cerebral blood flow velocity (CBFV) changes significantly 
after upright positioning in bed of acute stroke patients and related this to changes in 
neurological status, functional outcome and dynamic cerebral autoregulation status. We 
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investigated postural changes in neurological status and simultaneously recorded bilateral 
TCD, near-infrared spectroscopy (NIRS), etCO2 and non-invasive continuous BP data. We 
included 52 stroke patients and 20 controls. During the upright positioning, no neurological 
worsening or improvement (using motor NIHSS) was observed in any of the patients. The 
CBFV decrease upon sitting (70°) was not significantly different between healthy controls and 
stroke patients.  This was most evident the first 24 hrs after stroke. No significant differences 
were found between affected and unaffected stroke hemispheres and between patients 
with unfavorable and favorable outcome. Dynamic cerebral autoregulation was impaired 
in patients with acute stroke, especially large vessel strokes. This disturbance was bilateral 
initially, and tended to improve over time in the unaffected hemisphere. These changes were 
not correlated to changes in mean CBFV upon sitting. We conclude that upright positioning 
in bed of mildly to moderately affected stroke patients appears to be safe during the first 
3 days on the stroke unit, despite a bilaterally impaired dynamic cerebral autoregulation. 
Supine or Trendelenburg positioning did not seem to augment real time flow variables or 
improve neurological status.    
Part 4. aPPliCations in CliniCal researCh
Chapter 9. 
In this chapter we evaluated whether bilateral NIRS can be used for monitoring of patients 
with acute ischemic stroke. Therefore, the NIRS responsiveness to systemic and stroke-
related changes was studied overnight by assessing the effects of brief peripheral arterial 
oxygenation saturation and BP alterations in the affected versus nonaffected hemisphere in 
9 patients with acute stroke. Significantly more NIRS drops were registered in the affected 
compared with the nonaffected hemisphere (477 versus 184 drops, p < 0.001). In the affected 
hemispheres, nearly all peripheral oxygenation saturation drops (n = 128; 96%) were detected 
by NIRS; in the nonaffected hemispheres only 23% (n = 30; p = 0.17). Only a few BP drops were 
followed by a significant NIRS drop. This was however significantly different between both 
hemispheres (32% versus 13%, p = 0.01). We conclude that these pilot data demonstrated 
good responsiveness of the NIRS signal to systemic and stroke-related changes at the bedside 
but requires confirmation in a larger sample. This responsiveness to stroke-related changes 
makes NIRS an attractive technique when studying vulnerability of ischemic brain tissue to 
changes in the internal environment. 
Freeman et al. commented on our results in a ‘Letter to the editor’ to Stroke.1 They 
recently demonstrated a strong correlation between bilateral frontal NIRS measurements 
and corresponding regional CBF on CT perfusion imaging. However, both techniques were 
not applied simultaneously (minutes to hours apart).2 We responded that their findings 
would indicate that not only relative changes (like in our study), but also absolute (mean) 
regional cerebral oxygen saturation values might be of clinical use.3 
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Chapter 10. 
Chapter 10 and 11 concern retrospective analyses in severe traumatic brain injury (TBI) 
patients to improve (perfusion) monitoring and outcome. In chapter 10 we investigated the 
relationship between slow fluctuations of BP and ICP pulse amplitude (a new index called PAx) 
using a moving correlation technique to reflect the state of cerebrovascular reactivity. The 
index was compared to the well established and validated PRx index as a moving correlation 
coefficient between averaged values of BP and ICP. Data of 327 patients with continuous BP 
and ICP monitoring were used. The index PAx was worse in patients who died compared to 
those who survived (-0.04 ± 0.15 vs. -0.16 ± 0.15, χ2 = 28, p < 0.001). In contrast to PRx, PAx was 
able to differentiate between fatal and nonfatal outcome in a group of 120 patients with ICP 
levels below 15 mmHg (-0.04 ± 0.16 vs. -0.14 ± 0.16, χ2 = 6, p = 0.01). We conclude that PAx is a 
new modified index of cerebrovascular reactivity which performs equally well as established 
PRx in long-term monitoring in severe TBI patients, but is potentially more robust at lower 
values of ICP. In view of establishing a vasoreactivity-oriented cerebral perfusion pressure 
therapy (CPP), continuous determination of PAx is feasible but its value has to be evaluated 
in a prospective controlled trail.
Chapter 11. 
In this chapter we have sought to develop an automated methodology for the continuous 
updating of CPPopt for patients after severe TBI, using continuous monitoring of 
cerebrovascular pressure reactivity. We then validated the CPPopt algorithm by determining 
the association between outcome and the deviation of actual CPP from CPPopt. Data of 327 
patients with continuous BP and ICP monitoring were used. An automated curve fitting 
method was applied to determine CPP at the minimum value PRx (‘CPPopt’). A time trend 
of CPPopt was created using a moving 4-hr window, updated every minute. Identification of 
CPPopt was, on average, feasible during 55% of the whole recording period. Patient outcome 
correlated with the continuously updated difference between median CPP and CPPopt (χ
2 = 
45, p < 0.001; outcome dichotomized into fatal and nonfatal). Mortality was associated with 
relative ‘hypoperfusion’ (CPP < CPPopt), severe disability with ‘hyperperfusion’ (CPP > CPPopt), 
and favorable outcome was associated with smaller deviations of CPP from the individualized 
CPPopt. We conclude that real-time CPPopt could be identified during the recording time of 
majority of the patients. Patients with a median CPP close to CPPopt were more likely to have 
a favorable outcome than those in whom median CPP was widely different from CPPopt. 
CPP management to optimize individual cerebrovascular pressure reactivity should be the 
subject of future clinical trial in severe TBI patients.
Salvatori et al. commented on our results in a ‘Letter to the editor’ to Critical Care Medicine.4 
They advocated the use of TCD monitoring (and its derived indices) in management of severe 
TBI patients to optimize perfusion. We replied that TCD offers a useful estimator of CBF and 
the noninvasive nature of this technology makes it a readily available and desirable tool in 
ICU. However, with current TCD probe holders, monitoring over longer periods is not feasible, 
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even in sedated patients, allowing only intermittent assessments of CBFV. Therefore we 
believe that due to the intermittent nature it cannot, at present, replace continuous indices 
in establishing clear CPP thresholds in real time.5
general dIscussIon
methodologiCal Considerations
Blood pressure measurements 
After an acute stroke, autoregulation is impaired, which indicates that the brain becomes 
(to a certain extend) dependent on systemic BP.6 Accurate measurement of BP in the stroke 
unit is a vital component in the assessment and modification of cardiovascular risk factors 
and optimal perfusion management in the first hours to days after stroke. However, simply 
connecting patients to equipment that monitors BP, peripheral oxygen saturation, blood 
glucose and body temperature is only part of the process. It is critical that stroke physicians 
and nursing staff remain vigilant and act on any non-physiological variations.7 Factors able 
to affect readings by more than 5 mm Hg in high quality studies include are talking, acute 
exposure to cold, incorrect arm position, and incorrect cuff size.8 Another factor that needs 
to be considered are the hydrostatic effects of changing arm cuff positions relative the right 
atrium. This especially concerns stroke or critically ill patients with frequent lateral turning to 
overcome immobilization complications. In the stroke unit frequent indirect (oscillometric) 
BP measurements are done without specific attention for hydrostatic forces. In chapter 5, we 
found large variations of on average 18 mmHg that occur with turning acute stroke patients 
from one lateral (anti-decubitus) position to the other one. The most likely explanation is 
the (unnoticed!) position change of the BP arm cuff from several cm above the right atrium 
to below this BP reference level (or vice versa) with turning.9 Intraarterial measurements 
with automatic hydrostatic (height) correction can improve reliable BP measurements with 
turning,10 although (stroke-specific) anatomical (vascular) factors accompanying lateral 
turning always have to be considered. The latter deserves further research, but at present 
we advice to measure indirect BP on the right arm in (stroke) patients with alternating lateral 
positions and to account for hydrostatic effects.9
Measurements of cerebral perfusion 
Over the past years, there have been important advances in techniques to estimate cerebral 
perfusion.11 These include, but are not limited to TCD, NIRS, (functional) magnetic resonance 
imaging (MRI), and positron emission tomography (PET). All techniques have advantages 
and limitations, which are summarized in chapter 2. Importantly, both MRI and PET scanning 
require that the subject is and remains as motionless as possible in the supine position. This 
makes it difficult to investigate the hemodynamic effects of postural changes and poses 
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important limitations to the evaluation of physiological challenges in affected or recovering 
patients.12
Continuous TCD, NIRS and BP measurements 
Both transcranial Doppler (TCD) and near-infrared spectroscopy (NIRS) measurements 
provide an answer to these limitations and are easily combined with (non-invasive) 
continuous BP and peripheral oxygen saturation measurements. These instruments have 
low cost for acquisition and operation and are tolerated well by patients for intermittent 
recordings. Temporal resolution is excellent and as demonstrated in chapter 4 and 8, body 
position poses no important limitations for its use in healthy controls and acute stroke 
patients. NIRS measures changes in brain tissue hemoglobin oxygenation. The technique 
is limited to superficial areas of the brain, and it is impossible to know exactly the size and 
location of the tissue that is examined. This indicates that absolute NIRS values have limited 
value in awake subjects.3,13 However their relative changes correlate well with cortical 
brain changes measured with other techniques.14 NIRS can be regarded as an estimation 
of the ‘end result’ of complex hemodynamic changes at the brain tissue level. A reduction 
in rSO2 suggests that the balance between oxygen supply and demand has shifted. TCD 
provides a measure of cerebral blood flow velocity, which is determined by flow and by 
vessel diameter. Intra-individual changes in flow velocity reliably reflect changes in flow, 
since vessel diameter (of the major basal arteries) does not change significantly during 
autoregulation or vasoreactivity (CO2) tests.
15 By contrast, inter-individual differences 
in CBFV can be determined by differences in MCA diameter, especially in patients with 
(transient) vessel abnormalities (thrombi and spasms). Therefore, in chapter 4 and 8 relative 
changes in flow velocity (i.e., % changes from baseline) were used, eliminating the effects 
of vessel diameter. In a simplified model, TCD changes reflect the dynamics of downstream 
smaller vessels (arterioles) by vasoconstriction and vasodilatation, in response to changes 
in BP (pressure autoregulation) or CO2 (vasoreactivity).  In the literature, the combination of 
the non-invasive techniques BP, TCD and NIRS (and CO2) signals is advised.
1216 Because these 
techniques measure quite different aspects of cerebral hemodynamics, combining their 
results provides relevant complementary information. In chapter 8, we used the agreement 
in limited changes between TCD and NIRS to strengthen our statements concerning safety 
during early upright positioning in acute stroke patients.          
Cerebral autoregulation and vasoregulation and confounding factors 
Assessment of cerebral autoregulation seems an important adjunct to measurement of cere-
bral blood flow for diagnosis, monitoring or prognosis of cerebrovascular disease or traumatic 
brain injury. The most common approach evaluates the effects of changes in BP on cerebral 
blood flow, known as autoregulation. A ‘gold standard’ for this is not available and the litera-
ture shows considerable disparity of methods and criteria. Focusing on the stroke popula-
tion with continuous TCD measurements, many different autoregulation study designs and 
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analyzing methods were found, which limited the synthesis of the data (chapter 3).6 This is 
understandable because cerebral autoregulation is more a concept rather than a physically 
measurable entity.17 Static methods utilize steady-state values to test for changes in cerebral 
blood flow (or velocity) when BP is changed significantly. This is usually achieved with the 
use of vasoactive drugs or shifts in blood volume (static autoregulation). With the inhalation 
of 5 - 8% CO2 the static (metabolic) vasoreactivity can be tested in a similar way (chapter 2). 
The long time interval between static measurements is a particular concern in many 
studies. Parallel changes in other critical variables, such as CO2, venous drainage, hydrostatic 
forces, brain activation and sympathetic tone, are rarely reported or controlled for. Proposed 
indices of static autoregulation are based on changes in cerebrovascular resistance, on 
parameters of the linear regression of flow/velocity versus BP changes, or only on the 
absolute changes in flow. Static methods all have in common that they require large 
(controlled) changes in BP, volume or CO2, making them less suitable for clinical research 
(chapter 2). However, as we point out in the discussion of chapter 8, in everyday challenges 
such as upright positioning, several critical variables will change (or balance each other out) 
making calculation of current static (BP) autoregulation indices difficult or unreliable. Newer 
methods of dynamic assessment are based on transient changes in cerebral blood flow 
(or velocity) induced by the deflation of thigh cuffs, Valsalva maneuvers, repeated tilting, 
breathing instructions and induced or spontaneous slow fluctuations in BP. Dynamic testing 
overcomes several limitations of static methods but it is not clear whether the two approaches 
are interchangeable.17 We also found no correlation between relative postural CBFV changes 
and impaired bilateral dynamic autoregulation estimates in acute stroke patients. Others 
also reported this discrepancy in stroke patients, but the exact meaning of it is not clear 
and requires further investigation.18,19 Classification of autoregulation performance using 
dynamic methods has been based on mathematical modeling, coherent averaging, transfer 
function analysis, cross-correlation function or impulse response analysis. Many papers urge 
the need for more research on reproducibility, variability and inter-method comparisons of 
autoregulation estimates (considering both ‘snapshot’ and ‘monitoring’ assessments).16,17 In 
chapter 4 we introduced a new bedside method in which passively and repeatedly the legs 
of a patient are raised to induce large BP fluctuations. Large BP fluctuations challenge the 
individual global autoregulatory capacity.20 However, our results showed different effects 
on reproducibility and disappointing variability for 3 different autoregulation estimates 
in healthy cooperative volunteers. This is most probably explained by 1) the selective and 
disruptive influence of concurrent (leg raising induced) CO2 fluctuations  and 2) the limited 
size of the BP fluctuations induced with this maneuver (chapter 4). Different research groups 
also emphasize assessing autoregulation in individuals rather than patient groups.16,17,21 In 
collaboration with the  brain monitoring group in Cambridge we improved a method that 
uses continuously monitored cerebrovascular pressure reactivity (as a component of the 
autoregulation process) to estimate a target perfusion pressure in individual TBI patients 
with continuous updating (chapter 11).   
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Testing versus monitoring of autoregulation 
Classical testing of cerebral autoregulation requires the observer to apply a hemodynamic 
stimulus. With these methods the observer controls the exact time and grade of 
stimulation, and synchronously measures a change in CBF (or velocity) to quantify the 
reactive autoregulatory forces. Control over the hemodynamic input imparts precision to 
autoregulation testing techniques. Stimuli can be graded to create a favorable signal-to-
noise ratio. The assumption that associated responses of CBF are causally related to the 
hemodynamic stimulus is less subject to confounding influences than a similar assumption 
made with spontaneous hemodynamic fluctuations.16 Despite these precision advantages, 
practical and clinical reasons limit frequent autoregulation testing. This point touches on an 
important practical question concerning autoregulation studies in several clinical conditions: 
how often does the state of autoregulation change over time and what to do with this 
information? Ideally, the rate of acquisition of autoregulation information would match the 
time course of changes in the state of autoregulation. Some autoregulation techniques are 
able to inform the observer about (subtle) local regulation disorders that might progress 
over time (‘snapshot or risk factor assessment’). Other techniques are more suitable for 
long-term continuous monitoring of global vasoregulation (‘monitoring assessment’) where 
the continuously updated results can serve as feedback for treatment interventions and 
prognostification (chapter 2).
Continuous methods of autoregulation monitoring rely on the observation of 
spontaneous responses of CBF to spontaneous slow fluctuations in BP. The magnitude 
of such spontaneous ‘slow vasocycling’ in BP may be unpredictable and therefore, the 
signal-to-noise ratio, and subsequent precision is less favorable than in testing (‘snapshot 
assessment’). In addition, the assumption that synchronously measured spontaneous slow 
waves of perfusion pressure and CBF are causally related is vulnerable to confounding 
influences, such as CO2 changes, drugs, surgical interventions, etc. This loss of precision is 
compensated by the ability to repeat the measurements frequently and monitor changes in 
autoregulation continuously. Averaging the repeated measures over time reduces estimation 
error and renders the method clinically useful.16 This coupled to the clinical advantage of not 
requiring potentially harmful hemodynamic stimuli to patients with vulnerable brain. Several 
methods for continuous monitoring in critically ill patients (like severe traumatic brain injury 
patients) exist. One method (PRx) uses the invasive ICP signal to calculate cerebrovascular 
pressure reactivity (chapter 10 and 11). Cerebrovascular pressure-reactivity is defined as the 
ability of vascular smooth muscle to respond to changes in transmural pressure.22 This is one 
of the key mechanisms responsible for autoregulation of cerebral blood flow. However, the 
two expressions should not be used synonymously as vasodilatation reaches its maximum 
at BP below the lower threshold for constant cerebral blood flow.23 
In daily clinical practice, the pressure-reactivity indexes (PRx or PAx) can be displayed as a 
time trend alongside the primary modalities (like ICP, BP, CPP). The PRx has been extensively 
validated and shows significant agreement with the PET-CBF static rate of autoregulation 
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in TBI patients.24 In patients with continuously monitored ICP (traumatic brain injury, 
subarachnoid hemorrhage, major ischemic or hemorrhagic stroke) the comparison of slow 
waves of ICP and BP can contain information about cerebrovascular pressure-reactivity. The 
method is explained (simplified) in Figure 3 in chapter 2. In theory, with good cerebrovascular 
reactivity, a change in BP should provoke inverse, reactive change in cerebral blood volume. 
With a steep pressure-volume curve, the change in CBV should produce correlated changes in 
mean ICP.25,26 Therefore, a negative correlation coefficient between changes in mean ICP and 
BP signifies good pressure-reactivity of cerebral arterioles, which is a condition necessary for 
intact autoregulation. Conversely, with disturbed reactivity, changes in BP produce passive, 
positively correlated changes in brain blood volume, therefore, correlation between BP and 
ICP slow waves is positive. However, at lower levels of ICP the linear relation between ICP 
and intracerebral volume may be abolished -due to high cerebral compliance- affecting 
reliable PRx calculation.27,28 This may be the case after medical or surgical interventions 
like decompressive craniectomy. However the compliance of the cerebral vessels is thought 
to be preserved. We assumed that even with low levels of ICP, changes in vascular tone 
brought about by slow waves in BP will be reflected by changes in the BP to ICP pulse 
transmission (chapter 10, Figure 7). Therefore we investigated the relationship between 
slow BP fluctuations and the ICP pulse amplitude (a new index called PAx) using a moving 
correlation technique to reflect the state of cerebrovascular reactivity (chapter 10). PAx was 
worse in patients who died compared to those who survived. In contrast to PRx, PAx was 
able to differentiate between fatal and nonfatal outcome in the group of 120 patients with 
ICP levels below 15 mmHg. We conclude that PAx is a new modified index of cerebrovascular 
reactivity which performs equally well as established PRx in long term monitoring in severe 
TBI patients, but importantly is potentially more robust at lower values of ICP. 29
The relationship between the pressure-reactivity indexes (or autoregulation (Mx) assessed 
using TCD) and CPP resembles a U-shape curve.16,30 The curve indicates that inadequate CPP 
and excessive CPP are both associated with pressure reactivity failure. Therefore, the hypoth-
esis has been drawn that there is a CPP at which cerebral pressure reactivity is strongest, and 
that this ‘optimal CPP’ (CPPopt) can be identified by plotting PRx against CPP in individual pa-
tients (from a moving time window of at least 4 hrs or more). Patients with greater deviation 
between their averaged CPP and post-hoc assessed overall  CPPopt had worse outcome after 
head trauma in a retrospective study.30 The method which allows to obtain an individual CPPopt 
based on monitoring of PRx has been improved in chapter 11 allowing for automated calcula-
tion of the CPPopt from a clinically useful period of 4 hrs.
31 Using retrospective data of more 
than 300 patients, we conclude that CPP should be not too low, not too high, but optimal, i.e., 
matched to an individually assessed value, which provides the best milieu for cerebrovascular 
reactivity and maximizes the ability of the brain to protect itself from both ischemia and hy-
peremic injury.3233 The use of a moving window, updating at the bedside allows providers to 
track CPPopt, a value which may change over time. It remains to be demonstrated whether such 
a strategy is able to improve outcome in neuro-critical care patients.34
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ImplIcaTIons
Having described these methodological issues, we will now turn to the implications of the 
findings in this thesis looking at the aims. 
How does arterial blood pressure react to postural changes (decubitus, supine, sitting and 
standing position) in acute stroke and critically ill patients. Is there a correlation between 
postural BP responses and outcome after stroke.
In the upright position, the cerebral arteries are positioned ± 30 cm above the heart, and 
therefore their perfusion pressure seems to be reduced (but still within what is considered to 
be the autoregulatory range). Both the position of the cerebral circulation and the reduction 
on cardiac output (due to venous pooling) challenge cerebral blood flow. Although the 
postural reduction of flow velocity (TCD) and regional cerebral oxygenation (NIRS) is kept 
limited via systemic compensations and cerebral autoregulatory mechanisms, orthostatic 
intolerance is not uncommon in healthy subjects.35, 36 
Orthostatic changes are poorly investigated in acute stroke patients.37 We found that BP 
(without height correction) increased when patients moved from the supine to sitting and 
from sitting to an active standing position. These changes were most pronounced within 
the first 24 hrs after a stroke. BP decreased significantly on standing in 13% of patients and 
increased significantly in 20% of the patients. The latter was independently associated 
with a favorable outcome. The rate of orthostatic hypotension was not different from the 
ones reported in healthy or hypertensive elderly.38 Therefore we concluded that our results 
indicate no contraindication to early mobilisation in acute stroke patients.39 
In a way our findings are reassuring and would not support standard postural BP 
measurements to be included in stroke unit or early mobilisation protocol guidelines 
(covering the first 3 days post stroke). On the other hand, the association between postural 
orthostatic hypertension and good outcome suggests that the vulnerable penumbra may 
benefit from a ‘hyperdynamic’ cardiovascular system in de acute phase after stroke.37, 40 
Which autonomic or physiological mechanisms are involved to accomplish these responses 
are not fully clarified.41-43 Also the interaction between orthostatic hypertension and 
impaired cerebral autoregulation is unclear and deserves further research. All this might 
improve our knowledge in (sub) acute stroke physiology and guide difficult treatment 
decisions regarding early mobilisation, rehydration and medication adjustments, especially 
in hypertensive subjects.    
What are the effects of in-bed-mobilization on estimates of cerebral perfusion and 
neurological status in the acute phase after stroke. 
Little is known about the influence of different body positions on real time cerebral flow 
variables in the acute ischemic stroke phase. We assessed whether cerebral blood flow 
velocity (CBFV) changes significantly after (upright) positioning in bed and related this to 
changes in neurological status, functional outcome and dynamic autoregulatory status. We 
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investigated postural changes in neurological status and simultaneously recorded bilateral 
transcranial Doppler (TCD), near-infrared spectroscopy (NIRS), end-tidal CO2 and non-
invasive continuous BP data in 52 acute stroke patients. During the upright positioning, no 
neurological worsening or improvement (using motor NIHSS) was observed in any of the 
patients. The mean CBFV decrease upon sitting (70°) was not different between controls 
and stroke patients. No significant differences were found between affected and unaffected 
stroke hemispheres and between patients with unfavorable and favorable outcome. 
Dynamic cerebral autoregulation was bilaterally impaired in stroke patients However, no 
correlation between bilateral impaired autoregulation status and positional mean CBFV 
changes was found. We conclude that upright positioning in bed of mildly to moderately 
affected stroke patients appears to be safe during the first 3 days on the stroke unit, despite 
a bilaterally impaired dynamic cerebral autoregulation. Supine or Trendelenburg positioning 
did not seem to augment real time flow variables or improve neurological status.    
Our results indicate that sitting is well tolerated in mildly to moderately affected 
acute stroke patients. This may be due to the counterbalancing effects of BP elevation 
(hyperdynamic cardiovascular status), ICP reduction or increased cerebral venous return to 
stabilize cerebral perfusion pressure in the acute phase of stroke. Follow-up studies several 
days after stroke may be warranted because systemic compensatory mechanisms may 
become exhausted or cerebral autoregulation may deteriorate.44 Our results do not hold for 
early sitting to the standing position (out of bed mobilisation), which may provoke different 
(probably larger) hemodynamic responses.45 In the paucity of results from ‘the early out of 
bed mobilisation stroke trails’,46 we have found no indications  that upright positioning of 
mildly to moderately affected stroke patients is unsafe in the stroke unit. We propose that 
continuous CBF measurements in stroke patients during early activity out of bed could be 
the next investigation to reassure safe stroke unit (early) mobilisation. 
How can the bedside monitoring of estimates of cerebral autoregulation/vasoregulation 
be improved in stroke and traumatic brain injury patients? 
The near-infrared spectroscopy (NIRS)-derived rSO2 is theoretically linked with multiple 
variables describing the ratio of delivery and utilization of local cerebral oxygen. NIRS-based 
autoregulation monitoring has several advantages. NIRS optodes are non-invasive and do not 
require precision focusing on small vessels or continuous correction for shifts. Experience in 
acute stroke patients is very limited.47 In our pilot stroke study in 9 patients, 96% of systemic 
nocturnal peripheral desaturations were rapidly followed by local cerebral desaturations 
as measured by NIRS. Also, BP drops were more likely to be followed by NIRS drops in the 
affected than in the nonaffected hemisphere. Local nocturnal cerebral desaturations were 
more than twice as likely in the affected hemisphere.48 This responsiveness to stroke-related 
changes makes NIRS an attractive technique when monitoring vulnerability of ischemic 
brain tissue to changes in the internal environment on the stroke unit. 
Survival after TBI is dependent on the control of intracranial hypertension and the 
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provision of hemodynamic support to achieve an ‘adequate’ CPP and subsequent CBF 
(‘optimal perfusion’ concept). While methods of estimating CBF and CPP exist, there is 
still an ongoing debate with respect to which threshold of CPP should be adopted in TBI 
management and whether this threshold should be standardized or individual. While on 
the intensive care gross estimation of CBF (with for example TCD estimates) and ICP may 
be sufficient to initiate therapy, we believe that in the prolonged intensive care setting 
there is a need for a finer balance with the ability of continuous titration of hemodynamic 
parameters to minimize secondary brain damage.16,49 The method which allows obtaining 
an individual CPPopt based on monitoring of the cerebrovascular pressure reactivity index 
PRx has been improved in chapter 11 allowing for automated calculation of the CPPopt from 
a clinically useful period of 4 hrs.30,31 We conclude that in the management of severe TBI 
the threshold of CPP should be targeted to (continuously changing) physiology and not 
constitute a predefined number. We validated the new CPPopt algorithm by determining the 
association between outcome and the deviation of actual CPP from CPPopt. 
The choice of the physiological parameter by which to guide treatment is difficult and so 
far has not been clearly established. In clinical practice, the use of cerebrovascular pressure 
regulation (PRx) is twofold. Firstly, unlike TCD indices, it is a continuous parameter which 
gives credible values as long as ICP monitoring is available. Unfortunately, with current TCD 
probe holders, TCD monitoring over longer periods is not feasible, even in sedated patients, 
allowing only intermittent assessments of CBF surrogates. Secondly, unlike other invasive 
intracranial parameters such as PbTO2 microdialysis or thermal dilution regional CBF it 
is less susceptible to probe location.5 Further prospective studies are needed to support 
our hypothesis that aiming for CPPopt will be beneficial in severe TBI patients.
21,50 This can 
only be done with a randomized multicenter prospective trial, and can only be done with 
standardized interventions for PRx-monitoring results. Continuous calculation of CPPopt with 
regular updating (i.e., hourly) might be a necessary step to perform such standardization.
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InleIdIng
Vooruitgang in meettechnieken en rekenmethoden hebben het mogelijk gemaakt om stabiele 
en dynamische veranderingen in de bloeddruk, intracraniële druk en hersendoorbloeding 
te bestuderen. In dit proefschrift zijn deze technieken verder onderzocht, met specifieke 
aandacht voor hun inzet rondom de bewaking en verbetering van de zorg bij patiënten met 
een acuut herseninfarct of ernstig traumatisch schedelhersenletsel. Als eerste hebben we 
in dit proefschrift een overzicht opgenomen waarbij de waarde van het frequent meten 
van de bloeddruk, hersendoorbloeding, regionale hersenzuurstofvoorziening (rSO2) en de 
intracraniële druk in deze patiëntengroepen wordt weergegeven. Tevens introduceren wij 
het concept achter de autoregulatie of vasoregulatie van de hersenen: het systeem waarbij 
hersenbloedvaten reageren op schommelingen in de bloeddruk om de hersendoorbloeding 
zo constant mogelijk te houden (hoofdstuk 2, 3 en 4). Vervolgens hebben we onderzocht 
of het innemen van de linker en rechter zijligging belangrijke bloeddruk meetfouten geeft 
(hoofdstuk 5 en 6) en of de posities zitten en staan gevaarlijk zijn voor het herstellende 
hersenweefsel na een acuut herseninfarct. Het innemen van een andere lichaamshouding 
kan de bloeddruk plots doen dalen waarbij de zelfregulatie (autoregulatie) van de 
hersenbloedvaten tekort kan schieten (hoofdstuk 7 en 8). De resultaten van de vasoregulatie 
of autoregulatiemetingen kunnen mogelijk dienen als terugkoppeling voor belangrijke 
behandelinterventies en zodoende de bewaking en uiteindelijke overleving en herstel 
verbeteren. In de laatste twee hoofdstukken onderzochten wij nieuwe methoden om 
een ‘optimale’ doorbloedingsdruk te berekenen bij patiënten met ernstig traumatisch 
schedelhersenletsel waarbij naast de bloeddruk ook de intracraniële druk gemeten werd op 
de intensive care (hoofdstuk 10 en 11).
In dit hoofdstuk bespreken wij de belangrijkste bevindingen van dit proefschrift, gevolgd 
door een algemene discussie van de resultaten.
samenvaTTIng
deel 2. klinisChe en methodologisChe aChtergrond
Hoofdstuk 2. 
Vasoregulatie en autoregulatiemetingen van de hersenenvaten hebben als doel om perioden 
van verminderde hersendoorbloeding op te sporen en te voorkomen. Er zijn verschillende 
methoden om de autoregulatie, vasoregulatie en CO2 vasoreactiviteit van de hersenvaten 
te meten, te analyseren en te kwantificeren. Sommige technieken informeren de arts over 
lokale regulatiestoornissen (‘snapshot evaluatie’). Andere technieken zijn meer geschikt voor 
langdurige globale metingen (‘monitoring evaluatie’) waar de bijgewerkte resultaten als 
terugkoppeling kunnen dienen voor behandelingen. We concluderen dat deze methoden in 
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een verscheidenheid van ziektebeelden kunnen worden ingezet en in de toekomst mogelijk 
behandelingen kunnen sturen. Referentiewaarden ontbreken momenteel echter nog, 
hetgeen de inzet in de klinische praktijk momenteel beperkt. 
Hoofdstuk 3.
In dit hoofdstuk bespreken we de interactie tussen een (sub) acuut herseninfarct en de 
autoregulatie van de hersenen. Onderzoekers hebben hiervoor de transcraniële Doppler 
(TCD) techniek gebruikt omdat hiermee de hersendoorbloeding aan het bed van de patient 
voor een langere periode (niet-invasief) geschat kan worden. Deze methode is geschikt 
voor het bestuderen van de verschillende fysiologische regelmechanismen betrokken bij de 
autoregulatie (dynamische en statische autoregulatie). We hebben relevante studies uit de 
literatuur geselecteerd en beoordeeld. Deze studies tonen in het algemeen een belangrijke 
stoornis in de autoregulatie na een herseninfarct aan. De stoornis verslechtert mogelijk nog 
in de eerste vijf dagen na het herseninfarct en herstelt zich in de volgende drie maanden. Een 
gestoorde autoregulatie was geassocieerd met een verdere neurologische verslechtering, de 
noodzaak voor chirurgische ingrijpen en uiteindelijk slechter herstel. Ter verbetering van de 
synthese van gegevens uit de verschillende onderzoeksgroepen, is er dringend behoefte aan 
standaardisatie van de gebruikte methodologie in autoregulatiestudies.
Hoofdstuk 4. 
Voor het correct berekenen van de dynamische autoregulatie van de hersenen vormt de 
aanwezigheid van grote, trage bloeddrukschommelingen een belangrijke voorwaarde. 
In dit hoofdstuk hebben we getracht de reproduceerbaarheid en variabiliteit van drie 
autoregulatieuitkomstmaten te verbeteren bij 16 gezonde vrijwilligers door het passief optillen 
van de benen van de onderlaag. De bloeddruk, de CO2 spanning, en de doorbloedingssnelheid 
in de hersenen (transcraniële Doppler; TCD) werden continu tweemaal in rust en tweemaal 
tijdens het cyclisch optillen van de benen (5 sec omhoog, daarna 5 sec omlaag) gemeten. 
De bloeddrukschommelingen namen inderdaad toe rondom de opgelegde frequentie. De 
vrijwilligers gingen echter ook dieper en onregelmatiger ademen met veranderingen in het 
uitgeademde CO2 gehalte. De variabiliteit van de dynamische autoregulatieuitkomstmaten 
namen niet af door de manoeuvre. De reproduceerbaarheid nam enkel toe voor één 
uitkomstmaat (de ‘gain’ parameter). Wij concluderen dat het nut van deze manoeuvre voor 
het correct berekenen van de dynamische autoregulatie beperkt is, waarschijnlijk door 
gelijktijdige CO2 veranderingen. Het registreren van de CO2 mag derhalve niet ontbreken bij 
autoregulatieberekeningen en voor de interpretatie hiervan.     
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deel 3.  de bloeddruk, hersendoorbloeding en vasoregulatie in versChillende 
liChaamshoudingen bij Patiënten met een aCuut herseninfarCt en bij 
ernstig zieke Patiënten
Hoofdstuk 5. 
De bloeddruk wordt frequent gecontroleerd op de afdeling waar patiënten met een acuut 
herseninfarct worden opgenomen (stroke unit). Bedlegerige patiënten worden frequent in 
zijligging gelegd om complicaties van immobiliteit te voorkomen. Wij onderzochten het 
effect van deze wisselligging op de bloeddruk en keken of er een relatie is met de zijde van 
neurologische uitval. Bij 54 patiënten werd de (indirecte) bloeddruk gemeten aan de beide 
armen, allereerst liggend op de rug en vervolgens in beide zijliggingen (45°). De bloeddruk 
gemeten aan beide armen in rugligging was vergelijkbaar. In de zijligging was de bloeddruk 
significant lager (ongeveer 12 mmHg) indien de bloeddrukmanchet om de bovenliggende 
arm werd geplaatst. Significant hogere waarden (ongeveer 6 mmHg) werden gemeten in de 
onderliggende rechter arm. Dit effect leek minder uitgesproken wanneer de onderliggende 
linker arm werd gemeten. De zijde van uitval had hier geen invloed op. We concluderen dat 
bij het draaien van patiënten op de stroke unit grote verschillen in de bloeddrukwaarden 
gevonden worden (gemiddeld tot 18 mmHg). Dit kan grotendeels verklaard worden door 
hydrostatische factoren, mogelijk deels ook door anatomische veranderingen in de linker 
arm, maar niet door de zijde van neurologische uitval. 
Hoofdstuk 6. 
Op de intensive care worden patiënten frequent op de zij gedraaid om complicaties van 
immobiliteit te voorkomen. We onderzochten het effect van deze wissel zijligging (45°) op 
de intra-arteriëel gemeten bloeddruk (met hoogte correctie), hartslag en perifere arteriële 
oxygenatie in 20 intensive care patiënten. De bloeddruk in de linker en rechter zijligging was 
gemiddeld 5 mmHg hoger dan in rugligging. Wij vonden geen significante verschillen tussen 
bloeddruk gemeten in de linker en rechter zijligging. Er werden geen belangrijke verschillen 
in oxygenatie en hartfrequentie waargenomen tussen de drie posities. Na correctie voor 
covariaten bleven de effecten bestaan . We concluderen dat er een kleine - maar klinisch 
niet relevante - toename is van de  intra-arteriële bloeddruk in zijligging met continue 
hydrostatische hoogtecorrectie.
Hoofdstuk 7. 
In dit hoofdstuk hebben we de effecten van liggen, zitten en staan op de bloeddruk bestudeerd 
bij patiënten met een acuut herseninfarct. De indirecte bloeddruk, hartfrequentie en perifere 
zuurstofsaturatie werden hiervoor in de liggende, zittende, en (indien haalbaar) actief staande 
positie gemeten op dag 1, 2 en 3 na het infarct bij 167 patiënten. Tevens werd gekeken of een 
forse bloeddrukstijging of daling bij staan gecorreleerd was met het uiteindelijke herstel na 
3 maanden. Ongeveer 60% van de patiënten waren in staat om te staan . Gemiddeld nam de 
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bloeddruk toe bij de positieverandering van liggen naar zitten (Dag 1: ↑ ongeveer 4 mmHg) 
en bij van zitten naar staan (Dag 1: ↑ ongeveer 5 mmHg). Veranderingen waren het meest 
uitgesproken bij de metingen in de eerste 24 uur na het herseninfarct. Een significante 
bloeddrukdaling (orthostatische daling) trad op bij 13% van de patiënten, een significante 
stijging (orthostatische verhoging) werd gezien in 20%. De orthostatische verhoging was 
onafhankelijk geassocieerd met een gunstig herstel van het herseninfarct. We concluderen 
dat de bloeddrukveranderingen bij zitten en staan het meest uitgesproken zijn in de eerste 
24 uur na een herseninfarct. Een significante bloeddrukstijging tijdens staan is onafhankelijk 
geassocieerd met een gunstig herstel na een acuut herseninfarct. De resultaten leveren 
geen argumenten tegen de vroege mobilisatie van patiënten op de stroke unit. 
Hoofdstuk 8.
In deze studie onderzochten we of de doorbloedingssnelheid (TCD) van de grote hersenvaten 
significant verandert bij patiënten met een acuut herseninfarct die de zittende positie (in 
bed) innemen. Daarnaast hebben we het verband tussen deze fysiologische veranderingen 
en  veranderingen in de neurologische status, het uiteindelijk herstel en de dynamische 
autoregulatie van de hersenen geëxploreerd. Naast de doorbloedingssnelheid (in aangedane 
en niet-aangedane hersenhelft) werden ook het ‘near-infrared’ spectroscopie signaal (NIRS), 
de CO2 spanning en de niet-invasieve bloeddruk gemeten. In totaal werden 52 patiënten met 
een acuut herseninfarct en 20 gezonde controles gemeten. Na het innemen van de zittende 
positie werd geen verslechtering of verbetering van de neurologische uitval waargenomen. 
De gemiddelde doorbloedingssnelheid daalde niet meer in de zittende positie (70°) bij 
patiënten dan bij gezonde controles. Dit was het meest evident bij de meting op de eerste dag. 
Er werden geen significante verschillen gevonden tussen de aangedane en niet-aangedane 
hersenhelft en tussen patiënten met een ongunstige en gunstige uitkomst na 3 maanden. 
De dynamische autoregulatie was significant verminderd bij patiënten met een acuut 
herseninfarct, met name bij patiënten met afwijkingen in de grote toevoerende vaten. Deze 
verstoring werd aanvankelijk voor beide hersenhelften gevonden, en verbeterde enigszins bij 
de meting op dag 3 voor de niet-aangedane hersenhelft. Deze stoornissen hadden geen relatie 
met de veranderingen van de gemiddelde doorbloedingssnelheid tijdens de positiewisseling. 
Het innemen van de zittende positie in bed bij licht tot matig getroffen patiënten met een 
herseninfarct lijkt veilig tijdens de eerste 3 dagen op de stroke unit (ondanks een bilateraal 
aangetaste dynamische autoregulatie). De liggende of Trendelenburg positie verbetert de 
hersendoorbloeding niet en gaf geen verbetering van de neurologische uitval. 
deel 4. toePassingen in klinisCh onderzoek
Hoofdstuk 9. 
In dit hoofdstuk werd onderzocht of het meten van het bilaterale NIRS signaal kan worden 
gebruikt voor het bewaken van patiënten met een acuut herseninfarct. Het NIRS signaal 
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meet de veranderingen in de zuurstofconcentratie in de hersenen en kan mogelijk belangrijke 
effecten van forse schommelingen in de bloeddruk en dalingen van het zuurstofgehalte in 
het bloed opsporen. Negen patiënten met een acuut herseninfarct werden gedurende de 
nacht enkele uren op de stroke unit gemeten.  We vonden significant meer NIRS dalingen in 
de aangedane vergeleken met de niet-aangedane hersenhelft (477 versus 184 dalingen). In de 
aangedane hemisfeer werden bijna alle zuurstof dalingen in het bloed (n = 128, 96%) gevolgd 
door een NIRS daling, in de niet- aangedane hersenhelft was dit slechts in 23% het geval (n 
= 30). Slechts een gedeelte van de forse  bloeddrukdalingen werden gevolgd door een daling 
van het NIRS signaal. Dit was echter significant verschillend tussen de beide hersenhelften 
(32% versus 13%). Deze studie toont aan dat het NIRS signaal belangrijke fysiologische 
veranderingen in de aangedane hersenhelft weergeeft, maar vereist bevestiging in een 
grotere steekproef. Het lijkt aantrekkelijk om deze techniek in te zetten op de stroke unit om 
het kwetsbare hersenweefsel te bewaken.  
Hoofdstuk 10. 
Hoofdstuk 10 en 11 hebben betrekking op retrospectieve analyses met data van ernstig trauma-
tisch hersenletselpatiënten met continue metingen van de bloeddruk en intracraniële druk op 
de intensive care. De metingen werden verricht om de hersendoorbloeding te optimaliseren. In 
hoofdstuk 10 onderzochten we de relatie tussen langzame spontane wisselingen in de bloed-
druk en de amplitudo van het intracraniële druk signaal. Deze relatie kan worden uitgedrukt in 
een nieuwe index (PAx) en met een statistische bewerking als een trend over de tijd worden 
weergegeven. Deze trend weerspiegelt mogelijk de reactiviteit van de hersenvaten (vasculaire 
reactiviteit). In deze studie werd de nieuwe PAx index vergeleken met de gevestigde en gevali-
deerde PRx index (de correlatiecoëfficiënt tussen gemiddelde waarden van bloeddruk en in-
tracraniële druk signaal). De gegevens van 327 traumapatiënten werden gebruikt waarvan de 
uitkomst na zes maanden bekend was. De index PAx was minder negatief bij traumapatiënten 
die dood gingen in vergelijking met degenen die overleefden. In tegenstelling tot PRx, kon PAx 
differentiëren tussen een dodelijke en niet-dodelijke afloop in een groep van 120 patiënten met 
intracraniële druk lager dan 15 mmHg. We concluderen dat PAx een nieuwe index van de reac-
tiviteit van de hersenvaten vertegenwoordigt, die even goed presteert als de gevestigde PRx 
index in langdurige bewaking van patiënten met ernstig schedelhersenletsel, maar ook bruik-
baar is bij lagere waarden van de intracraniële druk. De definitieve waarde van deze nieuwe 
index moet verder worden onderzocht in prospectief gecontroleerd onderzoek. 
Hoofdstuk 11. 
In dit hoofdstuk hebben we geprobeerd een methode te ontwikkelen waarbij door het 
weergeven van de reactiviteit van de hersenvaten (PRx) over een periode van 4 uur een 
‘optimale’ doorbloedingsdruk (of ‘cerebral perfusion pressure’; CPP) gevonden kan worden 
voor patiënten met ernstig traumatisch schedelhersenletsel. De methode hebben we 
gevalideerd door de associatie tussen de uitkomst na zes maanden en het verschil tussen de 
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berekende waarde en de werkelijke doorbloedingsdruk te analyseren. Met een wiskundige 
methode werd de ‘optimale’ doorbloedingsdruk in de hersenen automatisch in een grafiek 
aangegeven als de waarde waarbij de hersenvaten de beste reactiviteit vertoonden. Door 
een statistische bewerking kan deze ‘optimale’ waarde als een trend worden weergegeven. 
Identificatie van een ‘optimale’ doorbloedingsdruk was gemiddeld mogelijk gedurende 
55% van de gehele registratieperiode op de intensive care. De uitkomst na zes maanden 
correleerde met het verschil tussen de berekende (optimale) en werkelijke waarde, waarbij 
de uitkomst gedichotomiseerd werd in dodelijke en niet-dodelijke afloop. Dodelijke afloop 
was geassocieerd met relatieve ‘verminderde doorbloeding’ (werkelijke waarde < ‘optimale’ 
waarde), ernstige invaliditeit met ‘toegenomen doorbloeding’ (werkelijke waarde > ‘optimale’ 
waarde), en een gunstige uitkomst was geassocieerd met kleine verschillen tussen de 
werkelijke en de individuele ‘optimale’ doorbloedingsdruk van de hersenen. Wij concluderen 
dat een ‘optimale’ doorbloedingsdruk kan worden geïdentificeerd in de meerderheid van de 
opnameperiode op de intensive care bij ernstig traumatisch schedelhersenletsel patiënten 
met continue intracraniële drukmetingen. Patiënten met een doorbloedingsdruk dicht bij 
berekende ‘optimale’ waarde hadden meer kans op een gunstige uitkomst dan degenen bij 
wie doorbloedingsdruk afwijkt van de individueel berekende ‘optimale’ waarde. Behandeling 
van ernstig schedelhersenletsel met het meewegen van de individuele reactiviteit van de 
hersenvaten verdient verder (prospectief) onderzoek om de uitkomst te verbeteren. 
ImplIcaTIes
Na de beschrijving van de samenvatting van de verschillende hoofdstukken, zullen we 
nu ingaan op de implicaties van de bevindingen in dit proefschrift aan de hand van de 
doelstellingen en vragen.
Hoe reageert de bloeddruk op verschillende houdingsveranderingen in patiënten met 
een acuut herseninfarct (zijligging, liggende, zittende en staande positie) en patiënten 
opgenomen op de IC (zijligging)? Is er een verband tussen deze bloeddruk-veranderingen 
en de uitkomst na een acuut herseninfarct?
In de zittende en staande positie bevinden de hersenvaten zich ± 30 cm boven het hart, 
met directe gevolgen voor de doorbloedingsdruk in de hersenen (maar nog steeds binnen 
wat wordt beschouwd als het bereik van de autoregulatie). Zowel de positie van de 
hersencirculatie als de verlaging van het hartminuutvolume (door veneuze pooling) vormen 
een uitdaging voor een constante bloedstroom in de hersenen in deze posities. Hoewel de 
gemeten vermindering van de bloedstroomsnelheid (TCD) en locale zuurstofvoorziening 
(gemeten met NIRS) in de hersenen beperkt worden gehouden via systemische fysiologische 
aanpassingen en via de autoregulatie, is houdingsgebonden intolerantie (orthostase) en 
flauwvallen niet ongewoon bij gezonde mensen.
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Houdingsgerelateerde fysiologische veranderingen zijn beperkt onderzocht bij patiënten met 
een acuut herseninfarct. Wij vonden dat de bloeddruk (zonder hoogtecorrectie) toeneemt 
wanneer patiënten gaan zitten en vanuit de zittende positie actief gaat staan. Deze 
veranderingen zijn het meest uitgesproken in de eerste 24 uur na een acuut herseninfarct. 
De bloeddruk neemt aanzienlijk af bij 13% en aanzienlijk toe bij 20% van de patiënten. Deze 
orthostatische bloeddruk toename (hypertensie) was onafhankelijk geassocieerd met een 
gunstig herstel van het herseninfarct. Het percentage patiënten met orthostatische afname 
(hypotensie) was niet anders dan gemeten bij gezonde en hypertensieve ouderen. Daarom 
concluderen wij dat onze resultaten geen contra-indicatie vormen voor het opstarten van 
vroege mobilisatie bij patiënten met een acuut herseninfarct. De wisselligging op de stroke 
unit gaf verrassende bloeddrukvariaties, die grotendeels op hydrostatische veranderingen 
terug te voeren zijn. Met intra-arteriële metingen met hoogtecorrectie bij ernstig zieke 
patiënten op de intensive care werden deze verschillen inderdaad fors teruggebracht. De 
lagere bloeddruk in de onderliggende linker arm bij patiënten met een acuut herseninfarct 
verdient verdere aandacht. Mogelijk dat er een anatomische verklaring bij deze patiënten 
gevonden kan worden. 
In zekere zin zijn onze bevindingen geruststellend en vormen zij geen ondersteuning 
voor het standaard invoeren van houdingsgerelateerde bloeddrukmetingen op de stroke 
unit of voorwaarden alvorens met vroege mobilisatie te starten. Anderzijds is de associatie 
tussen orthostatische hypertensie en een goed herstel na een herseninfarct mogelijk 
een indicatie dat het kwetsbare herstellende hersenweefsel (penumbra) voordeel heeft 
bij een ‘hyperdynamisch’ cardiovasculair systeem in de acute fase. De hierbij betrokken 
autonome of fysiologische mechanismen zijn nog niet opgehelderd. Ook de interactie tussen 
orthostatische hypertensie en een gestoorde autoregulatie van de hersenen is onduidelijk 
en verdient verder onderzoek. Dergelijke onderzoeken vergroten niet alleen onze kennis over 
de fysiologische veranderingen en aanpassingen in de (sub)acute fase na een herseninfarct, 
maar kunnen ook moeilijke beslissingen sturen met betrekking tot vroege mobilisatie, 
rehydratie en aanpassingen van de medicatie (met name van antihypertensiva).
Wat zijn de effecten van in-bed-mobilisatie op de doorbloeding van de hersenen en de 
neurologische status in de acute fase na een herseninfarct?
Er is weinig bekend over de invloed van de verschillende lichaamshoudingen op de 
doorbloeding van de hersenen in de acute fase na een herseninfarct. Wij onderzochten of 
de doorbloedingssnelheid significant afneemt bij rechtop zitten in bed en relateerden dit 
aan eventuele veranderingen in de neurologische status tijdens de meting, de uitkomst na 
drie maanden en de dynamische autoregulatie status. Tijdens rechtop zitten werd geen 
neurologische verslechtering of verbetering vastgesteld en daalde de doorbloedingssnelheid 
gemiddeld bij patiënten met een acuut herseninfarct niet meer dan bij gezonde controles. 
De dynamische autoregulatie was voor beide hersenhelften gestoord bij de patiënten 
in de acute fase. We concluderen dat de zittende positie bij licht tot matig aangedane 
c e r e b r a l  h e m o d y n a m i c s  i n  s t r o k e  a n d  t r a u m a t i c  b r a i n  i n j u r y  185
patiënten met een herseninfarct veilig is tijdens de eerste drie dagen op de stroke unit, 
ondanks een gestoorde autoregulatie. Onze resultaten geven aan dat de zittende positie 
goed verdragen wordt bij patiënten die gezien hun neurologische beperking en algemene 
conditie momenteel al redelijk snel in deze positie gebracht worden door de verpleging. 
De hydrostatische verandering wordt bij zitten blijkbaar voldoende gecompenseerd door 
een (tijdelijke) ‘hyperdynamische’ cardiovasculair systeem, een adequate intracraniële druk 
reductie, een toegenomen veneuze afvloed of een combinatie van deze factoren.  
Het herhalen van deze metingen tot meerdere dagen na het herseninfarct kan interessant 
zijn, aangezien de genoemde fysiologische compensatiemechanismen uitgeput kunnen raken 
en er aanwijzingen zijn dat de autoregulatie nog verder kan verslechteren na de subacute 
fase. Onze resultaten gelden niet voor het mobiliseren van patiënten van de zittende naar de 
staande positie omdat dit andere (waarschijnlijk grotere) hemodynamische veranderingen 
geeft. Bij gebrek aan resultaten uit lopend (gerandomiseerd) onderzoek aangaande de voor- 
en nadelen van vroege mobilisatie bij patiënten met een acuut herseninfarct, stellen wij 
voor bij milde tot matig aangedane patiënten het rechtop zitten niet te beperken in de (sub)
acute fase. Verder stellen wij voor om met continue doorbloedingssnelheidmetingen (TCD) 
de veiligheid van de staande positie te testen in de nabije toekomst.  
Kan de bewaking van patiënten met een acuut herseninfarct of traumatisch 
schedelhersenletsel verbeterd worden door inzet van autoregulatie/vasoregulatie 
monitoring? 
De NIRS-afgeleide regionale zuurstofvoorziening (rSO2) in de hersenen is theoretisch 
verbonden met meerdere variabelen die de verhouding tussen levering en verbruik van 
zuurstof in de hersenen aangeven. De op NIRS gebaseerde autoregulatie bewaking heeft 
verschillende voordelen. De techniek is niet-invasief en vereist geen precieze focus op 
hersenvaten of continue correctie door verschuiving van het meetinstrument. De techniek 
is vooralsnog zeer beperkt onderzocht bij patiënten met een acuut herseninfarct. In onze 
studie bij 9 patiënten met een herseninfarct werden bijna alle (96%) nachtelijke perifere 
zuurstof desaturaties gevolgd door een significante afname van het rSO2 signaal. Ook 
grote bloeddrukdalingen werden significant vaker opgepikt door de NIRS in de aangedane 
hersenhelft dan in de niet-aangedane hersenhelft. Nachtelijke rSO2 dalingen kwamen 
tweemaal zo vaak voor in de door het herseninfarct getroffen hersenhelft. Deze bevindingen 
maken NIRS een aantrekkelijke techniek voor de (nachtelijke) bewaking van kwetsbaar 
hersenweefsel op de stroke unit. 
De overleving na een ernstig schedelhersenletsel is mede afhankelijk van de beheersing 
van de oplopende intracraniële druk en het waarborgen van een adequate doorbloedingsdruk 
in de hersenen. Therapieën zijn erop gericht om voldoende doorbloeding in het gezwollen 
en gekneusde hersenweefsel te bereiken. Er bestaan diverse methoden om de doorbloeding 
(druk) te bepalen maar momenteel ontbreken individuele grenswaarden bij patiënten met 
ernstig schedelhersenletsel. Met TCD kan een goede schatting van de hersendoorbloeding en 
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de daaraan gekoppelde intracraniële druk gemaakt worden, maar voor langdurige bewaking is 
er behoefte aan een meer continue en derhalve gevoeligere methode om aanvullende schade 
door zwelling en zuurstoftekort van het omgevende weefsel te voorkomen. In hoofdstuk 
11 hebben wij een methode doorontwikkeld die het mogelijk maakt om automatisch een 
‘optimale’ doorbloedingsdruk te berekenen door het vervolgen (4 uur) van de vasoreactiviteit 
van de hersenvaten. We concluderen dat bij de behandeling geen vaste grenzen voor 
de doorbloedingsdruk moeten worden aangehouden maar dat het niveau op basis van 
fysiologische veranderingen in de hersenen moet worden aangepast. Onze nieuwe methode 
werd gevalideerd aan de hand van de gevonden relatie tussen de uitkomst na 6 maanden en 
het verschil tussen de berekende ‘optimale’ en werkelijke doorbloedingsdrukwaarde.   
Aan de hand van welke fysiologische parameter het beleid bij ernstig schedelhersenletsel 
patiënten moet worden aangepast is onderwerp van veel (wetenschappelijke) discussie. 
De voordelen van het gebruik van de vasoreactiviteitsmethode PRx (met bloeddruk en 
intracraniële druk als variabelen) is tweeledig. In tegenstelling tot de niet-invasieve TCD 
methode zijn de bloeddruk en intracraniële druk robuuste signalen die over lange tijd 
betrouwbare berekeningen geven. Met het huidige TCD bevestigingssysteem is bewaking 
van de doorbloeding (snelheid) gedurende een langere periode niet betrouwbaar. Zelfs 
in gesedeerde patiënten is een intermitterende meting van het TCD signaal het hoogst 
haalbare. In tegenstelling tot andere invasieve parameters zoals de lokale zuurstofspanning 
(‘partial pressure of oxygen in brain tissue’; PbTO2) metingen en analyse van metabolieten in 
het hersenvocht (microdialyse), is de intracraniële druk parameter minder gevoelig voor de 
locatie van de meting. Dit alles neemt niet weg dat verdere (prospectieve) studies nodig zijn 
om onze hypothese te ondersteunen dat een behandeling met een individueel berekende 
‘optimale’ doorbloedingsdruk gunstig is voor herstel van een ernstig hersentrauma. Definitief 
bewijs zal mogelijk volgen uit een goed opgezette prospectieve studie met gebruik van de 
reactiviteit van de hersenvaten (PRx). De door ons ontwikkelde automatische methode 
vormt een belangrijke voorwaarde voor de opzet van een dergelijke studie.
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der Hoeven), de afdeling Neurochirurgie (professor Groen, dr Van Dijk) en the department of 
Clinical Neurosciences Cambridge (Professor Pickard en Professor Menon) hiervoor bedanken. 
With preparing manuscripts or letters, I received many valuable comments of experienced 
researchers whom I would like to thank: Ken Brady, Peter Hutchinson, Angelos Kolias, Luzius 
Steiner, Andrea Lavinio, David Menon, John Pickard and Danila Radolovich. 
Het onderhouden van vriendschappen is niet gemakkelijk. Zeker niet als je dichter bij de 
Noordpool woont dan anderen. Maar ondanks fijne neurologie collegae, meegereisde 
huisdieren (Joris), (oud) UMCG fietsvrienden en fijne buren zijn bijeenkomsten met oud 
studiegenoten uit Boxtel en Nijmegen, Ferus Ebrius reünies, bezoekjes aan mijn H.H.D. 
huisgenoten, het jaarlijkse Meerssen fietsevent (familie Saris en spinning docters), vrienden 
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uit België (Dirk Bosmans en Jan Versijpt) en vrienden op leeftijd (Harry en Mariette Wegdam, 
Albert Lemmens) altijd weer een feest. Speciale gelegenheden zijn de weekenden met het 
culinair genootschap (Jack, Uriel, Chris, Stefan en Martijn) en het weerzien met de mannen 
van S.E.M.E.N (Teun, Edwin, Chris, Robert Jan en Daan).     
Mijn pa en ma wil ik hartelijk danken voor de eeuwige steun op vele vlakken. Voor deze 
promotie beperkte zich dit niet enkel tot interesse, bezoekjes of complimenten, maar ook tot 
serieuze bemoeienis met het invliegen van het Brabants kerkkoor als de ideale controlegroep 
voor één van de studies met collectief ‘informed consent’. 
Ook de schoonfamilie Joosten vormt al jaren een belangrijke rots in de branding. Ook jullie 
deuren staan altijd wagenwijd open, en daarachter schuilt immer gezelligheid! Ook familie op 
afstand ben ik dankbaar. De familie McCulloch (Stephen, Paul en Edna) konden mijn geklungel 
met figuren, Excel en Engels vocabulaire niet lang konden aanzien en grepen in. Many thanks!       
Myriam, het is fijn om mijn oudere en wijze zus als paranimf naast me te hebben staan. Door de 
jaren heen zijn al heel wat hulplijnen vanuit Brabant gebruikt! De intrigerende vraag wie van ons 
nu de échte Aries is (…of produceert) blijft er een voor de toekomst…. Ik heb wel zo een vermoeden. 
Lieve kleine Sarah, ook jij bent fan van Giraffes. Hopelijk wil ook jij papa’s boekje bekijken, 
beknagen en later hopelijk lezen. Daarom speciaal voor jou nog een beetje aangepaste 
‘literatuur’: 
Dikkertje Dap klom van de trap,
met een griezelig grote stap, 
Op de nek van de Giraf, 
zette Dikkertje Dap zich af, 
Roetsjj daar gleed hij met een vaart, 
Tot aan ’t kwastje van de staart, Boem! Au!! 
Dag Giraf, zei Dikkertje Dap, 
Morgen kom ik weer hier met de trap.
(Dikkertje Dap, Annie M.G. Schmidt)
Lieve Hanneke, al jaren zijn wij heel gelukkig bij elkaar! Stef vat ‘ons’ heel mooi samen:
En jouw armen zijn een haven
En jouw handen zijn een zegen
En al sta ik hier alleen
Ik draag jou altijd met mij mee
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Marinus Johannes Hermanus Aries was born on March 9th 1979 in Boxtel, The Netherlands. 
He completed his secondary education at Jacob Roelandscollege, Boxtel in 1997. After one 
year of veterinarian medicine in Gent, Belgium, he went on to medical school at the Radboud 
University Nijmegen in 1998. At the Institute of Pathology in Nijmegen (Professor Ruiter), 
Marcel performed a scientific research  on ‘cMET expression in different stages of prostate 
cancer’. He conducted this research in combination with the function of editor in chief of 
the Dutch Medical Journal student-edition (Amsterdam) and associate editor of studentBMJ 
(London). At the same time he was involved in writing a textbook on radiology. He obtained 
his doctoral degree in 2003. After clinical elective in Kazan, Republic of Tatarstan (Russia), 
he continued regular residencies in the Netherlands and Nottingham (United Kingdom). He 
completed his final residency in Techiman, Ghana (dr Wegdam). After graduating in 2005, 
Marcel started his training as a neurological resident at the department of Neurology of the 
University Medical Center Groningen (Professor Kremer), having spent six months of that 
time in Antwerp, Belgium (Professor De Deyn). In 2007, he obtained a ‘AGIKO’ research grant 
of the Netherlands Organization for Health Research and Development (ZonMw) to study 
the effect of body positions on physiological parameters and cerebral blood flow in acute 
stroke patients (promoters: Professor De Keyser; Professor Kremer). In 2010, he received 
a travel research grant from the European Federation of Neurological Societies to study 
cerebrovascular reactivity in severe traumatic brain injury patients at the Department of 
Clinical Neurosciences, Addenbrooke’s hospital in Cambridge, UK (Professor Pickard). After 
completing his neurological training, he started in November 2012 as a clinical fellow at the 
Critical Care Department in Groningen. Marcel is married to Hanneke and the father of Sarah. 
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zijn gymnasium schoolopleiding in 1997 aan het Jacob Roelandscollege in Boxtel. Na één 
jaar diergeneeskundestudie in Gent, België, begon hij in 1998 met de studie geneeskunde 
aan de Radboud Universiteit Nijmegen. Marcel verrichtte wetenschappelijk onderzoek bij 
de afdeling Pathologie in Nijmegen (Professor Ruiter) op het onderwerp ‘cMET expressie 
bij verschillende stadia van prostaatkanker’. Dit onderzoek combineerde hij met de functie 
van hoofdredacteur van het Nederlands Tijdschrift voor Geneeskunde studenteneditie 
(Amsterdam) en redacteur van de studentBMJ (Londen). Hij was betrokken als redacteur bij 
een radiologie leerboek. Marcel behaalde zijn doctoraalexamen in 2003. Na een klinische 
keuzestage in Kazan, Republiek Tatarstan (Rusland), volgde hij zijn reguliere coschappen in 
Nederland en Nottingham (Verenigd Koninkrijk). Zijn laatste coschap deed hij in Techiman, 
Ghana (dr Wegdam). In 2005 kreeg Marcel zijn artsenbul, waarna hij begon met zijn opleiding 
tot neuroloog aan de afdeling Neurologie van het Universitair Medisch Centrum Groningen 
(UMCG) (Professor Kremer). Hij volgde 6 maanden van zijn opleiding in Antwerpen, België 
(Professor De Deyn). In 2007 kreeg hij een ‘AGIKO’ subsidie van de Nederland Organisatie 
voor gezondheidsonderzoek en zorginnovatie (ZonMw) toegewezen om het effect van 
lichaamspositie op fysiologische parameters en cerebrale bloeddoorstroming bij patiënten 
met een acuut herseninfarct te bestuderen (promotors: Professor De Keyser; Professor 
Kremer). In 2010 ontving hij een reis onderzoekssubsidie van de ‘Europese Federatie 
van Neurologische Verenigingen’ om de cerebrovasculaire reactiviteit in patiënten met 
ernstig traumatisch schedelhersenletsel op de afdeling Klinische Neurowetenschappen, 
Addenbrooke’s ziekenhuis in Cambridge, UK (Professor Pickard) te bestuderen. Na zijn 
neurologische training, begon hij in november 2012 als klinische fellow op de afdeling 
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